data_1kd6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kd6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.563 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 18' ' ' ILE . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 20' ' ' LYS . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.787 ' H ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.675 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HA ' HG22 ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.803 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.731 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HB3' HG12 ' A' ' 87' ' ' VAL . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 77' ' ' LYS . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' N ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.803 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.628 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 85.7 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.597 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 53' ' ' ARG . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.849 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' HE1' HD11 ' A' ' 90' ' ' LEU . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 94' ' ' MET . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.432 ' N ' HD11 ' A' ' 93' ' ' LEU . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 121' ' ' ILE . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.849 ' HB ' HD23 ' A' ' 90' ' ' LEU . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.682 ' HE1' HG11 ' A' ' 106' ' ' VAL . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.682 HG11 ' HE1' ' A' ' 104' ' ' PHE . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.802 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.573 ' HB3' ' HE2' ' A' ' 132' ' ' MET . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.902 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.5 m120 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.768 HG21 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.799 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.768 ' HG2' HG21 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.518 ' HE3' ' CE2' ' A' ' 104' ' ' PHE . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.405 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.723 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 13' ' ' SER . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' HB1' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.008 HD23 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.468 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 26' ' ' LEU . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.856 ' HZ1' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 104' ' ' PHE . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 35' ' ' VAL . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.763 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HE3' ' HE2' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.798 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 60' ' ' VAL . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.556 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.824 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.784 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.441 ' HA ' HG23 ' A' ' 50' ' ' THR . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.61 ' HG2' HD23 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.763 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.008 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 ' HG2' ' A' ' 62' ' ' PRO . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.767 HD11 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.824 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.822 ' HB2' HD21 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.48 ' HH ' HD12 ' A' ' 71' ' ' LEU . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.541 ' HE2' ' HE3' ' A' ' 43' ' ' LYS . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.655 ' HB ' HD23 ' A' ' 90' ' ' LEU . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.634 ' CE1' HG12 ' A' ' 102' ' ' VAL . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.728 0.299 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 166' ' ' SER . 3.7 m120 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.626 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.506 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.588 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.588 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 1.013 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.816 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.013 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.506 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 . . . . . 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.858 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.858 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.2 m120 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.604 ' HB2' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.439 ' N ' HD13 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.858 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.676 ' H ' HD21 ' A' ' 158' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 1.069 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.791 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.53 ' HB2' HD12 ' A' ' 172' ' ' LEU . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.547 ' HB3' HG12 ' A' ' 171' ' ' ILE . 17.3 t30 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 1.02 ' HB3' HD12 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.547 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 174' ' ' ILE . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.599 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 1.069 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.665 ' HA2' ' HB1' ' A' ' 70' ' ' ALA . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.838 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.437 ' HB2' HD13 ' A' ' 18' ' ' ILE . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.691 ' HB2' HD11 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.905 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.502 ' N ' HG13 ' A' ' 35' ' ' VAL . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.466 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 59' ' ' ILE . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.497 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.838 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.905 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 84' ' ' THR . 51.7 tttm . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.431 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' CD2' ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 47' ' ' ALA . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.819 ' HG ' HD11 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.587 HG12 ' CE1' ' A' ' 104' ' ' PHE . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.7 HD12 HG23 ' A' ' 89' ' ' VAL . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG12 ' A' ' 102' ' ' VAL . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.228 -0.075 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.874 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.911 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.549 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.549 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 140' ' ' LEU . 35.4 m-85 . . . . . 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 133' ' ' TYR . 5.0 mp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.45 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.874 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.489 ' CZ ' ' HE1' ' A' ' 150' ' ' HIS . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' PHE . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.6 m120 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.972 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.495 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.6 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.911 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.481 ' HB2' HD22 ' A' ' 154' ' ' LEU . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.624 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.452 ' HB2' HD13 ' A' ' 172' ' ' LEU . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.787 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.787 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 104' ' ' PHE . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.472 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.624 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.69 HG12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.69 HD12 HG12 ' A' ' 9' ' ' ILE . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 18' ' ' ILE . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.727 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.807 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD22 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.701 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HB2' HG13 ' A' ' 87' ' ' VAL . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.807 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.639 ' HH ' ' HB2' ' A' ' 58' ' ' ASP . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 1.113 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 1.113 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 53' ' ' ARG . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 1.022 HG22 ' HE3' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.457 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 94' ' ' MET . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.728 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.972 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.565 ' HG ' ' HE3' ' A' ' 116' ' ' TRP . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.533 ' HG2' ' H ' ' A' ' 114' ' ' SER . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.75 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 71.2 t80 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.533 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 41.1 m . . . . . 0 C--O 1.222 -0.374 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.588 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.565 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 11.4 t30 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG13 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.414 ' O ' ' HE1' ' A' ' 132' ' ' MET . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.022 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.6 t80 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.597 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.597 ' HD3' ' H ' ' A' ' 141' ' ' SER . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 1.026 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.873 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.816 ' H ' HD21 ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.538 ' HZ3' ' HB2' ' A' ' 159' ' ' LYS . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 151' ' ' THR . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 1.026 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.904 ' HG3' HD21 ' A' ' 172' ' ' LEU . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.66 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.543 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.667 ' HB3' HD22 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.66 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.972 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 158' ' ' LEU . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD23 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 18' ' ' ILE . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' HB3' ' A' ' 169' ' ' HIS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.88 HD13 ' HZ2' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.845 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.845 ' H ' HG23 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.88 ' HZ2' HD13 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.788 HD12 ' HZ3' ' A' ' 77' ' ' LYS . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.636 ' OD1' HD23 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.677 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 41' ' ' SER . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.819 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG22 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.748 HD13 ' HH ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.403 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 71' ' ' LEU . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.467 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.732 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.765 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.788 ' HZ3' HD12 ' A' ' 33' ' ' ILE . 9.3 mptt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.617 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.764 HG21 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 102' ' ' VAL . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HB1' HG23 ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.748 ' HH ' HD13 ' A' ' 61' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.548 HD11 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.548 ' N ' HD11 ' A' ' 93' ' ' LEU . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.581 HD12 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 90' ' ' LEU . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.764 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HD21 ' A' ' 172' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 106' ' ' VAL . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.631 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.67 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.48 HG12 HG12 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.662 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 126' ' ' ARG . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 124' ' ' GLY . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.506 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.463 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.67 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.539 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.3 m120 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.426 ' HD1' ' HE2' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.775 HG21 ' HB3' ' A' ' 161' ' ' ARG . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.885 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.518 ' HG2' ' CG2' ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.775 ' HB3' HG21 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.581 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.603 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.458 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.51 ' HB3' HD13 ' A' ' 23' ' ' LEU . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 19' ' ' LEU . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 104' ' ' PHE . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.533 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.885 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.658 HG12 HD12 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 9' ' ' ILE . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.599 ' H ' HG23 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.599 HG23 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.691 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 HG21 ' HZ3' ' A' ' 32' ' ' LYS . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.691 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.775 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.909 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.621 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.404 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.638 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' ARG . 11.6 p-10 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.422 ' CB ' HD12 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.67 ' HD3' HG13 ' A' ' 87' ' ' VAL . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 58' ' ' ASP . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 59' ' ' ILE . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.909 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.67 HG13 ' HD3' ' A' ' 53' ' ' ARG . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.59 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.434 ' HH ' ' HB3' ' A' ' 61' ' ' LEU . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.537 ' HE1' HD12 ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' HE1' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.59 ' HE1' HD21 ' A' ' 90' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.563 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.84 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.715 ' HZ2' ' HD2' ' A' ' 150' ' ' HIS . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.819 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.633 HG23 ' HZ3' ' A' ' 117' ' ' TRP . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.441 ' HA ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.589 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.544 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.496 ' HG2' ' HB3' ' A' ' 128' ' ' ALA . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.84 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.2 m120 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.715 ' HD2' ' HZ2' ' A' ' 117' ' ' TRP . 67.8 t60 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.491 HD11 ' H ' ' A' ' 156' ' ' TYR . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.553 ' HB2' HD13 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 151' ' ' THR . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.608 ' HB3' HG21 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.598 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.483 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.787 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.775 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 174' ' ' ILE . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 172' ' ' LEU . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.892 HD11 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.546 ' H ' HG21 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' H ' ' A' ' 15' ' ' SER . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 23' ' ' LEU . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 30' ' ' LYS . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' H ' HG12 ' A' ' 29' ' ' VAL . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.481 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.752 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 127' ' ' ARG . 20.0 p30 -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.728 HG22 HD23 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' CZ ' ' HE2' ' A' ' 73' ' ' TYR . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.755 ' HG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.4 p-10 -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' A' ' 54' ' ' SER . 36.1 p . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.579 ' N ' ' HB3' ' A' ' 54' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD23 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HE1' HD11 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.565 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.845 ' HB ' HD23 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.63 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 . . . . . 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.527 0.203 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.61 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.434 ' HA ' HD22 ' A' ' 49' ' ' ASN . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB3' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.54 ' HE1' ' HB3' ' A' ' 128' ' ' ALA . 38.4 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.847 HD21 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.847 ' HD3' HD21 ' A' ' 140' ' ' LEU . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.444 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.6 m120 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.552 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.486 ' O ' ' HB1' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.844 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.908 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.675 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.675 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.492 HD23 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.631 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG21 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.643 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.813 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.813 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.64 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' HG23 ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' A' ' 67' ' ' HIS . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.823 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' A' ' 63' ' ' HIS . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.542 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.606 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.823 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.504 ' HB3' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.729 ' HB3' ' HE1' ' A' ' 73' ' ' TYR . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.523 ' HG2' HG22 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.646 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.236 0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.727 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.709 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.743 ' HB ' HD22 ' A' ' 90' ' ' LEU . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.734 HD12 ' HH ' ' A' ' 133' ' ' TYR . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.585 ' CE2' HD23 ' A' ' 172' ' ' LEU . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.422 0.153 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.824 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.587 HD12 HD12 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.579 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.734 ' HH ' HD12 ' A' ' 103' ' ' LEU . 9.3 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.837 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.502 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.681 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.2 m120 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.486 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.647 HG22 ' HD3' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.467 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.421 ' HB2' HD13 ' A' ' 121' ' ' ILE . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.547 HD11 ' OG ' ' A' ' 41' ' ' SER . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.746 ' HG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB2' HG21 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.681 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 10.0 t30 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 104' ' ' PHE . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.746 HG12 ' HG ' ' A' ' 160' ' ' SER . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.56 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 14' ' ' LEU . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.423 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 18' ' ' ILE . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.95 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 30' ' ' LYS . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' H ' HG11 ' A' ' 29' ' ' VAL . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.95 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 35' ' ' VAL . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' O ' HD23 ' A' ' 71' ' ' LEU . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.55 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.854 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.727 ' HD2' ' HE1' ' A' ' 94' ' ' MET . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 48' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 50' ' ' THR . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 49' ' ' ASN . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.789 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.732 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.692 ' O ' HG21 ' A' ' 59' ' ' ILE . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.692 HG21 ' O ' ' A' ' 58' ' ' ASP . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 61' ' ' LEU . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.518 ' H ' HG22 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 45' ' ' TRP . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.854 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.603 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.008 0.432 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' OG ' ' A' ' 105' ' ' SER . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.616 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.616 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.727 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.713 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.59 HD21 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.657 ' HZ3' HG12 ' A' ' 119' ' ' VAL . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.657 HG12 ' HZ3' ' A' ' 117' ' ' TRP . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HB3' ' HZ1' ' A' ' 125' ' ' LYS . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HD3' HD22 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.84 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.84 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.726 HD11 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.726 ' HD3' HD11 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 148' ' ' GLY . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 147' ' ' ASN . 0.1 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 146' ' ' ASP . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.656 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 161' ' ' ARG . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.788 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 160' ' ' SER . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.788 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.688 ' HB2' HD22 ' A' ' 154' ' ' LEU . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.529 ' HG2' HG23 ' A' ' 151' ' ' THR . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.59 ' HA ' HD21 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.77 ' HB3' HD22 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 165' ' ' ASN . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 164' ' ' MET . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.515 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.739 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 16.9 t-160 -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.603 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.652 HD11 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.629 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.505 ' HD2' HD13 ' A' ' 171' ' ' ILE . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HB3' HG22 ' A' ' 171' ' ' ILE . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB1' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.776 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.728 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.435 ' ND2' HD21 ' A' ' 71' ' ' LEU . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.529 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.855 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 1.009 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.609 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.009 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.536 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 106' ' ' VAL . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 HG22 HD13 ' A' ' 103' ' ' LEU . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.607 HD13 ' CE2' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.673 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.663 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.628 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.858 HG22 HG11 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.547 ' CE2' HG22 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.671 HG13 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.46 0.042 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.766 HD21 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.858 HG11 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.898 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.46 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.517 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.47 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.428 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.8 m120 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.412 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.893 HG23 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.898 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 41' ' ' SER . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.545 ' HG ' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.893 ' HG2' HG23 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.622 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.598 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.621 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.766 ' HA ' HD21 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.426 ' CG ' HD12 ' A' ' 23' ' ' LEU . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.598 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.404 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.552 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.513 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 20' ' ' LYS . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 34' ' ' ALA . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.648 ' HA2' ' HZ1' ' A' ' 32' ' ' LYS . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.648 ' HZ1' ' HA2' ' A' ' 27' ' ' GLY . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' HG22 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.514 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.542 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.628 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.628 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 63' ' ' HIS . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD22 HD22 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.41 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.614 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG21 ' N ' ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' N ' HG21 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.745 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.815 ' HB2' HD11 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 14' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.412 0.148 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.647 ' HB2' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.718 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.67 HD22 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.504 ' HB2' ' HE2' ' A' ' 94' ' ' MET . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.635 HG23 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 154' ' ' LEU . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.737 HG23 HG11 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HE2' ' HB2' ' A' ' 86' ' ' ALA . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.616 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.457 -0.076 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.569 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.679 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.453 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.645 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HD1' ' HD2' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 160' ' ' SER . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 7.8 p30 -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 100' ' ' LEU . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.593 ' HG3' ' HB3' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.432 ' HB3' ' CG2' ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.499 ' HD2' ' HD1' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.679 ' HE3' ' HB3' ' A' ' 170' ' ' ALA . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.679 ' HB3' ' HE3' ' A' ' 164' ' ' MET . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.808 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.498 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.433 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.23 0.042 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.597 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 18' ' ' ILE . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 34' ' ' ALA . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' HG11 ' A' ' 29' ' ' VAL . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.813 ' HZ3' ' HB2' ' A' ' 32' ' ' LYS . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB3' HD22 ' A' ' 23' ' ' LEU . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.582 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.839 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.64 ' HB ' HD23 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.788 HD11 HD21 ' A' ' 49' ' ' ASN . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.788 HD21 HD11 ' A' ' 48' ' ' LEU . 16.8 p30 -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.527 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.694 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.839 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.521 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB3' ' HA2' ' A' ' 11' ' ' GLY . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 37' ' ' VAL . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.608 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 90' ' ' LEU . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.678 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.64 HD23 ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.835 HG21 HG13 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 33' ' ' ILE . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.84 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.835 HG13 HG21 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.823 ' HD3' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 132' ' ' MET . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.835 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.7 m120 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 161' ' ' ARG . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.3 m120 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.801 HD13 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.769 ' HZ3' ' HB1' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 151' ' ' THR . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.784 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.703 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.84 ' HE3' ' HB3' ' A' ' 115' ' ' ASN . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.619 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.505 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.742 ' HB ' HD21 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.784 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.801 ' HA ' HD13 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.769 ' HB1' ' HZ3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.626 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.686 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.686 HD23 ' HA2' ' A' ' 11' ' ' GLY . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 19' ' ' LEU . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.904 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.677 ' HB3' ' HZ1' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 30' ' ' LYS . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.677 ' HZ1' ' HB3' ' A' ' 26' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.906 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.709 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 61' ' ' LEU . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 HD22 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.525 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.579 ' HG2' ' HH ' ' A' ' 92' ' ' TYR . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.709 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.906 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.506 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 103' ' ' LEU . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HH ' ' HG2' ' A' ' 62' ' ' PRO . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.542 HD22 HD21 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.696 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.519 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.545 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.712 ' HB ' HD21 ' A' ' 90' ' ' LEU . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.517 ' CE1' HG13 ' A' ' 102' ' ' VAL . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.938 HD13 HD21 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.601 ' HB3' ' HE3' ' A' ' 132' ' ' MET . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 130' ' ' GLN . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.784 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 2.8 pp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 140' ' ' LEU . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.796 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.4 m120 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.574 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.774 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.938 HD21 HD13 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' HB1' ' A' ' 179' ' ' ALA . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.774 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.934 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.792 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.792 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.866 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HE1' ' A' ' 164' ' ' MET . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.904 ' HB ' HD23 ' A' ' 19' ' ' LEU . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.539 HD13 ' SD ' ' A' ' 164' ' ' MET . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.934 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.451 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 23.2 m170 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 70' ' ' ALA . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.644 HD12 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 31' ' ' ARG . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.644 ' HG3' HD12 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.587 HG23 HG22 ' A' ' 35' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.938 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.406 ' HG ' ' HG ' ' A' ' 158' ' ' LEU . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD13 HD23 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 127' ' ' ARG . 21.7 p30 -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.736 ' HG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.574 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.769 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' OH ' ' A' ' 73' ' ' TYR . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.472 ' H ' ' CD1' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.938 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.736 ' HB ' ' HG ' ' A' ' 54' ' ' SER . 2.0 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 106' ' ' VAL . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 1.033 HG21 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.511 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.588 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.478 HG23 HD21 ' A' ' 48' ' ' LEU . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.77 HG13 HG13 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 1.033 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.491 0.186 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.715 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.799 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.77 HG13 HG13 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HA ' HD22 ' A' ' 49' ' ' ASN . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.507 ' HD2' ' HG ' ' A' ' 140' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.456 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.507 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 5.4 m120 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.887 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.715 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.772 HG21 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.723 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 1.7 t-20 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' HD13 ' A' ' 121' ' ' ILE . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.723 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 151' ' ' THR . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.772 ' HG3' HG21 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.887 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.469 ' HE1' ' O ' ' A' ' 105' ' ' SER . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 106' ' ' VAL . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.823 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 165' ' ' ASN . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.736 HD21 HG23 ' A' ' 35' ' ' VAL . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.535 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.623 HD12 ' HB1' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 34' ' ' ALA . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.961 HD11 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HD3' HD11 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 23' ' ' LEU . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.464 ' HA ' HG21 ' A' ' 176' ' ' VAL . 55.4 m-80 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.719 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 63' ' ' HIS . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.504 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.47 ' HB2' HG23 ' A' ' 46' ' ' THR . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.719 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.864 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HH ' ' HB2' ' A' ' 61' ' ' LEU . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.688 ' HB3' ' HZ2' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HD3' ' CD2' ' A' ' 108' ' ' TYR . 28.9 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 1.9 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.785 HD23 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.682 ' HE1' HD13 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.724 HD13 HD12 ' A' ' 154' ' ' LEU . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.706 ' CE2' HG12 ' A' ' 102' ' ' VAL . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.503 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.585 ' CD1' ' HA ' ' A' ' 144' ' ' ARG . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.466 HG11 HG13 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.657 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.436 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.497 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.699 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.585 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.7 m120 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.609 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.724 HD12 HD13 ' A' ' 100' ' ' LEU . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.726 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.706 ' HB2' HD11 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.582 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.662 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.864 HD12 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG21 ' HG3' ' A' ' 76' ' ' GLN . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.771 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.723 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 93' ' ' LEU . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 50' ' ' THR . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 49' ' ' ASN . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.639 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.771 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 8.1 t-160 -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 67' ' ' HIS . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 29' ' ' VAL . 7.7 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.819 ' HZ3' ' HA2' ' A' ' 85' ' ' GLY . 23.4 ttmm . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.819 ' HA2' ' HZ3' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.794 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.761 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.691 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.563 HD13 HD13 ' A' ' 154' ' ' LEU . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 90' ' ' LEU . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.739 HD12 ' HE3' ' A' ' 132' ' ' MET . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 102' ' ' VAL . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.409 ' HD1' ' HZ2' ' A' ' 77' ' ' LYS . 55.7 t80 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 170' ' ' ALA . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.712 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.856 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.529 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 103' ' ' LEU . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.586 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.857 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.1 m120 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.856 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.665 HD12 HG13 ' A' ' 176' ' ' VAL . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.816 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.703 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.636 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' A' ' 167' ' ' SER . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 166' ' ' SER . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.77 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 115' ' ' ASN . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.845 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.873 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.816 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.665 HG13 HD12 ' A' ' 154' ' ' LEU . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.893 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.458 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD21 ' HA2' ' A' ' 11' ' ' GLY . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.583 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.6 ' H ' HG21 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.816 HD21 HG11 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.508 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HD2' ' HE1' ' A' ' 94' ' ' MET . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.597 ' HD2' ' HG2' ' A' ' 64' ' ' LYS . 27.4 p-80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.597 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.816 HG11 HD21 ' A' ' 39' ' ' ASN . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.839 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.601 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.44 ' OE1' HG13 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.536 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.241 0.067 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.74 HG21 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD22 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.684 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.656 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD22 ' A' ' 90' ' ' LEU . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.74 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 33' ' ' ILE . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.618 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.753 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.592 HG11 HG13 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.72 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.44 ' HG2' HH11 ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.72 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.402 ' HB2' ' CE ' ' A' ' 132' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.546 0.213 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.753 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.478 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.6 m120 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' HD2' HD11 ' A' ' 174' ' ' ILE . 83.9 t60 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.519 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 160' ' ' SER . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.508 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.991 HD13 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.858 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.519 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.515 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.535 HD22 HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.584 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.858 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.991 ' HA ' HD13 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' HG21 ' A' ' 18' ' ' ILE . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.68 HD12 ' HB1' ' A' ' 34' ' ' ALA . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 30' ' ' LYS . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' H ' HG12 ' A' ' 29' ' ' VAL . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.671 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.458 ' OG ' HD23 ' A' ' 158' ' ' LEU . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.672 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.4 HD21 ' HG ' ' A' ' 48' ' ' LEU . 15.4 p30 -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' N ' HG21 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.834 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.537 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.568 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 48' ' ' LEU . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' CD2' ' HA ' ' A' ' 47' ' ' ALA . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.547 ' HE1' HD11 ' A' ' 100' ' ' LEU . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.547 HD11 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 t80 . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.783 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.727 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.785 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.649 ' HZ3' ' HB2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.621 ' HG3' ' H ' ' A' ' 133' ' ' TYR . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.621 ' H ' ' HG3' ' A' ' 132' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.729 ' H ' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.603 HG22 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.484 HD11 HG22 ' A' ' 176' ' ' VAL . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.458 HD23 ' OG ' ' A' ' 41' ' ' SER . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.81 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.603 ' HG3' HG22 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.783 ' HE3' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.629 ' ND2' HG13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.755 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.629 HG13 ' ND2' ' A' ' 165' ' ' ASN . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 164' ' ' MET . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.663 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.596 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.538 ' HB3' HD13 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.764 HD12 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' ILE . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 171' ' ' ILE . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HZ3' ' A' ' 77' ' ' LYS . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.808 ' HB3' HD22 ' A' ' 23' ' ' LEU . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.744 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.72 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' HD11 ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.504 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.565 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.476 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 14' ' ' LEU . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 72' ' ' LEU . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.744 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.655 ' HZ3' HG12 ' A' ' 29' ' ' VAL . 60.4 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.003 0.43 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.584 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.72 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.584 ' HB ' HD23 ' A' ' 90' ' ' LEU . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE2' HD23 ' A' ' 90' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.665 ' HG2' ' H ' ' A' ' 114' ' ' SER . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.478 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' SER . 6.5 m120 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.776 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.766 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 HG11 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.755 ' HD2' ' HB3' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.755 ' HB3' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.836 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.722 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.844 ' H ' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.788 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.764 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.776 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 158' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.651 ' H ' HD13 ' A' ' 158' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 151' ' ' THR . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.973 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.764 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.635 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.537 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 15.7 p30 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.556 HD11 ' HE3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.973 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 14.1 m170 -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 9' ' ' ILE . 10.2 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.642 0.258 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' HD13 ' A' ' 18' ' ' ILE . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 ' HB2' ' A' ' 15' ' ' SER . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB3' ' A' ' 32' ' ' LYS . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.92 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.772 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.495 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.91 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.665 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 HG23 ' A' ' 99' ' ' THR . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.668 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.841 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.91 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.841 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 43.0 tttm . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 1.043 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE2' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.665 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.853 HG23 HD22 ' A' ' 48' ' ' LEU . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.792 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 90' ' ' LEU . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 1.043 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 106' ' ' VAL . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.554 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 . . . . . 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.768 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.619 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.0 t30 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.792 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.652 ' H ' ' HD2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.768 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.432 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.817 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.625 HD11 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.771 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.644 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.817 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.859 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.699 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.41 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.71 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 171' ' ' ILE . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 19' ' ' LEU . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.859 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 160' ' ' SER . 42.0 m170 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 176' ' ' VAL . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' HD11 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.67 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.51 -56.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -82.25 50.19 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.118 0.485 . . . . 0.0 111.694 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.26 137.37 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.505 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.02 44.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.885 0.374 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 42.3 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.616 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 44.87 1.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.409 . . . . 0.0 111.25 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.01 142.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.563 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 18' ' ' ILE . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.757 ' HZ2' ' HB3' ' A' ' 20' ' ' LYS . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.787 ' H ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.675 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HA ' HG22 ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.803 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.731 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HB3' HG12 ' A' ' 87' ' ' VAL . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.575 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 78' ' ' ASP . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' N ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.803 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.628 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 85.7 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.687 ' HD3' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 52.64 175.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' N ' ' HA2' ' A' ' 55' ' ' GLY . 17.3 p-10 -69.77 -45.74 67.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.687 ' N ' ' HD3' ' A' ' 77' ' ' LYS . 21.4 tpt180 72.86 -46.93 0.66 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.374 1.07 . . . . 0.0 112.6 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.05 -61.91 6.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.156 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.53 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.323 2.682 . . . . 0.0 114.368 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' CG2' ' H ' ' A' ' 83' ' ' ALA . 5.3 p -77.55 -173.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.527 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' H ' ' CG2' ' A' ' 82' ' ' VAL . . . -78.38 114.48 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -153.51 138.0 16.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.848 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.597 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 53' ' ' ARG . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.849 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' HE1' HD11 ' A' ' 90' ' ' LEU . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 94' ' ' MET . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.432 ' N ' HD11 ' A' ' 93' ' ' LEU . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 121' ' ' ILE . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.849 ' HB ' HD23 ' A' ' 90' ' ' LEU . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.682 ' HE1' HG11 ' A' ' 106' ' ' VAL . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.682 HG11 ' HE1' ' A' ' 104' ' ' PHE . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -84.26 40.12 0.75 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -163.51 138.25 6.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -85.98 120.19 27.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -160.76 -131.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -87.68 -31.67 19.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.007 0.432 . . . . 0.0 111.08 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.45 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 12.5 m-85 -58.53 148.21 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.24 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -134.8 -179.89 5.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.802 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.573 ' HB3' ' HE2' ' A' ' 132' ' ' MET . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.875 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.617 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 5.0 m-85 -84.67 -38.46 19.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.94 -179.4 3.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 56.8 -56.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.137 1.775 . . . . 0.0 114.593 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.66 128.14 36.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -78.34 40.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.773 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -101.11 -41.62 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.753 0.311 . . . . 0.0 111.275 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.617 ' ND2' ' HA ' ' A' ' 133' ' ' TYR . 10.4 p-10 -128.49 58.78 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.563 0.697 . . . . 0.0 111.591 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.38 70.33 1.36 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.902 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.5 m120 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.768 HG21 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.799 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.768 ' HG2' HG21 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.518 ' HE3' ' CE2' ' A' ' 104' ' ' PHE . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.405 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.723 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 121.47 25.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.048 0.451 . . . . 0.0 111.224 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.91 -49.14 11.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.88 132.63 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.372 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.0 131.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.024 0.828 . . . . 0.0 112.263 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.26 -136.76 4.42 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.38 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.37 135.65 24.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t -78.76 134.63 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 13' ' ' SER . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' HB1' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.008 HD23 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.468 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 26' ' ' LEU . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.856 ' HZ1' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 104' ' ' PHE . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 35' ' ' VAL . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.763 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HE3' ' HE2' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.798 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 60' ' ' VAL . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.556 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.824 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.784 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.441 ' HA ' HG23 ' A' ' 50' ' ' THR . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' HG2' HD23 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.763 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.008 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 ' HG2' ' A' ' 62' ' ' PRO . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.767 HD11 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -80.36 -155.2 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.05 119.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.919 0.888 . . . . 0.0 111.507 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -170.42 -40.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.873 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.09 -63.62 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.619 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.72 140.94 44.06 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.81 2.34 . . . . 0.0 112.069 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.52 19.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.8 0.81 . . . . 0.0 111.085 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.49 41.59 1.47 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.506 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.824 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p -137.51 126.03 23.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.376 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.822 ' HB2' HD21 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.48 ' HH ' HD12 ' A' ' 71' ' ' LEU . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.541 ' HE2' ' HE3' ' A' ' 43' ' ' LYS . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.655 ' HB ' HD23 ' A' ' 90' ' ' LEU . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.634 ' CE1' HG12 ' A' ' 102' ' ' VAL . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 113' ' ' TYR . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -80.96 -170.74 2.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.3 t0 69.6 145.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.146 0.978 . . . . 0.0 111.14 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -84.23 42.03 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.399 0.619 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -114.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -153.49 37.97 0.48 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.111 0.481 . . . . 0.0 111.669 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 48.0 m-85 -81.07 129.02 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -89.88 153.03 20.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.297 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 166' ' ' SER . 3.7 m120 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.626 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.565 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.588 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.588 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 1.013 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.816 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.854 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.013 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.506 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 -126.9 -46.68 1.54 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.753 ' HA ' HD21 ' A' ' 140' ' ' LEU . 9.7 mt-10 -61.68 -27.36 68.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.854 ' HB2' ' HA ' ' A' ' 131' ' ' ARG . 32.1 tt0 -65.49 -41.88 92.76 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.904 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 139' ' ' ASN . 6.2 mp -90.57 130.88 36.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.697 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -64.57 -42.7 95.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.533 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -78.65 -31.72 46.94 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.641 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 5.5 m120 -88.55 44.83 1.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.633 0.254 . . . . 0.0 111.535 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.858 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp -151.54 138.83 19.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.858 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.2 m120 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.604 ' HB2' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.439 ' N ' HD13 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.858 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.676 ' H ' HD21 ' A' ' 158' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 1.069 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.791 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.53 ' HB2' HD12 ' A' ' 172' ' ' LEU . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.547 ' HB3' HG12 ' A' ' 171' ' ' ILE . 17.3 t30 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 1.02 ' HB3' HD12 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.547 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 174' ' ' ILE . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.599 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 1.069 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.396 0.617 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 121.23 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.953 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.64 132.68 41.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t 61.07 61.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.464 0.649 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.43 133.19 15.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.225 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.72 44.19 64.07 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.783 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.46 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.576 0.227 . . . . 0.0 111.156 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.35 137.62 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.665 ' HA2' ' HB1' ' A' ' 70' ' ' ALA . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.838 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HB2' HD13 ' A' ' 18' ' ' ILE . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.691 ' HB2' HD11 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.905 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.502 ' N ' HG13 ' A' ' 35' ' ' VAL . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.466 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.453 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 59' ' ' ILE . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.497 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.838 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.905 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' NZ ' ' HG2' ' A' ' 79' ' ' ARG . 51.7 tttm -100.66 116.15 31.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.07 8.35 43.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' HG2' ' NZ ' ' A' ' 77' ' ' LYS . 77.9 mtm180 72.53 145.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.252 0.621 . . . . 0.0 111.319 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.96 -159.35 12.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.59 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.43 -44.72 4.3 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.88 2.386 . . . . 0.0 112.872 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 m -102.83 137.16 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.271 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.72 113.67 18.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.802 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.431 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -151.06 -176.61 5.61 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' CD2' ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' A' ' 47' ' ' ALA . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.819 ' HG ' HD11 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.587 HG12 ' CE1' ' A' ' 104' ' ' PHE . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.7 HD12 HG23 ' A' ' 89' ' ' VAL . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG12 ' A' ' 102' ' ' VAL . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -93.49 42.43 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -153.25 160.76 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.732 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -120.89 63.05 0.87 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 111.702 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -132.12 -130.93 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.006 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -64.13 -35.05 79.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.618 0.367 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.08 143.64 56.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -147.02 164.23 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.509 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.874 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.849 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.911 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.549 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.549 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 140' ' ' LEU . 35.4 m-85 -131.29 -41.76 1.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HG2' HD23 ' A' ' 140' ' ' LEU . 50.5 mt-10 -73.32 54.35 0.42 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.985 0.421 . . . . 0.0 111.416 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -140.05 -58.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.282 0.563 . . . . 0.0 110.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.725 ' HB2' HD21 ' A' ' 139' ' ' ASN . 98.5 mt -90.9 138.6 31.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.67 -36.0 69.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -82.18 47.86 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.725 HD21 ' HB2' ' A' ' 136' ' ' LEU . 38.7 m-80 -147.84 -38.43 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.44 HD23 ' HG2' ' A' ' 134' ' ' GLU . 5.0 mp -87.65 133.85 33.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.45 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.874 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.489 ' CZ ' ' HE1' ' A' ' 150' ' ' HIS . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 143' ' ' PHE . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.6 m120 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.972 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.495 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.6 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.911 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.481 ' HB2' HD22 ' A' ' 154' ' ' LEU . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.624 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.452 ' HB2' HD13 ' A' ' 172' ' ' LEU . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.787 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.787 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.549 HD22 ' CE2' ' A' ' 104' ' ' PHE . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.472 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.624 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.464 0.173 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.89 43.85 26.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.204 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.06 124.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.811 0.815 . . . . 0.0 112.781 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -84.99 131.55 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.268 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.62 52.14 1.62 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.036 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.06 9.16 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.804 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.34 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.76 132.86 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.69 HG12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.69 HD12 HG12 ' A' ' 9' ' ' ILE . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.403 ' HA ' HD13 ' A' ' 18' ' ' ILE . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.727 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.807 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD22 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.701 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HB2' HG13 ' A' ' 87' ' ' VAL . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.807 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.639 ' HH ' ' HB2' ' A' ' 58' ' ' ASP . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 1.113 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt -97.78 156.18 16.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.61 119.63 7.41 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 50.54 -84.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.564 1.146 . . . . 0.0 113.665 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.6 -59.42 0.24 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.393 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.12 -39.04 33.26 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.461 2.108 . . . . 0.0 113.007 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.87 143.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.74 0.781 . . . . 0.0 112.072 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.712 ' HA ' ' CD2' ' A' ' 108' ' ' TYR . . . -79.46 57.54 2.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.636 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -136.87 130.51 31.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 1.113 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 53' ' ' ARG . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 1.022 HG22 ' HE3' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.457 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 94' ' ' MET . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.728 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.972 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.565 ' HG ' ' HE3' ' A' ' 116' ' ' TRP . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG23 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' HG2' ' H ' ' A' ' 114' ' ' SER . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.75 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 71.2 t80 -150.67 164.88 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 54.66 144.73 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.109 1.364 . . . . 0.0 113.811 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -80.76 43.6 0.69 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -89.24 -58.62 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.432 0.158 . . . . 0.0 110.611 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.57 48.36 0.24 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.276 0.56 . . . . 0.0 109.898 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 110' ' ' TYR . 53.9 p90 -75.08 137.18 41.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.176 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.533 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 41.1 m -154.81 132.93 11.7 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.852 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.588 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.565 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 11.4 t30 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG13 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.62 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.414 ' O ' ' HE1' ' A' ' 132' ' ' MET . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.022 ' HE3' HG22 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.573 ' HD1' ' C ' ' A' ' 139' ' ' ASN . 81.6 t80 -69.43 -178.72 1.46 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.58 ' HB2' HD11 ' A' ' 140' ' ' LEU . 34.3 tt0 -56.98 -44.2 82.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 8.7 pt-20 -175.32 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 96.4 mt -85.77 -60.16 2.1 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.61 -161.42 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' C ' ' HB2' ' A' ' 133' ' ' TYR . 5.1 m-85 -90.05 -49.6 6.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -151.7 146.22 25.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.89 0.376 . . . . 0.0 111.507 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -89.6 43.97 1.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.122 -178.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.597 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 139' ' ' ASN . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 1.026 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.873 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.816 ' H ' HD21 ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.538 ' HZ3' ' HB2' ' A' ' 159' ' ' LYS . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 151' ' ' THR . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 1.026 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.904 ' HG3' HD21 ' A' ' 172' ' ' LEU . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.66 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.543 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.667 ' HB3' HD22 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.66 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.972 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 158' ' ' LEU . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.81 -56.27 0.62 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.026 0.93 . . . . 0.0 111.943 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.56 -49.34 12.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.0 t 71.52 -53.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.795 0.838 . . . . 0.0 111.806 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.29 134.23 33.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 111.52 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.48 -55.63 2.03 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.017 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.98 118.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.581 0.752 . . . . 0.0 112.972 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -88.04 138.17 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.426 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.827 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD23 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 18' ' ' ILE . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' HB3' ' A' ' 169' ' ' HIS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.88 HD13 ' HZ2' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.845 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.845 ' H ' HG23 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.88 ' HZ2' HD13 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.788 HD12 ' HZ3' ' A' ' 77' ' ' LYS . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.636 ' OD1' HD23 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.598 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.677 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 41' ' ' SER . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.819 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG22 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.748 HD13 ' HH ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.403 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 71' ' ' LEU . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.467 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.732 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.765 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.788 ' HZ3' HD12 ' A' ' 33' ' ' ILE . 9.3 mptt -120.02 -155.77 0.64 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.59 156.81 36.39 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -99.33 -34.94 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.78 -157.84 9.81 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.022 -0.608 . . . . 0.0 114.242 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.14 -43.59 3.07 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.019 2.479 . . . . 0.0 112.189 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.74 129.93 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.052 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' HB1' ' CD2' ' A' ' 108' ' ' TYR . . . -141.85 135.58 29.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.769 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -100.16 -46.29 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.617 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.764 HG21 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 102' ' ' VAL . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HB1' HG23 ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.748 ' HH ' HD13 ' A' ' 61' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.548 HD11 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.548 ' N ' HD11 ' A' ' 93' ' ' LEU . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.581 HD12 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 90' ' ' LEU . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.764 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HD21 ' A' ' 172' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 106' ' ' VAL . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.458 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 18.0 t80 -98.9 37.45 1.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -164.97 137.59 4.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.781 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -89.01 120.64 30.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.367 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 112' ' ' TRP . 0.2 OUTLIER -168.94 -123.53 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.407 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 22.7 p90 -105.15 42.77 1.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.015 0.825 . . . . 0.0 111.328 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -126.49 150.05 48.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.69 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p -144.73 174.39 11.02 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.631 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.67 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.48 HG12 HG12 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.662 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 126' ' ' ARG . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 124' ' ' GLY . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.506 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.463 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 -124.63 40.05 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -100.52 -139.46 0.33 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 59.4 -107.84 0.36 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.134 0.574 . . . . 0.0 111.773 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.11 138.27 56.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.042 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.52 48.96 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.912 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -125.48 -22.14 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.163 0.506 . . . . 0.0 110.011 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.6 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 6.4 m120 -88.03 -42.74 12.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.307 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt -89.9 140.77 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.67 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.539 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.3 m120 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.426 ' HD1' ' HE2' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.775 HG21 ' HB3' ' A' ' 161' ' ' ARG . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.885 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.518 ' HG2' ' CG2' ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.775 ' HB3' HG21 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.581 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.603 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.458 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.51 ' HB3' HD13 ' A' ' 23' ' ' LEU . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.65 ' HB ' HD21 ' A' ' 19' ' ' LEU . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 104' ' ' PHE . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.533 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.885 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.66 143.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.927 0.767 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 56.9 45.78 20.78 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.622 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.68 46.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.222 0.534 . . . . 0.0 110.668 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.8 61.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.05 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.79 -135.73 2.52 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.72 127.04 15.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 0.0 111.017 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.11 134.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.658 HG12 HD12 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 9' ' ' ILE . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.599 ' H ' HG23 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.599 HG23 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.691 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 HG21 ' HZ3' ' A' ' 32' ' ' LYS . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.691 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.775 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.909 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.621 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.404 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.464 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.638 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 127' ' ' ARG . 11.6 p-10 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.422 ' CB ' HD12 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.67 ' HD3' HG13 ' A' ' 87' ' ' VAL . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 58' ' ' ASP . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 59' ' ' ILE . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.909 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -84.16 143.54 29.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.03 157.99 21.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.484 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 137.35 57.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.111 0.481 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . -177.7 147.98 8.44 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.078 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.1 Cg_exo -75.39 41.9 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.125 2.55 . . . . 0.0 112.691 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 81' ' ' PRO . 3.1 m -151.46 146.19 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.021 0.528 . . . . 0.0 110.134 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.69 112.27 16.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p -144.81 134.05 22.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.67 HG13 ' HD3' ' A' ' 53' ' ' ARG . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.59 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.434 ' HH ' ' HB3' ' A' ' 61' ' ' LEU . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.537 ' HE1' HD12 ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' HE1' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.59 ' HE1' HD21 ' A' ' 90' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.563 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -102.91 41.73 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -128.27 -134.4 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.182 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -71.89 139.92 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.693 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -71.75 43.31 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -102.98 -39.84 6.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.651 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -78.15 135.85 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -89.08 154.39 20.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.957 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.84 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.715 ' HZ2' ' HD2' ' A' ' 150' ' ' HIS . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.819 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.633 HG23 ' HZ3' ' A' ' 117' ' ' TRP . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.441 ' HA ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.589 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.544 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.496 ' HG2' ' HB3' ' A' ' 128' ' ' ALA . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 -74.25 -37.71 63.7 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -73.33 -38.4 65.79 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.07 -48.35 81.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.919 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.39 122.88 34.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.939 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.74 -43.74 98.26 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -91.71 46.6 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.418 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.52 -44.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -89.2 133.78 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.84 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.2 m120 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.715 ' HD2' ' HZ2' ' A' ' 117' ' ' TRP . 67.8 t60 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.491 HD11 ' H ' ' A' ' 156' ' ' TYR . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.553 ' HB2' HD13 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 151' ' ' THR . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.608 ' HB3' HG21 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.598 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.483 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.787 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.775 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 174' ' ' ILE . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 172' ' ' LEU . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.05 -58.79 0.56 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.81 0.844 . . . . 0.0 112.072 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.04 127.75 34.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.07 138.79 18.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.83 42.61 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.56 -140.55 3.63 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.24 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 111.734 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -79.78 145.56 9.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.092 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.892 HD11 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.546 ' H ' HG21 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' H ' ' A' ' 15' ' ' SER . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 23' ' ' LEU . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 30' ' ' LYS . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' H ' HG12 ' A' ' 29' ' ' VAL . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.481 ' CB ' ' HZ2' ' A' ' 43' ' ' LYS . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.752 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 127' ' ' ARG . 20.0 p30 -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.728 HG22 HD23 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' CZ ' ' HE2' ' A' ' 73' ' ' TYR . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.755 ' HG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.4 p-10 -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp -75.64 -176.59 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.07 -40.61 78.36 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -146.9 -47.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.681 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.04 -63.28 0.61 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.141 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.17 -30.38 46.5 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.779 2.32 . . . . 0.0 112.476 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' CG2' ' H ' ' A' ' 83' ' ' ALA . 8.8 p -85.2 -179.96 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.358 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.568 ' HA ' ' CD2' ' A' ' 108' ' ' TYR . . . -80.47 -152.5 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.73 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.755 ' HB ' ' HG ' ' A' ' 54' ' ' SER . 36.1 p 52.79 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.243 1.417 . . . . 0.0 113.101 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.579 ' N ' ' HB3' ' A' ' 54' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD23 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HE1' HD11 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.565 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.845 ' HB ' HD23 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' HD23 ' A' ' 172' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.63 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 -122.45 -174.94 3.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' N ' ' CG ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -61.15 -23.68 65.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.462 0.705 . . . . 0.0 112.55 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -69.48 -34.82 74.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.716 0.293 . . . . 0.0 111.507 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -137.38 103.03 4.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -74.87 54.99 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.249 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.501 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 3.3 m-85 -77.94 168.24 20.22 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.792 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -88.5 149.83 23.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.61 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.434 ' HA ' HD22 ' A' ' 49' ' ' ASN . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB3' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.54 ' HE1' ' HB3' ' A' ' 128' ' ' ALA . 38.4 m-85 -107.49 43.2 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HA ' HD11 ' A' ' 140' ' ' LEU . 58.0 tt0 -87.45 -59.1 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.54 42.77 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' HB2' ' OD1' ' A' ' 139' ' ' ASN . 84.6 mt -66.01 -45.61 80.91 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.273 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -173.36 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.73 43.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.725 0.774 . . . . 0.0 109.612 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 136' ' ' LEU . 5.4 m120 -91.93 -35.26 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.847 HD21 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt -88.66 119.47 29.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.847 ' HD3' HD21 ' A' ' 140' ' ' LEU . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.444 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.6 m120 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.552 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.486 ' O ' ' HB1' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.844 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.908 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.675 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.675 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.492 HD23 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.631 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.08 43.13 21.35 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.368 0.418 . . . . 0.0 111.819 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.86 125.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.485 0.714 . . . . 0.0 112.019 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.3 136.67 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.325 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.45 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.603 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.85 -135.1 2.73 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.299 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.78 21.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.38 0.672 . . . . 0.0 112.213 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t -138.4 71.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' HG21 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.643 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.813 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.813 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.64 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' HG23 ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' A' ' 67' ' ' HIS . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.823 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' A' ' 63' ' ' HIS . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.542 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.606 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.823 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.504 ' HB3' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.729 ' HB3' ' HE1' ' A' ' 73' ' ' TYR . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.523 ' HG2' HG22 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.646 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt -147.48 140.36 24.95 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -87.78 16.98 5.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.693 0.283 . . . . 0.0 111.645 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 66.34 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.417 0.627 . . . . 0.0 112.399 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.06 154.71 15.48 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.243 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.68 -42.23 40.88 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.941 2.427 . . . . 0.0 112.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.45 160.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.936 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.66 104.47 9.29 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.249 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p -141.31 135.73 30.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.727 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.709 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.743 ' HB ' HD22 ' A' ' 90' ' ' LEU . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.734 HD12 ' HH ' ' A' ' 133' ' ' TYR . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.585 ' CE2' HD23 ' A' ' 172' ' ' LEU . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -109.87 130.87 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 54.67 -44.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.855 1.662 . . . . 0.0 115.398 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -59.09 125.67 24.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.99 0.813 . . . . 0.0 111.451 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -84.23 -30.43 25.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -60.37 -37.58 81.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -80.57 139.81 36.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.937 0.399 . . . . 0.0 111.523 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -116.51 169.06 9.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.824 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.587 HD12 HD12 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.579 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.734 ' HH ' HD12 ' A' ' 103' ' ' LEU . 9.3 m-85 -84.31 -48.13 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -86.3 50.71 2.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.931 0.395 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 4.3 tp10 -90.09 -139.04 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.564 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 84.4 mt -80.25 -44.11 20.23 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.056 0.455 . . . . 0.0 110.951 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -84.93 152.2 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.115 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -72.24 67.38 0.68 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.123 0.487 . . . . 0.0 111.293 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.8 52.39 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.217 0.532 . . . . 0.0 110.969 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.19 113.12 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.837 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.502 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.681 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.2 m120 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.486 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.647 HG22 ' HD3' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.467 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.421 ' HB2' HD13 ' A' ' 121' ' ' ILE . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.547 HD11 ' OG ' ' A' ' 41' ' ' SER . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.746 ' HG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB2' HG21 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.681 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 10.0 t30 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 104' ' ' PHE . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.746 HG12 ' HG ' ' A' ' 160' ' ' SER . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.56 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.16 -48.82 8.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.176 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.588 ' O ' HG11 ' A' ' 4' ' ' VAL . 41.9 m-20 66.93 -44.89 0.45 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.383 1.073 . . . . 0.0 113.053 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 3' ' ' ASP . 7.1 p 45.89 38.45 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.411 1.084 . . . . 0.0 113.022 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.5 141.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.82 130.82 2.15 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.12 117.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.601 0.76 . . . . 0.0 112.951 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m -147.1 150.21 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.507 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.766 HG23 ' HB3' ' A' ' 14' ' ' LEU . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.766 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.423 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 18' ' ' ILE . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.95 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 30' ' ' LYS . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' H ' HG11 ' A' ' 29' ' ' VAL . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.95 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 35' ' ' VAL . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' O ' HD23 ' A' ' 71' ' ' LEU . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.55 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.641 ' HB3' HG23 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.854 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.727 ' HD2' ' HE1' ' A' ' 94' ' ' MET . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 63' ' ' HIS . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 48' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 50' ' ' THR . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 49' ' ' ASN . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.789 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.732 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.692 ' O ' HG21 ' A' ' 59' ' ' ILE . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.692 HG21 ' O ' ' A' ' 58' ' ' ASP . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 61' ' ' LEU . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 ' H ' HG22 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 45' ' ' TRP . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.854 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.603 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -73.47 159.11 33.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 138.24 18.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.09 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -75.55 -22.05 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.736 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.69 -164.81 8.09 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.099 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 -46.07 5.58 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.05 2.5 . . . . 0.0 112.126 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.44 149.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.678 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.84 113.85 7.66 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.384 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m -95.62 -54.73 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.217 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' OG ' ' A' ' 105' ' ' SER . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.616 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.616 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.727 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.713 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 -80.6 151.89 28.84 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 -27.22 11.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -64.0 -27.6 69.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.601 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 113' ' ' TYR . 6.8 m120 -119.95 98.44 6.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -69.84 56.36 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.102 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 4.1 m-85 -93.34 164.98 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 0.0 110.525 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p -86.0 163.74 17.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.59 HD21 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.657 ' HZ3' HG12 ' A' ' 119' ' ' VAL . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.657 HG12 ' HZ3' ' A' ' 117' ' ' TRP . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HB3' ' HZ1' ' A' ' 125' ' ' LYS . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HD3' HD22 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.84 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.84 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -92.29 -42.09 10.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -60.88 164.06 5.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.029 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.31 -51.09 0.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 112.278 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.4 mt -85.03 116.04 23.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.701 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -77.03 37.1 0.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -146.88 32.95 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.469 0.652 . . . . 0.0 109.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -143.28 -43.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.778 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.726 HD11 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? -87.1 120.98 28.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.726 ' HD3' HD11 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 148' ' ' GLY . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 147' ' ' ASN . 0.1 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 146' ' ' ASP . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.656 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 161' ' ' ARG . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.788 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 160' ' ' SER . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.788 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.688 ' HB2' HD22 ' A' ' 154' ' ' LEU . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.529 ' HG2' HG23 ' A' ' 151' ' ' THR . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.59 ' HA ' HD21 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.77 ' HB3' HD22 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 165' ' ' ASN . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 164' ' ' MET . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.515 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.739 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 16.9 t-160 -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.603 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.542 0.21 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 139.16 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.771 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 4' ' ' VAL . 66.1 m-20 69.68 -46.55 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.853 0.861 . . . . 0.0 112.641 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.696 HG22 ' H ' ' A' ' 5' ' ' ALA . 3.8 p 50.98 -152.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.318 1.047 . . . . 0.0 111.117 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.696 ' H ' HG22 ' A' ' 4' ' ' VAL . . . 67.94 -64.35 0.29 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.72 0.808 . . . . 0.0 112.105 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.03 49.13 0.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.15 138.08 31.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.535 -0.333 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.52 135.14 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.918 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.652 HD11 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.629 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.505 ' HD2' HD13 ' A' ' 171' ' ' ILE . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HB3' HG22 ' A' ' 171' ' ' ILE . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB1' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.776 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.728 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.435 ' ND2' HD21 ' A' ' 71' ' ' LEU . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.529 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.855 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 1.009 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.609 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.009 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt -64.42 -57.06 10.36 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.1 t70 -163.62 -136.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.961 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.5 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 10.0 mpt_? -85.8 -31.31 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.191 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.71 -136.96 2.13 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.665 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.46 121.71 9.2 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.763 HG22 ' H ' ' A' ' 83' ' ' ALA . 7.4 p -174.46 179.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.763 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -86.79 178.94 6.85 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.536 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p 58.37 165.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 106' ' ' VAL . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 HG22 HD13 ' A' ' 103' ' ' LEU . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.607 HD13 ' CE2' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.673 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.663 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.628 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.858 HG22 HG11 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.547 ' CE2' HG22 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.671 HG13 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 -95.21 47.98 1.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t70 66.4 104.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.681 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.794 ' HB2' ' HB2' ' A' ' 113' ' ' TYR . 17.3 m-85 -128.93 144.27 51.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.61 -24.7 22.51 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.454 ' HD1' ' CD1' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -145.32 50.04 1.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 112.386 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.794 ' HB2' ' HB2' ' A' ' 110' ' ' TYR . 29.7 m-85 -137.25 142.82 42.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.784 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m -137.61 156.96 47.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.651 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.766 HD21 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.858 HG11 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.898 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.46 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.517 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 -79.94 -51.68 8.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -94.29 167.94 11.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.65 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 69.87 -68.45 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.367 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.5 135.95 33.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -76.78 124.2 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.654 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -167.91 -45.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 133' ' ' TYR . 14.1 p30 -139.13 27.58 2.35 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.041 0.448 . . . . 0.0 111.963 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.47 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt -88.93 66.67 7.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.428 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.8 m120 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.412 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.893 HG23 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.898 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 41' ' ' SER . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.879 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.545 ' HG ' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.893 ' HG2' HG23 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.622 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.598 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.621 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.766 ' HA ' HD21 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.426 ' CG ' HD12 ' A' ' 23' ' ' LEU . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.598 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.552 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.659 0.266 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.84 -42.65 13.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.875 0.369 . . . . 0.0 110.646 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -86.74 136.93 32.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.6 t 69.73 -57.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.451 0.7 . . . . 0.0 112.602 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.31 140.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.469 0.708 . . . . 0.0 111.943 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.65 132.64 1.67 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.056 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.4 41.85 0.8 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 111.902 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m -145.65 144.96 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.513 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 20' ' ' LYS . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 34' ' ' ALA . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.648 ' HA2' ' HZ1' ' A' ' 32' ' ' LYS . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.648 ' HZ1' ' HA2' ' A' ' 27' ' ' GLY . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB2' HG22 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.514 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.542 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.628 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.628 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 63' ' ' HIS . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD22 HD22 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.41 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.614 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG21 ' N ' ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' N ' HG21 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.745 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.815 ' HB2' HD11 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 14' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -83.16 -141.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 71.54 142.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.729 0.812 . . . . 0.0 111.704 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 54' ' ' SER . 20.7 tpt180 -171.42 -42.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.42 -140.02 4.82 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.627 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.46 -41.59 11.53 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.194 2.596 . . . . 0.0 113.296 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 m -81.64 128.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.96 126.09 30.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.399 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p -144.07 148.67 35.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.679 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.647 ' HB2' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.718 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.67 HD22 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.504 ' HB2' ' HE2' ' A' ' 94' ' ' MET . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.635 HG23 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD12 HD11 ' A' ' 154' ' ' LEU . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.737 HG23 HG11 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.647 ' HE2' ' HB2' ' A' ' 86' ' ' ALA . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.616 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.47 43.27 1.06 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 113' ' ' TYR . 2.1 p30 -123.46 173.62 7.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -117.93 58.63 0.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.103 0.477 . . . . 0.0 111.72 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.75 -123.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.176 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.62 48.55 0.46 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.411 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 22.6 p90 -78.36 135.0 37.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m -148.2 143.44 27.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.818 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.569 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.679 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.453 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.645 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 -78.68 -38.81 38.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.5 ' HG3' ' CD1' ' A' ' 133' ' ' TYR . 36.0 mt-10 -88.3 43.38 1.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -94.31 -134.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.29 -39.54 16.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 109.944 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.55 141.59 34.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -76.07 57.82 1.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.24 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.42 48.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp -143.1 145.02 32.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.499 ' HD1' ' HD2' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 160' ' ' SER . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 7.8 p30 -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 100' ' ' LEU . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.593 ' HG3' ' HB3' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.432 ' HB3' ' CG2' ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.499 ' HD2' ' HD1' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.679 ' HE3' ' HB3' ' A' ' 170' ' ' ALA . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.679 ' HB3' ' HE3' ' A' ' 164' ' ' MET . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.808 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.498 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.433 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.518 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.87 -62.96 0.33 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.713 0.805 . . . . 0.0 112.509 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -75.1 135.59 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.205 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.3 t 73.52 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.931 0.77 . . . . 0.0 112.225 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.88 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.315 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.56 55.68 4.7 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.732 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.084 0.469 . . . . 0.0 111.425 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m -147.83 141.09 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.845 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.597 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 18' ' ' ILE . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 34' ' ' ALA . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' N ' HG11 ' A' ' 29' ' ' VAL . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.813 ' HZ3' ' HB2' ' A' ' 32' ' ' LYS . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB3' HD22 ' A' ' 23' ' ' LEU . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.582 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.839 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.64 ' HB ' HD23 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.788 HD11 HD21 ' A' ' 49' ' ' ASN . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.788 HD21 HD11 ' A' ' 48' ' ' LEU . 16.8 p30 -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.527 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.694 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.839 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.521 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB3' ' HA2' ' A' ' 11' ' ' GLY . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 37' ' ' VAL . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.608 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp -89.09 -46.51 8.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' N ' ' HG3' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -90.41 140.27 29.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.557 0.694 . . . . 0.0 111.692 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -105.81 -36.19 7.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.603 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' A' ' 81' ' ' PRO . . . -174.44 -127.31 0.99 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.79 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 18.8 Cg_endo -59.53 -40.8 62.78 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.059 2.506 . . . . 0.0 112.444 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.22 125.25 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.384 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.8 130.27 34.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p -148.81 165.55 31.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.842 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 90' ' ' LEU . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.678 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.64 HD23 ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.835 HG21 HG13 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE1' HG21 ' A' ' 33' ' ' ILE . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -110.52 38.04 2.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -147.94 -136.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.518 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -64.16 140.05 58.83 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.401 0.62 . . . . 0.0 112.125 -179.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -70.76 40.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 110' ' ' TYR . 15.1 m95 -90.03 -46.29 8.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.98 0.419 . . . . 0.0 110.432 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.425 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 6.6 m-85 -75.99 144.14 41.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p -96.07 151.51 19.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.504 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.84 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.835 HG13 HG21 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.823 ' HD3' ' H ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 132' ' ' MET . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 -87.74 -41.34 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -79.1 111.81 15.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 -171.59 3.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.25 -29.41 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -81.9 -98.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.761 0.315 . . . . 0.0 111.405 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -172.19 120.91 0.44 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.965 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 133' ' ' TYR . 59.9 t30 -147.06 -34.63 0.26 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 110.432 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.835 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -88.15 137.14 32.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 178.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.7 m120 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 161' ' ' ARG . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.3 m120 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.801 HD13 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.769 ' HZ3' ' HB1' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 151' ' ' THR . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.784 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.703 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.84 ' HE3' ' HB3' ' A' ' 115' ' ' ASN . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.619 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.505 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.742 ' HB ' HD21 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.784 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.801 ' HA ' HD13 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.769 ' HB1' ' HZ3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.628 0.252 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 133.27 34.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.526 0.203 . . . . 0.0 110.749 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 4' ' ' VAL . 11.4 p-10 -138.28 155.09 48.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.973 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 3' ' ' ASP . 35.4 m 44.47 48.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.581 1.153 . . . . 0.0 113.427 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.68 54.71 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.51 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.38 -136.77 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.139 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.94 130.43 12.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.81 0.305 . . . . 0.0 110.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t -135.58 129.79 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.664 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.626 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.686 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.686 HD23 ' HA2' ' A' ' 11' ' ' GLY . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 19' ' ' LEU . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.904 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.677 ' HB3' ' HZ1' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 30' ' ' LYS . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.677 ' HZ1' ' HB3' ' A' ' 26' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.906 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.709 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 61' ' ' LEU . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 HD22 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.525 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.579 ' HG2' ' HH ' ' A' ' 92' ' ' TYR . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.709 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.906 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -87.47 -9.6 54.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 1.1 m-20 -56.89 116.55 3.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -155.47 -50.32 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.552 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.07 11.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.93 -36.88 5.52 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.11 2.54 . . . . 0.0 112.991 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -56.76 124.74 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.412 0.625 . . . . 0.0 112.586 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.54 121.65 27.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.41 -47.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.91 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.654 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 103' ' ' LEU . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HH ' ' HG2' ' A' ' 62' ' ' PRO . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD22 HD21 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.696 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.519 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.545 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.712 ' HB ' HD21 ' A' ' 90' ' ' LEU . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.517 ' CE1' HG13 ' A' ' 102' ' ' VAL . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -90.47 -139.72 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.37 43.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.93 -0.481 . . . . 0.0 111.34 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.52 ' HE1' ' HA ' ' A' ' 113' ' ' TYR . 1.0 OUTLIER -112.86 156.28 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.092 -0.38 . . . . 0.0 110.851 179.321 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -61.76 -44.77 96.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.199 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -78.14 57.19 1.77 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' HA ' ' HE1' ' A' ' 110' ' ' TYR . 3.7 p90 -82.26 129.71 34.92 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m -168.76 131.87 1.39 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.859 0.464 . . . . 0.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.796 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.938 HD13 HD21 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.601 ' HB3' ' HE3' ' A' ' 132' ' ' MET . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 130' ' ' GLN . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.784 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 -79.54 -42.39 25.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 140' ' ' LEU . 92.0 mt-10 -85.73 48.43 1.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' A' ' 139' ' ' ASN . 25.0 mt-10 -81.47 -122.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.586 0.231 . . . . 0.0 110.976 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -71.56 -61.15 1.88 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -176.53 -50.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.09 53.1 0.94 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 135' ' ' GLU . 7.8 m120 -133.24 -49.75 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.669 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 134' ' ' GLU . 2.8 pp -97.71 133.96 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 140' ' ' LEU . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.796 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.623 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.4 m120 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.688 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.574 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.774 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.938 HD21 HD13 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' HB1' ' A' ' 179' ' ' ALA . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.774 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.934 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.792 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.792 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.866 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HE1' ' A' ' 164' ' ' MET . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.904 ' HB ' HD23 ' A' ' 19' ' ' LEU . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.539 HD13 ' SD ' ' A' ' 164' ' ' MET . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.934 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.451 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 23.2 m170 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.787 0.327 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.94 45.24 1.14 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.268 0.556 . . . . 0.0 110.158 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.85 122.24 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.389 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.42 -54.3 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.316 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.46 48.51 10.56 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.699 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.63 44.95 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.74 58.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 70' ' ' ALA . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.569 ' O ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.644 HD12 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 31' ' ' ARG . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.644 ' HG3' HD12 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.587 HG23 HG22 ' A' ' 35' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.938 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.804 ' HB3' HG23 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.406 ' HG ' ' HG ' ' A' ' 158' ' ' LEU . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD13 HD23 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 127' ' ' ARG . 21.7 p30 -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 90' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.736 ' HG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.574 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.769 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' OH ' ' A' ' 73' ' ' TYR . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' H ' ' CD1' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.938 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt -93.35 115.1 27.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -145.54 62.91 1.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.71 0.767 . . . . 0.0 109.342 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -98.44 -40.63 8.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.744 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.39 -143.34 8.05 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.052 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.29 -38.24 15.86 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.303 2.669 . . . . 0.0 112.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.8 131.11 34.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.555 0.693 . . . . 0.0 111.853 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.79 136.62 37.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.594 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.736 ' HB ' ' HG ' ' A' ' 54' ' ' SER . 2.0 m -130.48 -47.86 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 106' ' ' VAL . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 1.033 HG21 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.588 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.478 HG23 HD21 ' A' ' 48' ' ' LEU . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.77 HG13 HG13 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 1.033 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.616 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.602 ' HB3' ' HE1' ' A' ' 110' ' ' TYR . 11.0 t80 -82.07 59.58 4.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 62.87 39.1 10.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.602 ' HE1' ' HB3' ' A' ' 108' ' ' TYR . 27.2 m-85 -89.96 144.67 25.71 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.701 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.75 -43.79 35.74 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.46 0.475 . . . . 0.0 111.615 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.632 ' HD1' ' HD1' ' A' ' 113' ' ' TYR . 1.4 p90 -75.62 -38.46 58.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.632 ' HD1' ' HD1' ' A' ' 112' ' ' TRP . 2.2 m-85 -79.15 149.07 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -145.75 155.42 42.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.215 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.715 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.799 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.77 HG13 HG13 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HA ' HD22 ' A' ' 49' ' ' ASN . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 7.9 m-85 -60.19 -51.99 67.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -94.7 32.68 1.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.19 -59.15 2.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.345 . . . . 0.0 111.507 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.428 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 95.8 mt -89.68 -96.45 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.912 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -162.34 -58.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.733 0.302 . . . . 0.0 110.572 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -89.02 44.11 1.19 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 82.2 m-20 -100.43 -38.72 8.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 110.757 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt -89.2 64.58 7.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.456 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.507 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 5.4 m120 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.887 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.715 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.772 HG21 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.723 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 1.7 t-20 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.451 ' HB2' HD13 ' A' ' 121' ' ' ILE . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.723 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 151' ' ' THR . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.772 ' HG3' HG21 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.887 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.469 ' HE1' ' O ' ' A' ' 105' ' ' SER . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 106' ' ' VAL . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.823 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 165' ' ' ASN . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.736 HD21 HG23 ' A' ' 35' ' ' VAL . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.535 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.86 128.75 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.379 1.05 . . . . 0.0 112.677 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -75.34 132.84 41.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.544 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.48 -55.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.055 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.66 144.4 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.234 0.614 . . . . 0.0 111.472 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.73 47.93 4.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.812 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.91 136.57 38.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.5 127.92 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.631 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.623 HD12 ' HB1' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 15' ' ' SER . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 34' ' ' ALA . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.961 HD11 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HD3' HD11 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 23' ' ' LEU . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.464 ' HA ' HG21 ' A' ' 176' ' ' VAL . 55.4 m-80 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.719 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 63' ' ' HIS . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.504 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.47 ' HB2' HG23 ' A' ' 46' ' ' THR . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.719 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.864 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HH ' ' HB2' ' A' ' 61' ' ' LEU . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.688 ' HB3' ' HZ2' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.974 ' HE3' ' HA ' ' A' ' 83' ' ' ALA . 28.9 tttm -83.49 136.0 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.23 107.35 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.904 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.469 ' NH2' ' O ' ' A' ' 53' ' ' ARG . 91.7 mtt180 -156.77 -63.51 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.294 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.13 -57.32 0.47 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.452 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.68 -136.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.382 2.721 . . . . 0.0 114.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.16 145.99 8.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 122.158 0.98 . . . . 0.0 112.744 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.974 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . . . -82.38 108.64 15.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.835 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 1.9 m -109.63 -39.06 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.785 HD23 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.682 ' HE1' HD13 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.724 HD13 HD12 ' A' ' 154' ' ' LEU . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.706 ' CE2' HG12 ' A' ' 102' ' ' VAL . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.503 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.524 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 -104.61 127.78 52.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 69.74 -49.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.93 114.97 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 111.285 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.77 -26.53 40.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.866 0.365 . . . . 0.0 111.454 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -61.82 -42.06 98.56 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.422 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 7.5 m-85 -70.89 138.91 50.58 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.92 0.391 . . . . 0.0 111.23 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p -100.51 170.25 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.607 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.585 ' CD1' ' HA ' ' A' ' 144' ' ' ARG . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.466 HG11 HG13 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.657 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.436 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.497 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.699 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.597 ' HA ' ' HB3' ' A' ' 139' ' ' ASN . 4.7 m-85 -67.83 -45.36 74.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.2 -34.42 63.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.369 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -62.72 -53.34 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.045 0.45 . . . . 0.0 112.077 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.498 HD21 ' ND2' ' A' ' 139' ' ' ASN . 30.2 tp -90.94 134.41 34.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.988 0.423 . . . . 0.0 111.383 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -61.29 -44.05 97.87 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.656 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -85.69 39.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.597 ' HB3' ' HA ' ' A' ' 133' ' ' TYR . 1.8 m120 -126.11 -44.6 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.117 -0.364 . . . . 0.0 111.36 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -89.2 131.35 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.585 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.7 m120 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.609 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.726 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.724 HD12 HD13 ' A' ' 100' ' ' LEU . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.726 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.706 ' HB2' HD11 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.582 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.662 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.706 HD11 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 121.616 0.722 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.86 47.54 1.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.093 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 55.4 43.12 29.31 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t 72.01 -47.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 -41.26 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.4 -150.34 12.7 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.628 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 139.35 43.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.069 0.461 . . . . 0.0 111.458 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -152.29 140.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.847 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.864 HD12 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG21 ' HG3' ' A' ' 76' ' ' GLN . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' HG11 ' A' ' 35' ' ' VAL . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.771 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.723 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 93' ' ' LEU . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 50' ' ' THR . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 49' ' ' ASN . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.639 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.771 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 8.1 t-160 -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' N ' ' HD2' ' A' ' 67' ' ' HIS . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.747 ' HG3' HG21 ' A' ' 29' ' ' VAL . 7.7 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.819 ' HZ3' ' HA2' ' A' ' 85' ' ' GLY . 23.4 ttmm -68.25 145.71 54.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.67 -61.53 2.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.193 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.0 tpt85 -142.46 -62.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.076 -0.39 . . . . 0.0 111.399 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.692 ' HA2' ' HD3' ' A' ' 77' ' ' LYS . . . 155.22 -59.52 0.38 Allowed Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.977 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.55 -37.76 63.46 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.414 2.742 . . . . 0.0 114.14 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 m -61.96 142.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.18 0.514 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . . . -77.49 39.3 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.371 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -147.72 143.59 27.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.502 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.819 ' HA2' ' HZ3' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.794 HD22 ' HB ' ' A' ' 102' ' ' VAL . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.761 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.691 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.563 HD13 HD13 ' A' ' 154' ' ' LEU . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 90' ' ' LEU . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.739 HD12 ' HE3' ' A' ' 132' ' ' MET . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 102' ' ' VAL . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.864 ' HG2' ' HB2' ' A' ' 113' ' ' TYR . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 55.7 t80 -99.16 164.84 11.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.3 t0 71.88 148.16 0.08 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.463 0.705 . . . . 0.0 111.127 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.72 116.32 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.957 0.408 . . . . 0.0 111.119 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -162.47 -142.43 0.07 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.55 41.19 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.625 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.864 ' HB2' ' HG2' ' A' ' 107' ' ' PRO . 42.8 p90 -77.46 149.21 35.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.533 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m -140.19 145.76 37.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.375 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 170' ' ' ALA . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.712 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.856 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HG2' ' OD1' ' A' ' 139' ' ' ASN . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.529 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 103' ' ' LEU . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -127.46 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' HA ' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -47.46 117.87 1.97 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.894 0.478 . . . . 0.0 111.127 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -172.35 -106.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.036 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.09 -166.28 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.173 -0.329 . . . . 0.0 110.17 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -76.67 44.5 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.223 0.535 . . . . 0.0 111.864 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -111.72 -110.89 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 111.54 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.422 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 2.8 m120 -89.21 175.53 7.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp -152.24 -144.17 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.88 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.586 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.857 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 147' ' ' ASN . 1.1 m120 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.856 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.665 HD12 HG13 ' A' ' 176' ' ' VAL . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.816 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.703 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.636 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' A' ' 167' ' ' SER . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 166' ' ' SER . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.77 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 115' ' ' ASN . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.845 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.873 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.816 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.665 HG13 HD12 ' A' ' 154' ' ' LEU . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.893 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.567 0.223 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.71 127.65 34.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 65.19 135.41 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.95 0.9 . . . . 0.0 112.563 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -95.86 73.9 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.801 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.76 36.7 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.56 132.67 3.31 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.681 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 138.96 33.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.259 . . . . 0.0 111.548 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -136.84 139.25 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.223 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.458 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD21 ' HA2' ' A' ' 11' ' ' GLY . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.583 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.6 ' H ' HG21 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.816 HD21 HG11 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.508 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HD2' ' HE1' ' A' ' 94' ' ' MET . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.536 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.597 ' HD2' ' HG2' ' A' ' 64' ' ' LYS . 27.4 p-80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.597 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.816 HG11 HD21 ' A' ' 39' ' ' ASN . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.839 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.601 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.44 ' OE1' HG13 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -86.25 126.77 34.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.1 137.66 32.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.574 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 66.6 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.802 0.841 . . . . 0.0 112.432 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . 127.07 133.88 3.88 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.75 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.483 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 6.3 Cg_exo -73.73 -36.56 3.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.038 2.492 . . . . 0.0 112.314 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.57 161.73 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.42 121.57 24.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.536 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p -134.86 141.42 46.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.96 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.74 HG21 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD22 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.684 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.656 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD22 ' A' ' 90' ' ' LEU . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.74 ' HG ' HG21 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 33' ' ' ILE . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HB3' ' HB2' ' A' ' 113' ' ' TYR . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.407 ' O ' ' HD1' ' A' ' 110' ' ' TYR . 17.9 t80 -96.29 115.88 28.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p30 59.48 -38.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 108' ' ' TYR . 55.9 m-85 -62.29 126.48 27.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.773 0.715 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -86.26 -23.27 26.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.156 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -64.08 -38.99 93.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 9.3 m-85 -79.23 152.85 30.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.39 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -127.27 162.81 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.618 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.753 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.592 HG11 HG13 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.72 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.44 ' HG2' HH11 ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.72 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.575 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -153.0 36.36 0.48 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.55 60.56 0.81 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -77.38 -144.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.635 0.255 . . . . 0.0 111.526 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.39 -44.6 14.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -162.52 -46.5 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.776 0.322 . . . . 0.0 111.049 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -78.67 63.76 3.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 4.9 p-10 -149.52 -49.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.6 mt -150.45 141.47 22.99 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.471 0.308 . . . . 0.0 110.683 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.753 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.478 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.6 m120 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' HD2' HD11 ' A' ' 174' ' ' ILE . 83.9 t60 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.519 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 160' ' ' SER . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.508 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.991 HD13 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.858 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.515 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.535 HD22 HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.584 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.858 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.991 ' HA ' HD13 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . 3.0 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.24 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.799 0.687 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.09 134.86 44.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.85 45.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.791 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 52.01 10.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.39 52.53 0.22 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.56 46.48 0.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.119 0.485 . . . . 0.0 111.104 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -141.27 132.5 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' HG21 ' A' ' 18' ' ' ILE . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.68 HD12 ' HB1' ' A' ' 34' ' ' ALA . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 30' ' ' LYS . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' H ' HG12 ' A' ' 29' ' ' VAL . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.671 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.458 ' OG ' HD23 ' A' ' 158' ' ' LEU . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.672 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD13 HD21 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.4 HD21 ' HG ' ' A' ' 48' ' ' LEU . 15.4 p30 -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 1' ' ' SER . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' N ' HG21 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.834 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.537 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.568 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt -81.5 -28.78 33.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -47.5 121.99 4.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.46 0.475 . . . . 0.0 111.884 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -168.45 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.37 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.62 -152.29 7.42 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.463 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.5 -37.64 16.62 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.122 2.548 . . . . 0.0 113.591 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.2 130.18 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.621 0.724 . . . . 0.0 112.112 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.87 141.84 50.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.191 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -157.99 -54.44 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 48' ' ' LEU . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' CD2' ' HA ' ' A' ' 47' ' ' ALA . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.547 ' HE1' HD11 ' A' ' 100' ' ' LEU . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.547 HD11 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.819 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -126.9 40.34 3.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.07 -141.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.205 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -79.07 -170.67 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.128 0.489 . . . . 0.0 111.743 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -82.8 54.72 2.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.483 0.658 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -113.62 -46.87 3.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.904 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.819 ' HB3' ' HB3' ' A' ' 107' ' ' PRO . 1.5 t80 -84.78 143.65 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p -115.95 152.18 33.98 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.783 ' HB3' ' HE3' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.727 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.785 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.649 ' HZ3' ' HB2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.621 ' HG3' ' H ' ' A' ' 133' ' ' TYR . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.814 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 49.2 m-85 -143.26 25.99 1.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -99.91 54.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.093 0.473 . . . . 0.0 110.547 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -144.94 -56.55 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.506 ' N ' HD22 ' A' ' 136' ' ' LEU . 3.5 mm? -88.6 146.84 24.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.461 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.09 -42.53 99.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -86.06 45.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 2.3 m120 -125.63 -56.75 1.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.729 ' H ' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -98.15 141.21 31.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.603 HG22 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.484 HD11 HG22 ' A' ' 176' ' ' VAL . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.458 HD23 ' OG ' ' A' ' 41' ' ' SER . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.81 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.603 ' HG3' HG22 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.783 ' HE3' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.629 ' ND2' HG13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.755 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.629 HG13 ' ND2' ' A' ' 165' ' ' ASN . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 164' ' ' MET . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.663 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.81 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.592 0.234 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.8 -50.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.71 135.5 35.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 p 42.25 55.41 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.146 0.978 . . . . 0.0 112.549 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.48 124.26 7.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.658 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.62 -58.2 0.07 OUTLIER Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.711 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.79 125.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 112.592 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.62 130.59 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.922 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.596 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.538 ' HB3' HD13 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.764 HD12 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' ILE . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 171' ' ' ILE . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HZ3' ' A' ' 77' ' ' LYS . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.597 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.808 ' HB3' HD22 ' A' ' 23' ' ' LEU . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.744 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.72 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' HD11 ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.504 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.565 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.476 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.596 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 14' ' ' LEU . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 72' ' ' LEU . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.744 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.655 ' HZ3' HG12 ' A' ' 29' ' ' VAL . 60.4 pttt -149.13 144.95 26.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.87 -53.17 35.03 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.475 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 72.04 131.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.202 1.001 . . . . 0.0 112.181 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.71 -138.94 4.23 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.16 -41.61 9.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.978 2.452 . . . . 0.0 112.346 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 t -104.76 142.0 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.464 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.38 123.95 28.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.812 0.339 . . . . 0.0 110.515 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -143.0 142.87 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.584 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.72 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.584 ' HB ' HD23 ' A' ' 90' ' ' LEU . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE2' HD23 ' A' ' 90' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.665 ' HG2' ' H ' ' A' ' 114' ' ' SER . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.478 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.3 -71.49 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -66.56 145.15 55.93 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.85 -26.44 66.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.17 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -76.72 55.95 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.385 0.612 . . . . 0.0 111.115 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -98.7 135.78 39.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m -140.61 127.97 21.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.553 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' SER . 6.5 m120 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.776 ' HZ2' ' HE2' ' A' ' 150' ' ' HIS . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.766 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 HG11 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.755 ' HD2' ' HB3' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.755 ' HB3' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.836 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.722 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 -85.39 -49.55 8.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -78.25 67.19 4.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.673 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -159.78 -70.93 0.08 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.454 0.645 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.501 ' HB2' ' ND2' ' A' ' 139' ' ' ASN . 96.0 mt -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.09 64.86 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.18 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -164.42 -25.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.537 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 136' ' ' LEU . 1.5 p30 -89.28 -41.02 12.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.844 ' H ' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -87.53 130.22 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.788 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.764 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.776 ' HE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 158' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.651 ' H ' HD13 ' A' ' 158' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 151' ' ' THR . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.973 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.764 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.635 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.537 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 15.7 p30 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.597 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.556 HD11 ' HE3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.973 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 14.1 m170 -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.568 0.223 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.64 123.34 23.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.77 131.4 35.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.91 -44.21 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.02 -44.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.01 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 55.0 5.88 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.398 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 50.0 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.106 0.479 . . . . 0.0 111.582 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 9' ' ' ILE . 10.2 m -139.0 140.34 38.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.641 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' HD13 ' A' ' 18' ' ' ILE . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 ' HB2' ' A' ' 15' ' ' SER . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD11 ' HB3' ' A' ' 32' ' ' LYS . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.92 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.772 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.495 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.91 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.665 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 HG23 ' A' ' 99' ' ' THR . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.668 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.841 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.91 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.841 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 43.0 tttm -80.4 -27.77 38.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -58.46 123.47 16.31 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -167.87 -28.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.564 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.55 -130.73 1.3 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.3 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.86 -135.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.439 2.759 . . . . 0.0 112.59 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.68 139.36 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.816 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.5 156.78 43.93 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.59 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m -80.44 -3.42 49.8 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 1.043 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.731 HD23 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE2' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.665 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.853 HG23 HD22 ' A' ' 48' ' ' LEU . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.792 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.731 ' HB ' HD23 ' A' ' 90' ' ' LEU . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 1.043 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 106' ' ' VAL . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.554 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 -82.98 40.26 0.68 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 49.68 52.34 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.989 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.91 -35.52 7.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.26 -129.51 0.1 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -135.19 47.49 2.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.437 ' HB2' ' HG3' ' A' ' 107' ' ' PRO . 6.6 m-85 -68.89 141.17 55.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -80.64 152.46 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.768 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.619 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.596 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.0 t30 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.792 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.652 ' H ' ' HD2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 134' ' ' GLU . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 -136.16 -37.13 0.72 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . 1.9 mm-40 -54.78 159.93 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 73.48 -46.51 0.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.717 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.37 120.06 21.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -71.89 -39.87 69.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -64.99 -30.07 71.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.411 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.32 -37.56 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -136.05 129.08 31.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.768 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.432 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.817 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.625 HD11 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.771 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.644 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.817 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.859 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.699 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.41 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 170' ' ' ALA . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.71 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 171' ' ' ILE . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 19' ' ' LEU . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.859 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 160' ' ' SER . 42.0 m170 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 176' ' ' VAL . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' HD11 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.67 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD11 ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 18' ' ' ILE . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.565 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.74 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' N ' HD22 ' A' ' 23' ' ' LEU . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.811 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.591 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 77' ' ' LYS . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 77' ' ' LYS . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 60' ' ' VAL . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 59' ' ' ILE . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 46' ' ' THR . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.811 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 32.6 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.62 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 99' ' ' THR . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 98' ' ' ASN . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD13 ' CH2' ' A' ' 45' ' ' TRP . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.866 HG22 HG12 ' A' ' 119' ' ' VAL . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 142' ' ' PRO . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' HG23 ' A' ' 33' ' ' ILE . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 86' ' ' ALA . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.413 ' HB2' ' N ' ' A' ' 85' ' ' GLY . 14.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.933 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.808 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.901 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.933 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.945 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 33.1 p30 -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.499 ' HG2' HG23 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.744 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.945 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 115' ' ' ASN . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.735 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' HB ' ' A' ' 9' ' ' ILE . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.007 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD2' ' HG3' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.719 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.797 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.746 ' HG ' HD23 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.432 ' O ' ' HD1' ' A' ' 51' ' ' TYR . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.606 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.83 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.831 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.782 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HD22 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 65' ' ' VAL . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.867 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 62' ' ' PRO . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.746 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.471 ' N ' HD13 ' A' ' 93' ' ' LEU . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' HE1' HD21 ' A' ' 90' ' ' LEU . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.728 0.299 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.675 ' ND2' ' HA ' ' A' ' 166' ' ' SER . 41.0 m-20 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 1.026 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.026 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.507 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 . . . . . 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.861 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.861 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.621 HH11 ' HB2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.548 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.857 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 1.067 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.792 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.583 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.6 t-20 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.675 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.886 ' HB3' HD11 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.95 HG22 ' HB3' ' A' ' 34' ' ' ALA . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.632 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.067 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' HD13 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.902 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 65' ' ' VAL . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.872 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 84' ' ' THR . 51.7 tttm . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 90' ' ' LEU . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HE1' HD21 ' A' ' 90' ' ' LEU . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 87' ' ' VAL . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 33' ' ' ILE . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.228 -0.075 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.847 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.598 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.895 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.458 ' O ' ' HD1' ' A' ' 116' ' ' TRP . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.984 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.601 ' HE1' ' HZ2' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.477 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.94 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 177' ' ' THR . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.819 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.603 ' HB3' HG13 ' A' ' 35' ' ' VAL . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.647 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 13' ' ' SER . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.565 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 72' ' ' LEU . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.894 HD21 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG21 ' H ' ' A' ' 77' ' ' LYS . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.76 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 177' ' ' THR . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.795 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 22' ' ' VAL . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.648 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 1.146 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 1.146 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.525 HG21 ' CE ' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG22 ' A' ' 50' ' ' THR . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.753 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.48 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 HG12 ' A' ' 119' ' ' VAL . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.959 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.602 HG22 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.673 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 71.2 t80 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.222 -0.374 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.639 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.489 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 11.4 t30 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 130' ' ' GLN . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 53' ' ' ARG . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.6 t80 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.641 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.641 ' HD3' ' H ' ' A' ' 141' ' ' SER . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 1.033 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.682 ' HB3' HG12 ' A' ' 176' ' ' VAL . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.781 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 1.033 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.639 ' HE2' ' HB3' ' A' ' 115' ' ' ASN . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.67 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.894 ' HB3' HD21 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.959 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.781 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.682 HG12 ' HB3' ' A' ' 160' ' ' SER . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 40' ' ' GLU . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.863 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' HD13 ' A' ' 18' ' ' ILE . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.71 HD23 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 18' ' ' ILE . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HZ1' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.898 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.898 ' H ' HG22 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HZ1' HD12 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.85 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.569 ' OD1' HD21 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' HE1' ' A' ' 45' ' ' TRP . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.828 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.69 HG21 HD21 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 HG23 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 50' ' ' THR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.462 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.611 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.588 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.628 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 9.3 mptt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.942 HG22 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.614 ' HE1' HD12 ' A' ' 90' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.595 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 119' ' ' VAL . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.942 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HE1' HD21 ' A' ' 90' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' SER . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.666 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 100' ' ' LEU . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.484 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.658 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.647 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.69 HG22 ' HG2' ' A' ' 159' ' ' LYS . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 158' ' ' LEU . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.69 ' HG2' HG22 ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.617 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 34' ' ' ALA . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.808 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.598 ' H ' HG22 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.581 HG21 HD13 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 130' ' ' GLN . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD13 HG21 ' A' ' 50' ' ' THR . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 65' ' ' VAL . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.928 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' H ' ' HB3' ' A' ' 54' ' ' SER . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' THR . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 103' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' HG22 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.675 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.846 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 102' ' ' VAL . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.514 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.87 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.426 ' ND1' ' HZ2' ' A' ' 117' ' ' TRP . 20.8 t-80 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 158' ' ' LEU . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.745 ' HB2' HD12 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.663 ' HB3' HG12 ' A' ' 176' ' ' VAL . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.794 ' HB3' HG23 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.609 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 33' ' ' ILE . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.688 ' HB3' HG13 ' A' ' 35' ' ' VAL . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.424 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.496 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 18' ' ' ILE . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 32' ' ' LYS . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.531 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.807 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 HG21 HD21 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.607 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 59' ' ' ILE . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.63 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.694 HD21 HG22 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.607 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 36.1 p . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 105' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.844 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 48' ' ' LEU . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.844 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 90' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.636 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 . . . . . 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.527 0.203 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.639 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' HD21 ' A' ' 48' ' ' LEU . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.461 ' HE1' ' HB1' ' A' ' 128' ' ' ALA . 38.4 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.507 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.856 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.714 ' HE3' ' HB1' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.856 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.437 ' H ' ' HD2' ' A' ' 163' ' ' PHE . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.691 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.649 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.454 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.714 ' HB1' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.802 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 14' ' ' LEU . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 18' ' ' ILE . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.826 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.826 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 177' ' ' THR . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.673 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 61' ' ' LEU . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.738 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.562 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.581 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 HG13 ' A' ' 65' ' ' VAL . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.811 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG2' HG21 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.664 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.236 0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.738 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.754 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.661 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.673 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.743 HG22 ' HB1' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 119' ' ' VAL . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 33' ' ' ILE . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.422 0.153 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.841 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.588 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 130' ' ' GLN . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.447 ' CE2' HD21 ' A' ' 103' ' ' LEU . 9.3 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.863 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 11.4 m-20 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.798 HG23 ' HB2' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 154' ' ' LEU . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 154' ' ' LEU . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.433 ' OG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.798 ' HB2' HG23 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.518 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t-20 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 40' ' ' GLU . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.539 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' ILE . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.904 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.904 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HB ' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.88 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB2' ' ND1' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.558 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' HD22 ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.794 HD12 HD23 ' A' ' 93' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.606 HD22 HD22 ' A' ' 48' ' ' LEU . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 90' ' ' LEU . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.555 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.754 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 60' ' ' VAL . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 58' ' ' ASP . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.614 HG11 HD22 ' A' ' 71' ' ' LEU . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.838 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD22 HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.68 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.008 0.432 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HA ' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.621 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' THR . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.723 HG21 ' HB1' ' A' ' 91' ' ' ALA . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.461 ' CE2' HD22 ' A' ' 172' ' ' LEU . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.643 HD22 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 102' ' ' VAL . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.867 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.867 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.464 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 160' ' ' SER . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.812 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 3.9 p30 -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 119' ' ' VAL . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.809 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 166' ' ' SER . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.821 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.88 HG22 ' HB3' ' A' ' 34' ' ' ALA . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.461 HD22 ' CE2' ' A' ' 104' ' ' PHE . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.809 HG12 ' HB2' ' A' ' 160' ' ' SER . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.62 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.552 ' CB ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.758 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 18' ' ' ILE . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 30' ' ' LYS . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 29' ' ' VAL . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.755 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.53 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.672 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.853 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.915 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.656 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.525 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.717 ' HD2' HD12 ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.525 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 105' ' ' SER . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.656 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.686 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.672 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.649 HG21 ' HB1' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 HG12 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' HZ ' HD12 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.526 ' HA ' HG22 ' A' ' 87' ' ' VAL . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.46 0.042 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.832 HD22 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.867 HG12 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.917 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.48 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.484 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 156' ' ' TYR . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.917 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 158' ' ' LEU . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.903 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.585 ' HB2' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.778 ' HG2' HG22 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.605 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.657 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.832 ' HA ' HD22 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.657 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.605 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.425 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.755 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HG13 ' A' ' 9' ' ' ILE . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 18' ' ' ILE . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 171' ' ' ILE . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' OG ' ' A' ' 15' ' ' SER . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 18' ' ' ILE . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 32' ' ' LYS . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 31' ' ' ARG . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HG3' HD22 ' A' ' 23' ' ' LEU . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.785 ' HB3' HG23 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 73' ' ' TYR . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.586 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.752 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.617 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.647 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 59' ' ' ILE . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HG23 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.752 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.782 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.722 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.412 0.148 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.779 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.667 HG22 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.703 HG22 HG12 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CE2' HG12 ' A' ' 33' ' ' ILE . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.457 -0.076 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.645 HD13 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.733 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.71 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.733 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.91 ' HE2' ' HB1' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.721 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.818 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.502 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.461 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.544 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.684 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.91 ' HB1' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.23 0.042 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 70' ' ' ALA . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD23 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 18' ' ' ILE . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' C ' ' HE ' ' A' ' 31' ' ' ARG . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.961 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.876 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.61 ' O ' HD13 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 93' ' ' LEU . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 61' ' ' LEU . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.543 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 50' ' ' THR . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.876 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 14' ' ' LEU . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.539 HD13 ' HE2' ' A' ' 73' ' ' TYR . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.729 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 105' ' ' SER . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.787 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.787 ' HE1' HD12 ' A' ' 90' ' ' LEU . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.789 HG22 HG12 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.658 HD23 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.502 ' HA ' HG22 ' A' ' 87' ' ' VAL . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.896 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.876 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.789 HG12 HG22 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' HG ' ' A' ' 100' ' ' LEU . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.877 ' H ' ' HD3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.75 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.896 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 9.9 m-20 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.805 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.71 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.629 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.961 ' HB ' HD23 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.805 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.815 ' HA ' HD12 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.624 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.624 ' HB3' HD12 ' A' ' 9' ' ' ILE . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' ILE . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.653 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB3' HD11 ' A' ' 23' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.8 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.903 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.783 ' HB2' HD13 ' A' ' 158' ' ' LEU . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.679 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.82 HD13 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.903 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.517 ' HD2' ' C ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.646 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 90' ' ' LEU . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.529 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.711 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 119' ' ' VAL . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 172' ' ' LEU . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 86' ' ' ALA . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.652 HD11 HD22 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.814 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.814 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 140' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.816 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.786 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.786 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.968 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.809 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.898 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 165' ' ' ASN . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' A' ' 174' ' ' ILE . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.968 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.457 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 1.7 m-70 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.6 ' H ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 173' ' ' GLU . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.824 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HG3' HD11 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 106' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' HG22 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.701 ' HB2' HD22 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 61' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 60' ' ' VAL . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 HG23 ' A' ' 59' ' ' ILE . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 40' ' ' GLU . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 62' ' ' PRO . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.926 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.906 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.581 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 2.0 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.891 HG22 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.891 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' HD21 ' A' ' 172' ' ' LEU . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.491 0.186 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.778 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.516 ' HD2' ' HG ' ' A' ' 140' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.516 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.503 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 76.8 m-20 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.935 HG22 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.72 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 56.1 t30 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.421 ' H ' HD12 ' A' ' 154' ' ' LEU . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.935 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 147' ' ' ASN . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 166' ' ' SER . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.63 HD21 ' CE1' ' A' ' 104' ' ' PHE . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' A' ' 19' ' ' LEU . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.555 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 160' ' ' SER . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.957 HG22 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.438 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 18' ' ' ILE . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.674 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.907 HD13 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HD2' ' A' ' 32' ' ' LYS . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.907 ' HD3' HD13 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 176' ' ' VAL . 29.8 m120 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.893 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 47' ' ' ALA . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HB ' ' A' ' 46' ' ' THR . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD13 HD23 ' A' ' 93' ' ' LEU . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.542 HG21 HD21 ' A' ' 61' ' ' LEU . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 HG22 ' A' ' 60' ' ' VAL . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 59' ' ' ILE . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 50' ' ' THR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.893 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' A' ' 108' ' ' TYR . 28.9 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.9 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.501 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HE1' HD12 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.716 HG21 ' HB1' ' A' ' 91' ' ' ALA . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HB ' HD21 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 172' ' ' LEU . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 142' ' ' PRO . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.622 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.434 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.716 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.501 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.716 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.602 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 12.5 m-20 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 161' ' ' ARG . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.737 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.768 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.65 ' HB2' HD12 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.599 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.674 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.729 HG22 ' HB3' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.768 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.679 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.667 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.55 HG21 HD13 ' A' ' 61' ' ' LEU . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 130' ' ' GLN . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.843 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.667 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.772 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.848 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.627 ' HZ1' ' HD1' ' A' ' 108' ' ' TYR . 23.4 ttmm . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 105' ' ' SER . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.684 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.775 HG22 HG12 ' A' ' 119' ' ' VAL . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 172' ' ' LEU . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.735 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.627 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 55.7 t80 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 102' ' ' VAL . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.643 HD13 ' HG ' ' A' ' 100' ' ' LEU . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.417 ' HB3' HH21 ' A' ' 53' ' ' ARG . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.59 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.725 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.499 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.871 HG22 ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.725 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.605 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.714 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.875 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.742 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' ILE . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.778 ' H ' HG22 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.523 HD22 HG12 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.522 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.769 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 HD23 ' A' ' 61' ' ' LEU . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.646 ' HG2' HD11 ' A' ' 71' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 71' ' ' LEU . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.646 HD11 ' HG2' ' A' ' 62' ' ' PRO . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.489 ' OE1' HG12 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.241 0.067 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 105' ' ' SER . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.692 HG22 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG22 HG12 ' A' ' 119' ' ' VAL . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.692 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HE1' HD21 ' A' ' 90' ' ' LEU . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.629 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.697 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.76 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.76 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.416 ' HB2' ' CE ' ' A' ' 132' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 103' ' ' LEU . 69.6 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.546 0.213 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.717 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 8.8 m-20 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.522 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.838 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 13.7 p30 -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 119' ' ' VAL . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.838 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.889 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.522 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.645 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.558 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.593 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.889 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 1.006 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 32' ' ' LYS . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 23' ' ' LEU . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.708 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.586 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG3' ' OE1' ' A' ' 130' ' ' GLN . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 HG23 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.764 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.468 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.847 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD11 HD13 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.595 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.615 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 102' ' ' VAL . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.582 ' OH ' ' HG ' ' A' ' 61' ' ' LEU . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.515 HG21 ' HB1' ' A' ' 91' ' ' ALA . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD12 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.766 HG23 HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 87' ' ' VAL . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 t80 . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.766 HG12 HG23 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 132' ' ' MET . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 53' ' ' ARG . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.618 ' H ' ' HG3' ' A' ' 132' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.757 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.919 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 178' ' ' LYS . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.82 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.752 ' HG3' HG23 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.919 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.472 ' OD1' HG13 ' A' ' 171' ' ' ILE . 26.8 p30 -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.776 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.776 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.835 HG22 ' HB3' ' A' ' 34' ' ' ALA . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.458 HD13 ' HE2' ' A' ' 104' ' ' PHE . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.687 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.569 ' HA ' HD23 ' A' ' 158' ' ' LEU . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.82 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.579 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.825 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.818 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HB3' HG13 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 54' ' ' SER . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.488 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.756 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.77 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 76' ' ' GLN . 60.4 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.003 0.43 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 103' ' ' LEU . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.728 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.721 HG21 ' HB1' ' A' ' 91' ' ' ALA . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 154' ' ' LEU . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 HG12 ' A' ' 119' ' ' VAL . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 103' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.491 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.402 ' N ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 71.8 m-20 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.823 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.53 HD13 ' HG ' ' A' ' 100' ' ' LEU . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.983 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.983 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.731 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.823 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 154' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.548 ' HB3' HD11 ' A' ' 174' ' ' ILE . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.97 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.793 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.593 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.554 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 1.2 p-10 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.607 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.825 HG22 ' HB3' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.97 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.642 0.258 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HB3' HG21 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.932 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.858 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 84' ' ' THR . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.858 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 43.0 tttm . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.583 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.996 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.656 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.676 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 119' ' ' VAL . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.996 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.583 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 . . . . . 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.797 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.644 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 19.4 t-20 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 102' ' ' VAL . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 156' ' ' TYR . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.731 ' HD2' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.56 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.612 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.522 ' N ' HD13 ' A' ' 140' ' ' LEU . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.797 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.858 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.659 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.858 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.905 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 117' ' ' TRP . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.686 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.602 ' CA ' HG21 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.932 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.905 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' SER . 2.5 m-70 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 160' ' ' SER . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HA ' HD12 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.695 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.51 -56.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -82.25 50.19 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.118 0.485 . . . . 0.0 111.694 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.26 137.37 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.505 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.02 44.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.885 0.374 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 42.3 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.616 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 44.87 1.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.409 . . . . 0.0 111.25 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.01 142.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD11 ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 18' ' ' ILE . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.565 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.74 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' N ' HD22 ' A' ' 23' ' ' LEU . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.811 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.591 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 78' ' ' ASP . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 77' ' ' LYS . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 60' ' ' VAL . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 59' ' ' ILE . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 46' ' ' THR . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.811 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 32.6 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.717 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 52.64 175.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' N ' ' HA2' ' A' ' 55' ' ' GLY . 17.3 p-10 -69.77 -45.74 67.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.717 ' H ' ' HD3' ' A' ' 77' ' ' LYS . 21.4 tpt180 72.86 -46.93 0.66 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.374 1.07 . . . . 0.0 112.6 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.05 -61.91 6.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.156 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.53 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.323 2.682 . . . . 0.0 114.368 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 83' ' ' ALA . 5.3 p -77.55 -173.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.527 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -78.38 114.48 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -153.51 138.0 16.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.848 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.62 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 99' ' ' THR . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 98' ' ' ASN . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD13 ' CH2' ' A' ' 45' ' ' TRP . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.866 HG22 HG12 ' A' ' 119' ' ' VAL . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 142' ' ' PRO . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' HG23 ' A' ' 33' ' ' ILE . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 86' ' ' ALA . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.413 ' HB2' ' N ' ' A' ' 85' ' ' GLY . 14.3 t80 -84.26 40.12 0.75 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -163.51 138.25 6.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -85.98 120.19 27.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 112' ' ' TRP . 54.0 t30 -160.76 -131.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.415 ' H ' ' ND2' ' A' ' 111' ' ' ASN . 16.5 m95 -87.68 -31.67 19.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.007 0.432 . . . . 0.0 111.08 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 12.5 m-85 -58.53 148.21 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.24 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -134.8 -179.89 5.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.933 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.808 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.901 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.614 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 5.0 m-85 -84.67 -38.46 19.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.94 -179.4 3.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 56.8 -56.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.137 1.775 . . . . 0.0 114.593 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -89.66 128.14 36.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -78.34 40.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.773 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.674 ' HB2' HD22 ' A' ' 136' ' ' LEU . 22.2 t80 -101.11 -41.62 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.753 0.311 . . . . 0.0 111.275 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 133' ' ' TYR . 10.4 p-10 -128.49 58.78 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.563 0.697 . . . . 0.0 111.591 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.38 70.33 1.36 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.933 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.945 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 33.1 p30 -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.499 ' HG2' HG23 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.744 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.945 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 115' ' ' ASN . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.735 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 121.47 25.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.048 0.451 . . . . 0.0 111.224 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.91 -49.14 11.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.88 132.63 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.372 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.0 131.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.024 0.828 . . . . 0.0 112.263 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.26 -136.76 4.42 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.38 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.37 135.65 24.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t -78.76 134.63 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' HB ' ' A' ' 9' ' ' ILE . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.007 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD2' ' HG3' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.719 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.797 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.746 ' HG ' HD23 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.432 ' O ' ' HD1' ' A' ' 51' ' ' TYR . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.606 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.83 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.831 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.782 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HD22 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 65' ' ' VAL . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.867 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -80.36 -155.2 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.05 119.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.919 0.888 . . . . 0.0 111.507 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -170.42 -40.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.873 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.09 -63.62 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.619 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.72 140.94 44.06 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.81 2.34 . . . . 0.0 112.069 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.52 19.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.8 0.81 . . . . 0.0 111.085 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.49 41.59 1.47 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.506 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p -137.51 126.03 23.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.376 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 62' ' ' PRO . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.746 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.471 ' N ' HD13 ' A' ' 93' ' ' LEU . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' HE1' HD21 ' A' ' 90' ' ' LEU . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HG2' ' HB3' ' A' ' 113' ' ' TYR . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -80.96 -170.74 2.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.3 t0 69.6 145.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.146 0.978 . . . . 0.0 111.14 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -84.23 42.03 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.399 0.619 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.401 HD21 ' HE1' ' A' ' 113' ' ' TYR . 35.1 t30 -80.18 -114.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -153.49 37.97 0.48 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.111 0.481 . . . . 0.0 111.669 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 48.0 m-85 -81.07 129.02 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -89.88 153.03 20.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.297 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.675 ' ND2' ' HA ' ' A' ' 166' ' ' SER . 41.0 m-20 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 1.026 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.868 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.026 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.507 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 -126.9 -46.68 1.54 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.686 ' HA ' HD22 ' A' ' 140' ' ' LEU . 9.7 mt-10 -61.68 -27.36 68.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.868 ' HB2' ' HA ' ' A' ' 131' ' ' ARG . 32.1 tt0 -65.49 -41.88 92.76 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.904 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 139' ' ' ASN . 6.2 mp -90.57 130.88 36.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.697 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -64.57 -42.7 95.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.533 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -78.65 -31.72 46.94 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 5.5 m120 -88.55 44.83 1.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.633 0.254 . . . . 0.0 111.535 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.861 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp -151.54 138.83 19.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.861 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.621 HH11 ' HB2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.548 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.857 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 1.067 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.792 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.583 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.6 t-20 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.675 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.886 ' HB3' HD11 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.95 HG22 ' HB3' ' A' ' 34' ' ' ALA . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.632 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.067 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.396 0.617 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 121.23 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.953 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.64 132.68 41.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t 61.07 61.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.464 0.649 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.43 133.19 15.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.225 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.72 44.19 64.07 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.783 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.46 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.576 0.227 . . . . 0.0 111.156 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.35 137.62 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' HD13 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.902 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 65' ' ' VAL . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.872 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' NZ ' ' HG2' ' A' ' 79' ' ' ARG . 51.7 tttm -100.66 116.15 31.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.07 8.35 43.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.456 ' HG2' ' NZ ' ' A' ' 77' ' ' LYS . 77.9 mtm180 72.53 145.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.252 0.621 . . . . 0.0 111.319 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.96 -159.35 12.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.59 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.43 -44.72 4.3 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.88 2.386 . . . . 0.0 112.872 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 m -102.83 137.16 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.271 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.72 113.67 18.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.802 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -151.06 -176.61 5.61 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 90' ' ' LEU . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HE1' HD21 ' A' ' 90' ' ' LEU . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 87' ' ' VAL . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 33' ' ' ILE . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -93.49 42.43 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -153.25 160.76 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.732 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -120.89 63.05 0.87 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 111.702 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -132.12 -130.93 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.006 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -64.13 -35.05 79.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.618 0.367 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.08 143.64 56.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -147.02 164.23 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.509 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.847 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.598 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -131.29 -41.76 1.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 140' ' ' LEU . 50.5 mt-10 -73.32 54.35 0.42 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.985 0.421 . . . . 0.0 111.416 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -140.05 -58.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.282 0.563 . . . . 0.0 110.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' HB2' ' OD1' ' A' ' 139' ' ' ASN . 98.5 mt -90.9 138.6 31.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.67 -36.0 69.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -82.18 47.86 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 136' ' ' LEU . 10.9 m120 -147.84 -38.43 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 134' ' ' GLU . 5.0 mp -87.65 133.85 33.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.895 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.458 ' O ' ' HD1' ' A' ' 116' ' ' TRP . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.984 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.601 ' HE1' ' HZ2' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.477 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.94 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 177' ' ' THR . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.819 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.603 ' HB3' HG13 ' A' ' 35' ' ' VAL . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.647 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.464 0.173 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.89 43.85 26.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.204 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.06 124.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.811 0.815 . . . . 0.0 112.781 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -84.99 131.55 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.268 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.62 52.14 1.62 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.036 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.06 9.16 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.804 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.34 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.76 132.86 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 13' ' ' SER . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.565 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 72' ' ' LEU . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.894 HD21 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG21 ' H ' ' A' ' 77' ' ' LYS . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.76 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 177' ' ' THR . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.795 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 22' ' ' VAL . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.648 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 1.146 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt -97.78 156.18 16.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.61 119.63 7.41 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 50.54 -84.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.564 1.146 . . . . 0.0 113.665 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.6 -59.42 0.24 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.393 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.12 -39.04 33.26 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.461 2.108 . . . . 0.0 113.007 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.87 143.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.74 0.781 . . . . 0.0 112.072 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HA ' ' CD2' ' A' ' 108' ' ' TYR . . . -79.46 57.54 2.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.636 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -136.87 130.51 31.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 1.146 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.525 HG21 ' CE ' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG22 ' A' ' 50' ' ' THR . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.753 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.48 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 HG12 ' A' ' 119' ' ' VAL . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.959 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.602 HG22 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' ' H ' ' A' ' 114' ' ' SER . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.713 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 71.2 t80 -150.67 164.88 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 54.66 144.73 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.109 1.364 . . . . 0.0 113.811 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -80.76 43.6 0.69 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -89.24 -58.62 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.432 0.158 . . . . 0.0 110.611 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.57 48.36 0.24 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.276 0.56 . . . . 0.0 109.898 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 110' ' ' TYR . 53.9 p90 -75.08 137.18 41.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.176 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.554 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 41.1 m -154.81 132.93 11.7 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.852 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.639 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.489 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 4.2 t-20 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 130' ' ' GLN . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 53' ' ' ARG . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' HD1' ' C ' ' A' ' 139' ' ' ASN . 81.6 t80 -69.43 -178.72 1.46 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 34.3 tt0 -56.98 -44.2 82.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.505 ' H ' ' HD2' ' A' ' 133' ' ' TYR . 8.7 pt-20 -175.32 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 96.4 mt -85.77 -60.16 2.1 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' HB3' ' H ' ' A' ' 138' ' ' TYR . 3.7 m-85 -67.61 -161.42 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.56 ' C ' ' HB2' ' A' ' 133' ' ' TYR . 5.1 m-85 -90.05 -49.6 6.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.572 ' C ' ' HD1' ' A' ' 133' ' ' TYR . 35.6 p-10 -151.7 146.22 25.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.89 0.376 . . . . 0.0 111.507 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.6 43.97 1.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.122 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.641 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.641 ' HD3' ' H ' ' A' ' 141' ' ' SER . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 1.033 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.682 ' HB3' HG12 ' A' ' 176' ' ' VAL . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.781 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 1.033 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.639 ' HE2' ' HB3' ' A' ' 115' ' ' ASN . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.67 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.894 ' HB3' HD21 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.959 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.781 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.682 HG12 ' HB3' ' A' ' 160' ' ' SER . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 40' ' ' GLU . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.81 -56.27 0.62 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.026 0.93 . . . . 0.0 111.943 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.56 -49.34 12.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.0 t 71.52 -53.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.795 0.838 . . . . 0.0 111.806 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.29 134.23 33.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 111.52 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.48 -55.63 2.03 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.017 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.98 118.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.581 0.752 . . . . 0.0 112.972 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -88.04 138.17 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.426 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.863 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' HD13 ' A' ' 18' ' ' ILE . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.71 HD23 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 18' ' ' ILE . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HZ1' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.898 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.898 ' H ' HG22 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HZ1' HD12 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.85 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' OD1' HD21 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' HE1' ' A' ' 45' ' ' TRP . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.828 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.69 HG21 HD21 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 HG23 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 50' ' ' THR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.462 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.611 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.588 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.628 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 9.3 mptt -120.02 -155.77 0.64 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 77' ' ' LYS . 3.3 m-20 -74.59 156.81 36.39 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -99.33 -34.94 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.78 -157.84 9.81 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.022 -0.608 . . . . 0.0 114.242 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.14 -43.59 3.07 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.019 2.479 . . . . 0.0 112.189 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.74 129.93 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.052 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.85 135.58 29.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.769 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -100.16 -46.29 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.942 HG22 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.614 ' HE1' HD12 ' A' ' 90' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.595 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 119' ' ' VAL . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.942 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HE1' HD21 ' A' ' 90' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -98.9 37.45 1.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -164.97 137.59 4.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.781 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -89.01 120.64 30.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.367 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 112' ' ' TRP . 16.8 p-10 -168.94 -123.53 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.45 ' H ' ' ND2' ' A' ' 111' ' ' ASN . 22.7 p90 -105.15 42.77 1.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.015 0.825 . . . . 0.0 111.328 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -126.49 150.05 48.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.69 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p -144.73 174.39 11.02 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' SER . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.666 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 100' ' ' LEU . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.484 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.658 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 -124.63 40.05 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -100.52 -139.46 0.33 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 59.4 -107.84 0.36 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.134 0.574 . . . . 0.0 111.773 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.11 138.27 56.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.042 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.52 48.96 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.912 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -125.48 -22.14 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.163 0.506 . . . . 0.0 110.011 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.607 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 6.4 m120 -88.03 -42.74 12.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.307 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt -89.9 140.77 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.647 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.69 HG22 ' HG2' ' A' ' 159' ' ' LYS . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 158' ' ' LEU . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.69 ' HG2' HG22 ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.617 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 34' ' ' ALA . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.808 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.66 143.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.927 0.767 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 56.9 45.78 20.78 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.622 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.68 46.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.222 0.534 . . . . 0.0 110.668 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.8 61.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.05 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.79 -135.73 2.52 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.72 127.04 15.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 0.0 111.017 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.11 134.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.598 ' H ' HG22 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.581 HG21 HD13 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 130' ' ' GLN . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD13 HG21 ' A' ' 50' ' ' THR . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 65' ' ' VAL . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.928 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -84.16 143.54 29.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.03 157.99 21.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.484 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 137.35 57.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.111 0.481 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . -177.7 147.98 8.44 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.078 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 3.1 Cg_exo -75.39 41.9 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.125 2.55 . . . . 0.0 112.691 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 m -151.46 146.19 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.021 0.528 . . . . 0.0 110.134 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.69 112.27 16.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p -144.81 134.05 22.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' H ' ' HB3' ' A' ' 54' ' ' SER . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' THR . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 103' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -102.91 41.73 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -128.27 -134.4 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.182 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 11.1 m-85 -71.89 139.92 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.693 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -71.75 43.31 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 110' ' ' TYR . 22.0 m95 -102.98 -39.84 6.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.651 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -78.15 135.85 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -89.08 154.39 20.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.957 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' HG22 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.675 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.846 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 102' ' ' VAL . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.514 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 -74.25 -37.71 63.7 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -73.33 -38.4 65.79 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.07 -48.35 81.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.919 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.39 122.88 34.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.939 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.74 -43.74 98.26 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -91.71 46.6 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.418 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.52 -44.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -89.2 133.78 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.87 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.426 ' ND1' ' HZ2' ' A' ' 117' ' ' TRP . 20.8 t-80 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 158' ' ' LEU . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.745 ' HB2' HD12 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.663 ' HB3' HG12 ' A' ' 176' ' ' VAL . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.794 ' HB3' HG23 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.609 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 33' ' ' ILE . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.688 ' HB3' HG13 ' A' ' 35' ' ' VAL . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.424 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.496 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.05 -58.79 0.56 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.81 0.844 . . . . 0.0 112.072 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.04 127.75 34.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.07 138.79 18.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.83 42.61 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.56 -140.55 3.63 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.24 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 111.734 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -79.78 145.56 9.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.092 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 18' ' ' ILE . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 32' ' ' LYS . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.807 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.539 HG21 HD21 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.607 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 59' ' ' ILE . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.63 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.694 HD21 HG22 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp -75.64 -176.59 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.07 -40.61 78.36 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -146.9 -47.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.681 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.04 -63.28 0.61 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.141 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.17 -30.38 46.5 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.779 2.32 . . . . 0.0 112.476 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 83' ' ' ALA . 8.8 p -85.2 -179.96 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.358 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.725 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -80.47 -152.5 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.73 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.607 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 36.1 p 52.79 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.243 1.417 . . . . 0.0 113.101 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 105' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.844 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 48' ' ' LEU . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.844 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 90' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 -122.45 -174.94 3.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' N ' ' CG ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -61.15 -23.68 65.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.462 0.705 . . . . 0.0 112.55 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -69.48 -34.82 74.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.716 0.293 . . . . 0.0 111.507 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -137.38 103.03 4.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -74.87 54.99 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.249 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.498 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 3.3 m-85 -77.94 168.24 20.22 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.792 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -88.5 149.83 23.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.639 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' HD21 ' A' ' 48' ' ' LEU . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 38.4 m-85 -107.49 43.2 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 140' ' ' LEU . 58.0 tt0 -87.45 -59.1 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.54 42.77 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 139' ' ' ASN . 84.6 mt -66.01 -45.61 80.91 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.273 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -173.36 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.73 43.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.725 0.774 . . . . 0.0 109.612 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 136' ' ' LEU . 5.4 m120 -91.93 -35.26 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt -88.66 119.47 29.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.507 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.856 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.714 ' HE3' ' HB1' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.856 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.437 ' H ' ' HD2' ' A' ' 163' ' ' PHE . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.691 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.649 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.454 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.714 ' HB1' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.08 43.13 21.35 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.368 0.418 . . . . 0.0 111.819 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.86 125.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.485 0.714 . . . . 0.0 112.019 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.3 136.67 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.325 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.45 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.603 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.85 -135.1 2.73 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.299 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.78 21.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.38 0.672 . . . . 0.0 112.213 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t -138.4 71.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.802 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 14' ' ' LEU . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 18' ' ' ILE . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.826 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.826 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 177' ' ' THR . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.673 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 61' ' ' LEU . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.738 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.562 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.581 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 HG13 ' A' ' 65' ' ' VAL . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.811 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG2' HG21 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.664 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt -147.48 140.36 24.95 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -87.78 16.98 5.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.693 0.283 . . . . 0.0 111.645 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 66.34 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.417 0.627 . . . . 0.0 112.399 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.06 154.71 15.48 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.243 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.68 -42.23 40.88 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.941 2.427 . . . . 0.0 112.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 p -77.45 160.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.936 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -78.66 104.47 9.29 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.249 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p -141.31 135.73 30.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.738 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.754 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.661 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.673 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.743 HG22 ' HB1' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 119' ' ' VAL . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 33' ' ' ILE . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -109.87 130.87 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 54.67 -44.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.855 1.662 . . . . 0.0 115.398 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -59.09 125.67 24.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.99 0.813 . . . . 0.0 111.451 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -84.23 -30.43 25.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -60.37 -37.58 81.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -80.57 139.81 36.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.937 0.399 . . . . 0.0 111.523 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -116.51 169.06 9.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.841 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.588 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 130' ' ' GLN . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.447 ' CE2' HD21 ' A' ' 103' ' ' LEU . 9.3 m-85 -84.31 -48.13 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -86.3 50.71 2.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.931 0.395 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.542 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 4.3 tp10 -90.09 -139.04 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.542 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 84.4 mt -80.25 -44.11 20.23 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.056 0.455 . . . . 0.0 110.951 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -84.93 152.2 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.115 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -72.24 67.38 0.68 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.123 0.487 . . . . 0.0 111.293 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.8 52.39 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.217 0.532 . . . . 0.0 110.969 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.19 113.12 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.863 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 11.4 m-20 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.798 HG23 ' HB2' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 154' ' ' LEU . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 154' ' ' LEU . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.433 ' OG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.798 ' HB2' HG23 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.518 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t-20 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 40' ' ' GLU . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.539 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.16 -48.82 8.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.176 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 66.93 -44.89 0.45 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.383 1.073 . . . . 0.0 113.053 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.89 38.45 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.411 1.084 . . . . 0.0 113.022 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.5 141.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.82 130.82 2.15 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.12 117.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.601 0.76 . . . . 0.0 112.951 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m -147.1 150.21 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.507 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' ILE . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.904 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.904 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HB ' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.88 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB2' ' ND1' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.558 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' HD22 ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.794 HD12 HD23 ' A' ' 93' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.606 HD22 HD22 ' A' ' 48' ' ' LEU . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 90' ' ' LEU . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.555 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.754 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 60' ' ' VAL . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 58' ' ' ASP . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.614 HG11 HD22 ' A' ' 71' ' ' LEU . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.838 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD22 HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.68 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -73.47 159.11 33.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 138.24 18.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.09 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -75.55 -22.05 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.736 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.69 -164.81 8.09 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.099 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 -46.07 5.58 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.05 2.5 . . . . 0.0 112.126 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.44 149.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.678 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.84 113.85 7.66 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.384 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m -95.62 -54.73 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.217 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HA ' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.621 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' THR . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.723 HG21 ' HB1' ' A' ' 91' ' ' ALA . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.461 ' CE2' HD22 ' A' ' 172' ' ' LEU . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 -80.6 151.89 28.84 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 -27.22 11.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -64.0 -27.6 69.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.601 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' TYR . 6.8 m120 -119.95 98.44 6.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -69.84 56.36 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.102 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 4.1 m-85 -93.34 164.98 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 0.0 110.525 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p -86.0 163.74 17.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.643 HD22 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 102' ' ' VAL . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.867 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.867 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -92.29 -42.09 10.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -60.88 164.06 5.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.029 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.31 -51.09 0.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 112.278 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.4 mt -85.03 116.04 23.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.701 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -77.03 37.1 0.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -146.88 32.95 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.469 0.652 . . . . 0.0 109.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -143.28 -43.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.778 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? -87.1 120.98 28.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.464 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 160' ' ' SER . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.812 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 3.9 p30 -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 119' ' ' VAL . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.809 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 166' ' ' SER . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.821 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.88 HG22 ' HB3' ' A' ' 34' ' ' ALA . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.461 HD22 ' CE2' ' A' ' 104' ' ' PHE . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.809 HG12 ' HB2' ' A' ' 160' ' ' SER . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.62 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.552 ' CB ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.542 0.21 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 139.16 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.771 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 4' ' ' VAL . 66.1 m-20 69.68 -46.55 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.853 0.861 . . . . 0.0 112.641 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 5' ' ' ALA . 3.8 p 50.98 -152.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.318 1.047 . . . . 0.0 111.117 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 4' ' ' VAL . . . 67.94 -64.35 0.29 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.72 0.808 . . . . 0.0 112.105 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.03 49.13 0.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.15 138.08 31.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.535 -0.333 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.52 135.14 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.918 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.758 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 18' ' ' ILE . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 30' ' ' LYS . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 29' ' ' VAL . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.755 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.53 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.672 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.853 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.915 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.656 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.525 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.717 ' HD2' HD12 ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt -64.42 -57.06 10.36 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.1 t70 -163.62 -136.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.961 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 10.0 mpt_? -85.8 -31.31 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.191 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.71 -136.96 2.13 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.665 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.46 121.71 9.2 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 83' ' ' ALA . 7.4 p -174.46 179.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.666 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -86.79 178.94 6.85 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.525 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p 58.37 165.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 105' ' ' SER . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.656 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.686 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.672 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.649 HG21 ' HB1' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 HG12 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' HZ ' HD12 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.526 ' HA ' HG22 ' A' ' 87' ' ' VAL . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 -95.21 47.98 1.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t70 66.4 104.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.681 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.814 ' HB2' ' HB2' ' A' ' 113' ' ' TYR . 17.3 m-85 -128.93 144.27 51.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.61 -24.7 22.51 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.461 ' HD1' ' CD1' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -145.32 50.04 1.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 112.386 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.814 ' HB2' ' HB2' ' A' ' 110' ' ' TYR . 29.7 m-85 -137.25 142.82 42.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.784 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m -137.61 156.96 47.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.651 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.832 HD22 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.867 HG12 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.917 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.48 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 -79.94 -51.68 8.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' A' ' 133' ' ' TYR . 94.6 mt-10 -94.29 167.94 11.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.65 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 69.87 -68.45 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.367 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.5 135.95 33.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -76.78 124.2 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.654 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -167.91 -45.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 133' ' ' TYR . 14.1 p30 -139.13 27.58 2.35 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.041 0.448 . . . . 0.0 111.963 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.484 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt -88.93 66.67 7.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 156' ' ' TYR . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.917 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 158' ' ' LEU . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.903 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.585 ' HB2' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.778 ' HG2' HG22 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.605 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.657 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.832 ' HA ' HD22 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.657 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.605 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.425 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.755 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.659 0.266 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.84 -42.65 13.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.875 0.369 . . . . 0.0 110.646 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -86.74 136.93 32.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.6 t 69.73 -57.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.451 0.7 . . . . 0.0 112.602 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.31 140.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.469 0.708 . . . . 0.0 111.943 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.65 132.64 1.67 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.056 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.4 41.85 0.8 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 111.902 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m -145.65 144.96 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HG13 ' A' ' 9' ' ' ILE . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 18' ' ' ILE . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 171' ' ' ILE . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' OG ' ' A' ' 15' ' ' SER . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 18' ' ' ILE . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 32' ' ' LYS . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 31' ' ' ARG . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HG3' HD22 ' A' ' 23' ' ' LEU . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.785 ' HB3' HG23 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 73' ' ' TYR . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.586 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.752 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.617 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.647 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 59' ' ' ILE . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HG23 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.752 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.782 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.722 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -83.16 -141.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 71.54 142.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.729 0.812 . . . . 0.0 111.704 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 54' ' ' SER . 20.7 tpt180 -171.42 -42.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.42 -140.02 4.82 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.627 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.46 -41.59 11.53 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.194 2.596 . . . . 0.0 113.296 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 m -81.64 128.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.96 126.09 30.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.399 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p -144.07 148.67 35.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.679 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.779 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.667 HG22 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.703 HG22 HG12 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CE2' HG12 ' A' ' 33' ' ' ILE . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.47 43.27 1.06 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 113' ' ' TYR . 2.1 p30 -123.46 173.62 7.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -117.93 58.63 0.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.103 0.477 . . . . 0.0 111.72 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.403 ' H ' ' HD2' ' A' ' 113' ' ' TYR . 33.9 p30 -149.75 -123.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.176 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.62 48.55 0.46 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 107' ' ' PRO . 22.6 p90 -78.36 135.0 37.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m -148.2 143.44 27.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.818 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.645 HD13 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.733 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.71 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.733 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 -78.68 -38.81 38.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG3' ' CD1' ' A' ' 133' ' ' TYR . 36.0 mt-10 -88.3 43.38 1.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -94.31 -134.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.29 -39.54 16.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 109.944 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.55 141.59 34.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -76.07 57.82 1.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.24 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -90.42 48.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp -143.1 145.02 32.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.91 ' HE2' ' HB1' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.721 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.818 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.502 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.461 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.544 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.684 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.91 ' HB1' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.87 -62.96 0.33 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.713 0.805 . . . . 0.0 112.509 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -75.1 135.59 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.205 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.3 t 73.52 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.931 0.77 . . . . 0.0 112.225 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.88 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.315 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.56 55.68 4.7 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.732 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.084 0.469 . . . . 0.0 111.425 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m -147.83 141.09 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.845 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 70' ' ' ALA . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD23 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 18' ' ' ILE . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' C ' ' HE ' ' A' ' 31' ' ' ARG . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.961 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.876 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.61 ' O ' HD13 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 93' ' ' LEU . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 61' ' ' LEU . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.543 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 50' ' ' THR . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.876 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 14' ' ' LEU . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.539 HD13 ' HE2' ' A' ' 73' ' ' TYR . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.729 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp -89.09 -46.51 8.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' N ' ' HG3' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -90.41 140.27 29.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.557 0.694 . . . . 0.0 111.692 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -105.81 -36.19 7.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.603 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' ' 81' ' ' PRO . . . -174.44 -127.31 0.99 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.79 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 18.8 Cg_endo -59.53 -40.8 62.78 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.059 2.506 . . . . 0.0 112.444 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.22 125.25 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.384 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.8 130.27 34.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p -148.81 165.55 31.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.842 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 105' ' ' SER . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.787 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.787 ' HE1' HD12 ' A' ' 90' ' ' LEU . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.789 HG22 HG12 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.658 HD23 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.502 ' HA ' HG22 ' A' ' 87' ' ' VAL . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -110.52 38.04 2.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -147.94 -136.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -64.16 140.05 58.83 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.401 0.62 . . . . 0.0 112.125 -179.038 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -70.76 40.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 110' ' ' TYR . 15.1 m95 -90.03 -46.29 8.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.98 0.419 . . . . 0.0 110.432 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE1' ' HE1' ' A' ' 110' ' ' TYR . 6.6 m-85 -75.99 144.14 41.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p -96.07 151.51 19.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.504 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.896 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.876 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.789 HG12 HG22 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' HG ' ' A' ' 100' ' ' LEU . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.877 ' H ' ' HD3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.75 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 -87.74 -41.34 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -79.1 111.81 15.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 -171.59 3.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 136' ' ' LEU . 3.2 mm? -82.25 -29.41 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -81.9 -98.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.761 0.315 . . . . 0.0 111.405 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -172.19 120.91 0.44 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.965 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.06 -34.63 0.26 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 110.432 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -88.15 137.14 32.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 178.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.896 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 9.9 m-20 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.805 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.71 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.629 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.961 ' HB ' HD23 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.805 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.815 ' HA ' HD12 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.628 0.252 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 133.27 34.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.526 0.203 . . . . 0.0 110.749 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -138.28 155.09 48.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.973 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m 44.47 48.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.581 1.153 . . . . 0.0 113.427 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.68 54.71 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.51 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.38 -136.77 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.139 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.94 130.43 12.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.81 0.305 . . . . 0.0 110.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t -135.58 129.79 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.664 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.624 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.624 ' HB3' HD12 ' A' ' 9' ' ' ILE . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' ILE . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.653 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB3' HD11 ' A' ' 23' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.8 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.903 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.783 ' HB2' HD13 ' A' ' 158' ' ' LEU . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.679 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.82 HD13 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.903 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.517 ' HD2' ' C ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -87.47 -9.6 54.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 1.1 m-20 -56.89 116.55 3.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -155.47 -50.32 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.552 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.07 11.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.93 -36.88 5.52 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.11 2.54 . . . . 0.0 112.991 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -56.76 124.74 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.412 0.625 . . . . 0.0 112.586 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.54 121.65 27.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.7 OUTLIER -152.41 -47.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.91 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.646 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 90' ' ' LEU . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.529 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.711 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 119' ' ' VAL . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 172' ' ' LEU . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 86' ' ' ALA . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -90.47 -139.72 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.37 43.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.93 -0.481 . . . . 0.0 111.34 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' HE1' ' HA ' ' A' ' 113' ' ' TYR . 1.0 OUTLIER -112.86 156.28 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.092 -0.38 . . . . 0.0 110.851 179.321 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -61.76 -44.77 96.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.199 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -78.14 57.19 1.77 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.524 ' HA ' ' HE1' ' A' ' 110' ' ' TYR . 3.7 p90 -82.26 129.71 34.92 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m -168.76 131.87 1.39 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.859 0.464 . . . . 0.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.652 HD11 HD22 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.814 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.814 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 -79.54 -42.39 25.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.73 48.43 1.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 139' ' ' ASN . 25.0 mt-10 -81.47 -122.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.586 0.231 . . . . 0.0 110.976 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -71.56 -61.15 1.88 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -176.53 -50.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.09 53.1 0.94 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.419 ' CG ' ' HB2' ' A' ' 135' ' ' GLU . 7.8 m120 -133.24 -49.75 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.669 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 140' ' ' LEU . 2.8 pp -97.71 133.96 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.816 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.786 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.786 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.968 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.809 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.898 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 165' ' ' ASN . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' A' ' 174' ' ' ILE . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.968 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.457 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 1.7 m-70 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.787 0.327 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.94 45.24 1.14 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.268 0.556 . . . . 0.0 110.158 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.85 122.24 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.389 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.42 -54.3 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.316 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.46 48.51 10.56 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.699 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.63 44.95 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.74 58.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.6 ' H ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 173' ' ' GLU . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.824 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HG3' HD11 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 106' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' HG22 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.701 ' HB2' HD22 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 61' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 60' ' ' VAL . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 HG23 ' A' ' 59' ' ' ILE . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 40' ' ' GLU . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 62' ' ' PRO . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.926 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.906 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt -93.35 115.1 27.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -145.54 62.91 1.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.71 0.767 . . . . 0.0 109.342 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -98.44 -40.63 8.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.744 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.39 -143.34 8.05 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.052 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.29 -38.24 15.86 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.303 2.669 . . . . 0.0 112.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.8 131.11 34.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.555 0.693 . . . . 0.0 111.853 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.79 136.62 37.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.594 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.581 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 2.0 m -130.48 -47.86 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.891 HG22 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.891 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' HD21 ' A' ' 172' ' ' LEU . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.61 ' HB3' ' HE1' ' A' ' 110' ' ' TYR . 11.0 t80 -82.07 59.58 4.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 62.87 39.1 10.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.61 ' HE1' ' HB3' ' A' ' 108' ' ' TYR . 27.2 m-85 -89.96 144.67 25.71 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.701 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.75 -43.79 35.74 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.46 0.475 . . . . 0.0 111.615 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.64 ' HD1' ' HD1' ' A' ' 113' ' ' TYR . 1.4 p90 -75.62 -38.46 58.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.657 ' HB3' ' HB3' ' A' ' 107' ' ' PRO . 2.2 m-85 -79.15 149.07 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -145.75 155.42 42.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.215 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.778 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 7.9 m-85 -60.19 -51.99 67.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -94.7 32.68 1.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.19 -59.15 2.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.345 . . . . 0.0 111.507 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 95.8 mt -89.68 -96.45 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.912 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -162.34 -58.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.733 0.302 . . . . 0.0 110.572 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -89.02 44.11 1.19 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 82.2 m-20 -100.43 -38.72 8.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 110.757 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.516 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt -89.2 64.58 7.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.503 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 76.8 m-20 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.935 HG22 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.72 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 56.1 t30 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.421 ' H ' HD12 ' A' ' 154' ' ' LEU . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.935 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 147' ' ' ASN . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 166' ' ' SER . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.63 HD21 ' CE1' ' A' ' 104' ' ' PHE . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' A' ' 19' ' ' LEU . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.555 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 160' ' ' SER . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.957 HG22 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.86 128.75 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.379 1.05 . . . . 0.0 112.677 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -75.34 132.84 41.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.544 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.48 -55.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.055 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.66 144.4 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.234 0.614 . . . . 0.0 111.472 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.73 47.93 4.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.812 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.91 136.57 38.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.5 127.92 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.631 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 18' ' ' ILE . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.674 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.907 HD13 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HD2' ' A' ' 32' ' ' LYS . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.907 ' HD3' HD13 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 176' ' ' VAL . 29.8 m120 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.893 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 47' ' ' ALA . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HB ' ' A' ' 46' ' ' THR . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD13 HD23 ' A' ' 93' ' ' LEU . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.542 HG21 HD21 ' A' ' 61' ' ' LEU . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 HG22 ' A' ' 60' ' ' VAL . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 59' ' ' ILE . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 50' ' ' THR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.893 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 83' ' ' ALA . 28.9 tttm -83.49 136.0 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.23 107.35 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.904 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.469 ' NH2' ' O ' ' A' ' 53' ' ' ARG . 91.7 mtt180 -156.77 -63.51 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.294 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.13 -57.32 0.47 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.452 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.68 -136.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.382 2.721 . . . . 0.0 114.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.16 145.99 8.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 122.158 0.98 . . . . 0.0 112.744 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.961 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . . . -82.38 108.64 15.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.835 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.9 m -109.63 -39.06 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.501 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HE1' HD12 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.716 HG21 ' HB1' ' A' ' 91' ' ' ALA . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HB ' HD21 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 172' ' ' LEU . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 -104.61 127.78 52.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 69.74 -49.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.93 114.97 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 111.285 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.77 -26.53 40.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.866 0.365 . . . . 0.0 111.454 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -61.82 -42.06 98.56 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.441 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 7.5 m-85 -70.89 138.91 50.58 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.92 0.391 . . . . 0.0 111.23 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p -100.51 170.25 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 142' ' ' PRO . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.622 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.434 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.716 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.501 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.716 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.624 ' HA ' ' HB3' ' A' ' 139' ' ' ASN . 4.7 m-85 -67.83 -45.36 74.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.2 -34.42 63.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.369 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -62.72 -53.34 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.045 0.45 . . . . 0.0 112.077 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.2 tp -90.94 134.41 34.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.988 0.423 . . . . 0.0 111.383 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -61.29 -44.05 97.87 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.656 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -85.69 39.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.624 ' HB3' ' HA ' ' A' ' 133' ' ' TYR . 25.3 m-20 -126.11 -44.6 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.117 -0.364 . . . . 0.0 111.36 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.46 ' CD1' ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -89.2 131.35 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.602 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 12.5 m-20 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 161' ' ' ARG . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.737 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.768 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.65 ' HB2' HD12 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.599 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.674 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.729 HG22 ' HB3' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.768 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 121.616 0.722 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.86 47.54 1.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.093 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 55.4 43.12 29.31 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t 72.01 -47.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 -41.26 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.4 -150.34 12.7 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.628 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 139.35 43.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.069 0.461 . . . . 0.0 111.458 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -152.29 140.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.847 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.679 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.667 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.55 HG21 HD13 ' A' ' 61' ' ' LEU . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 130' ' ' GLN . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.843 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.667 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.772 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.848 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.715 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 23.4 ttmm -68.25 145.71 54.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.67 -61.53 2.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.193 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.0 tpt85 -142.46 -62.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.076 -0.39 . . . . 0.0 111.399 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.715 ' HA2' ' HD3' ' A' ' 77' ' ' LYS . . . 155.22 -59.52 0.38 Allowed Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.977 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.55 -37.76 63.46 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.414 2.742 . . . . 0.0 114.14 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 m -61.96 142.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.18 0.514 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . . . -77.49 39.3 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.371 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -147.72 143.59 27.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.502 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 105' ' ' SER . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.684 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.775 HG22 HG12 ' A' ' 119' ' ' VAL . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 172' ' ' LEU . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.735 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 113' ' ' TYR . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.627 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 55.7 t80 -99.16 164.84 11.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.3 t0 71.88 148.16 0.08 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.463 0.705 . . . . 0.0 111.127 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.72 116.32 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.957 0.408 . . . . 0.0 111.119 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -162.47 -142.43 0.07 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.55 41.19 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.625 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.859 ' HB2' ' HG2' ' A' ' 107' ' ' PRO . 42.8 p90 -77.46 149.21 35.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.533 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m -140.19 145.76 37.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.375 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 102' ' ' VAL . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 139' ' ' ASN . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.643 HD13 ' HG ' ' A' ' 100' ' ' LEU . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.417 ' HB3' HH21 ' A' ' 53' ' ' ARG . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.59 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -127.46 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -47.46 117.87 1.97 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.894 0.478 . . . . 0.0 111.127 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -172.35 -106.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.036 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.09 -166.28 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.173 -0.329 . . . . 0.0 110.17 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -76.67 44.5 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.223 0.535 . . . . 0.0 111.864 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -111.72 -110.89 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 111.54 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.431 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 2.8 m120 -89.21 175.53 7.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp -152.24 -144.17 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.88 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.725 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.499 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.871 HG22 ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.725 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.605 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.714 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.875 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.742 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.567 0.223 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.71 127.65 34.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 65.19 135.41 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.95 0.9 . . . . 0.0 112.563 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -95.86 73.9 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.801 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.76 36.7 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.56 132.67 3.31 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.681 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 138.96 33.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.259 . . . . 0.0 111.548 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -136.84 139.25 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.223 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' ILE . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.778 ' H ' HG22 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.523 HD22 HG12 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.522 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.769 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 HD23 ' A' ' 61' ' ' LEU . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.646 ' HG2' HD11 ' A' ' 71' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 71' ' ' LEU . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.646 HD11 ' HG2' ' A' ' 62' ' ' PRO . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.489 ' OE1' HG12 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 126.77 34.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.1 137.66 32.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.574 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 66.6 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.802 0.841 . . . . 0.0 112.432 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . 127.07 133.88 3.88 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.75 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 6.3 Cg_exo -73.73 -36.56 3.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.038 2.492 . . . . 0.0 112.314 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.57 161.73 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.42 121.57 24.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p -134.86 141.42 46.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.96 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 105' ' ' SER . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.692 HG22 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG22 HG12 ' A' ' 119' ' ' VAL . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.692 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HE1' HD21 ' A' ' 90' ' ' LEU . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.629 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 113' ' ' TYR . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.406 ' O ' ' HD1' ' A' ' 110' ' ' TYR . 17.9 t80 -96.29 115.88 28.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p30 59.48 -38.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' A' ' 108' ' ' TYR . 55.9 m-85 -62.29 126.48 27.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.773 0.715 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -86.26 -23.27 26.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.156 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -64.08 -38.99 93.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 9.3 m-85 -79.23 152.85 30.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.39 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -127.27 162.81 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.697 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.76 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.76 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -153.0 36.36 0.48 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.55 60.56 0.81 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -77.38 -144.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.635 0.255 . . . . 0.0 111.526 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.83 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.6 pt? -83.39 -44.6 14.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -162.52 -46.5 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.776 0.322 . . . . 0.0 111.049 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -78.67 63.76 3.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 4.9 p-10 -149.52 -49.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 103' ' ' LEU . 69.6 mt -150.45 141.47 22.99 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.471 0.308 . . . . 0.0 110.683 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.717 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 165' ' ' ASN . 8.8 m-20 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.522 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.838 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 13.7 p30 -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 119' ' ' VAL . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.838 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.889 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.522 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.645 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.558 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.593 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.889 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 1.006 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.512 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . 3.0 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.24 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.799 0.687 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.09 134.86 44.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.85 45.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.791 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 52.01 10.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.39 52.53 0.22 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.56 46.48 0.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.119 0.485 . . . . 0.0 111.104 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -141.27 132.5 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 32' ' ' LYS . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 23' ' ' LEU . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.708 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.586 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG3' ' OE1' ' A' ' 130' ' ' GLN . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 1' ' ' SER . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 HG23 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.764 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.468 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.847 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD11 HD13 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.595 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.615 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt -81.5 -28.78 33.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -47.5 121.99 4.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.46 0.475 . . . . 0.0 111.884 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -168.45 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.37 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.62 -152.29 7.42 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.463 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.5 -37.64 16.62 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.122 2.548 . . . . 0.0 113.591 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.2 130.18 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.621 0.724 . . . . 0.0 112.112 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 108' ' ' TYR . . . -120.87 141.84 50.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.191 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -157.99 -54.44 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 102' ' ' VAL . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.582 ' OH ' ' HG ' ' A' ' 61' ' ' LEU . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.515 HG21 ' HB1' ' A' ' 91' ' ' ALA . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD12 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.766 HG23 HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 87' ' ' VAL . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.845 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.456 ' HD2' ' HB1' ' A' ' 83' ' ' ALA . 7.8 t80 -126.9 40.34 3.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.07 -141.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.205 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -79.07 -170.67 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.128 0.489 . . . . 0.0 111.743 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.8 54.72 2.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.483 0.658 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -113.62 -46.87 3.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.904 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.845 ' HB3' ' HB3' ' A' ' 107' ' ' PRO . 1.5 t80 -84.78 143.65 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p -115.95 152.18 33.98 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.766 HG12 HG23 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 132' ' ' MET . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 53' ' ' ARG . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.818 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 49.2 m-85 -143.26 25.99 1.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -99.91 54.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.093 0.473 . . . . 0.0 110.547 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -144.94 -56.55 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.6 146.84 24.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.461 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.09 -42.53 99.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -86.06 45.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.818 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 2.3 m120 -125.63 -56.75 1.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.669 HD13 ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -98.15 141.21 31.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.757 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.919 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 178' ' ' LYS . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.82 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.752 ' HG3' HG23 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.919 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.472 ' OD1' HG13 ' A' ' 171' ' ' ILE . 26.8 p30 -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.776 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.776 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.835 HG22 ' HB3' ' A' ' 34' ' ' ALA . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.458 HD13 ' HE2' ' A' ' 104' ' ' PHE . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.687 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.569 ' HA ' HD23 ' A' ' 158' ' ' LEU . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.82 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.592 0.234 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.8 -50.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.71 135.5 35.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 p 42.25 55.41 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.146 0.978 . . . . 0.0 112.549 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.48 124.26 7.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.658 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.62 -58.2 0.07 OUTLIER Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.711 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.79 125.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 112.592 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.62 130.59 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.922 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.579 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.825 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.818 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HB3' HG13 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 54' ' ' SER . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.488 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.756 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.77 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 76' ' ' GLN . 60.4 pttt -149.13 144.95 26.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.87 -53.17 35.03 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.475 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 72.04 131.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.202 1.001 . . . . 0.0 112.181 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.71 -138.94 4.23 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.16 -41.61 9.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.978 2.452 . . . . 0.0 112.346 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 t -104.76 142.0 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.464 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.38 123.95 28.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.812 0.339 . . . . 0.0 110.515 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -143.0 142.87 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 103' ' ' LEU . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.728 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.721 HG21 ' HB1' ' A' ' 91' ' ' ALA . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 154' ' ' LEU . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 HG12 ' A' ' 119' ' ' VAL . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 103' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.661 ' HG2' ' H ' ' A' ' 114' ' ' SER . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.491 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.3 -71.49 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -66.56 145.15 55.93 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.85 -26.44 66.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.17 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -76.72 55.95 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.385 0.612 . . . . 0.0 111.115 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -98.7 135.78 39.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.661 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m -140.61 127.97 21.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.553 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 71.8 m-20 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.823 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.53 HD13 ' HG ' ' A' ' 100' ' ' LEU . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.983 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.983 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.731 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 -85.39 -49.55 8.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -78.25 67.19 4.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.673 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -159.78 -70.93 0.08 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.454 0.645 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 139' ' ' ASN . 96.0 mt -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.09 64.86 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.18 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -164.42 -25.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.537 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.523 HD21 ' HB2' ' A' ' 136' ' ' LEU . 1.5 p30 -89.28 -41.02 12.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -87.53 130.22 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.823 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 154' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.548 ' HB3' HD11 ' A' ' 174' ' ' ILE . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.97 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.793 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.593 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.554 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 1.2 p-10 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.607 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.825 HG22 ' HB3' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.97 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.568 0.223 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.64 123.34 23.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.77 131.4 35.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.91 -44.21 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.02 -44.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.01 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 55.0 5.88 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.398 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 50.0 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.106 0.479 . . . . 0.0 111.582 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m -139.0 140.34 38.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HB3' HG21 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.932 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.858 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.858 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 83' ' ' ALA . 43.0 tttm -80.4 -27.77 38.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -58.46 123.47 16.31 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -167.87 -28.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.564 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.55 -130.73 1.3 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.3 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 82' ' ' VAL . 7.0 Cg_exo -74.86 -135.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.439 2.759 . . . . 0.0 112.59 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' H ' ' HB2' ' A' ' 81' ' ' PRO . 27.4 m -67.68 139.36 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.816 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -145.5 156.78 43.93 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.59 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.583 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m -80.44 -3.42 49.8 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.996 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.656 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.676 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 119' ' ' VAL . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.996 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' A' ' 113' ' ' TYR . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.583 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 -82.98 40.26 0.68 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 49.68 52.34 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.989 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.91 -35.52 7.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -141.26 -129.51 0.1 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -135.19 47.49 2.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HB2' ' HG3' ' A' ' 107' ' ' PRO . 6.6 m-85 -68.89 141.17 55.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -80.64 152.46 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.797 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.644 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 19.4 t-20 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 102' ' ' VAL . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 156' ' ' TYR . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.731 ' HD2' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.56 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.625 ' HA ' ' HB2' ' A' ' 134' ' ' GLU . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.612 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 -136.16 -37.13 0.72 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . 1.9 mm-40 -54.78 159.93 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 73.48 -46.51 0.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.717 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.37 120.06 21.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -71.89 -39.87 69.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -64.99 -30.07 71.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.411 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -90.32 -37.56 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -136.05 129.08 31.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.522 ' N ' HD13 ' A' ' 140' ' ' LEU . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.797 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.858 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.659 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.858 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.905 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 117' ' ' TRP . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.686 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.602 ' CA ' HG21 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.932 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.905 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' SER . 2.5 m-70 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 160' ' ' SER . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HA ' HD12 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.695 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD11 ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 18' ' ' ILE . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.565 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.74 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' N ' HD22 ' A' ' 23' ' ' LEU . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.811 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.591 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 77' ' ' LYS . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 77' ' ' LYS . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 60' ' ' VAL . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 59' ' ' ILE . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 46' ' ' THR . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.811 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 85.7 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.62 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 99' ' ' THR . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 98' ' ' ASN . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD13 ' CH2' ' A' ' 45' ' ' TRP . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.866 HG22 HG12 ' A' ' 119' ' ' VAL . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 142' ' ' PRO . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' HG23 ' A' ' 33' ' ' ILE . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 86' ' ' ALA . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.413 ' HB2' ' N ' ' A' ' 85' ' ' GLY . 14.3 t80 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.224 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.933 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.808 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.901 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.933 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.5 m120 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.945 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.499 ' HG2' HG23 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.744 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.945 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 115' ' ' ASN . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.735 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' HB ' ' A' ' 9' ' ' ILE . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.007 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD2' ' HG3' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.719 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.797 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.746 ' HG ' HD23 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.432 ' O ' ' HD1' ' A' ' 51' ' ' TYR . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.606 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.83 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.831 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.782 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HD22 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 65' ' ' VAL . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.867 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 62' ' ' PRO . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.746 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.471 ' N ' HD13 ' A' ' 93' ' ' LEU . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' HE1' HD21 ' A' ' 90' ' ' LEU . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.442 HG12 ' ND2' ' A' ' 115' ' ' ASN . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.728 0.299 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.525 ' OD1' ' HA ' ' A' ' 166' ' ' SER . 3.7 m120 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 1.026 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.026 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.507 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 . . . . . 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.861 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.861 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.2 m120 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.621 HH11 ' HB2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.548 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.857 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 1.067 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.792 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.583 ' HB3' HG12 ' A' ' 171' ' ' ILE . 17.3 t30 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.525 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.886 ' HB3' HD11 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.95 HG22 ' HB3' ' A' ' 34' ' ' ALA . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.632 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.067 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' HD13 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.902 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 65' ' ' VAL . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.872 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 84' ' ' THR . 51.7 tttm . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 90' ' ' LEU . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HE1' HD21 ' A' ' 90' ' ' LEU . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 87' ' ' VAL . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 33' ' ' ILE . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.228 -0.075 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.847 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.598 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.895 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.488 ' CZ ' ' HE1' ' A' ' 150' ' ' HIS . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.6 m120 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.984 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.488 ' HE1' ' CZ ' ' A' ' 143' ' ' PHE . 0.6 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.477 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.94 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 177' ' ' THR . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.819 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.603 ' HB3' HG13 ' A' ' 35' ' ' VAL . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.647 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 13' ' ' SER . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.565 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 72' ' ' LEU . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.894 HD21 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG21 ' H ' ' A' ' 77' ' ' LYS . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.76 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 177' ' ' THR . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.795 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 22' ' ' VAL . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.648 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 1.146 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 1.146 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.525 HG21 ' CE ' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG22 ' A' ' 50' ' ' THR . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.753 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.48 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 HG12 ' A' ' 119' ' ' VAL . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.959 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.602 HG22 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.673 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 71.2 t80 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.222 -0.374 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.639 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.489 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 11.4 t30 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 130' ' ' GLN . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 53' ' ' ARG . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.6 t80 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.641 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.641 ' HD3' ' H ' ' A' ' 141' ' ' SER . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 1.033 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.682 ' HB3' HG12 ' A' ' 176' ' ' VAL . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.781 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 1.033 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.639 ' HE2' ' HB3' ' A' ' 115' ' ' ASN . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.67 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.894 ' HB3' HD21 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.959 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.781 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.682 HG12 ' HB3' ' A' ' 160' ' ' SER . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 40' ' ' GLU . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.863 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' HD13 ' A' ' 18' ' ' ILE . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.71 HD23 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 18' ' ' ILE . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HZ1' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.898 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.898 ' H ' HG22 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HZ1' HD12 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.85 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.569 ' OD1' HD21 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' HE1' ' A' ' 45' ' ' TRP . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.828 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.69 HG21 HD21 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 HG23 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 50' ' ' THR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.462 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.611 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.588 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.628 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 9.3 mptt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.942 HG22 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.614 ' HE1' HD12 ' A' ' 90' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.595 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 119' ' ' VAL . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.942 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HE1' HD21 ' A' ' 90' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' SER . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.666 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 100' ' ' LEU . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.484 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.658 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.647 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.531 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.3 m120 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.69 HG22 ' HG2' ' A' ' 159' ' ' LYS . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 158' ' ' LEU . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.69 ' HG2' HG22 ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.617 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.464 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 34' ' ' ALA . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.808 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.598 ' H ' HG22 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.632 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 127' ' ' ARG . 11.6 p-10 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.581 HG21 HD13 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 130' ' ' GLN . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD13 HG21 ' A' ' 50' ' ' THR . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 65' ' ' VAL . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.928 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' H ' ' HB3' ' A' ' 54' ' ' SER . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' THR . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 103' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' HG22 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.719 ' HZ2' ' HD2' ' A' ' 150' ' ' HIS . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.846 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 102' ' ' VAL . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HA ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.514 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.87 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.2 m120 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.719 ' HD2' ' HZ2' ' A' ' 117' ' ' TRP . 67.8 t60 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 158' ' ' LEU . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.745 ' HB2' HD12 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.663 ' HB3' HG12 ' A' ' 176' ' ' VAL . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.794 ' HB3' HG23 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.609 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.5 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 33' ' ' ILE . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.688 ' HB3' HG13 ' A' ' 35' ' ' VAL . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.424 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.496 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 18' ' ' ILE . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 32' ' ' LYS . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 74' ' ' ASN . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.807 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.468 HD21 ' HA ' ' A' ' 127' ' ' ARG . 20.0 p30 -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 HG21 HD21 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.607 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 59' ' ' ILE . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.63 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.694 HD21 HG22 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.587 HD22 HD21 ' A' ' 26' ' ' LEU . 14.4 p-10 -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.607 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 36.1 p . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 105' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.844 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 48' ' ' LEU . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.844 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 90' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.636 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 . . . . . 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.527 0.203 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.639 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' HD21 ' A' ' 48' ' ' LEU . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HD21 ' A' ' 49' ' ' ASN . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.461 ' HE1' ' HB1' ' A' ' 128' ' ' ALA . 38.4 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.507 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.464 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 1.6 m120 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.856 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.714 ' HE3' ' HB1' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.856 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.437 ' H ' ' HD2' ' A' ' 163' ' ' PHE . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.691 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.649 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.454 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.714 ' HB1' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.802 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 14' ' ' LEU . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 18' ' ' ILE . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.826 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.826 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 177' ' ' THR . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.673 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 61' ' ' LEU . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.738 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.562 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.581 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 HG13 ' A' ' 65' ' ' VAL . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.811 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG2' HG21 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.664 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt . . . . . 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.236 0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.738 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.754 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.661 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.673 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.743 HG22 ' HB1' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 119' ' ' VAL . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 33' ' ' ILE . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.225 -0.212 0 CA-C-O 120.422 0.153 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.841 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.588 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 130' ' ' GLN . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.447 ' CE2' HD21 ' A' ' 103' ' ' LEU . 9.3 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.863 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.687 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.2 m120 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.798 HG23 ' HB2' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 154' ' ' LEU . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 154' ' ' LEU . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.433 ' OG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.798 ' HB2' HG23 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.518 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.687 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 10.0 t30 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 40' ' ' GLU . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.539 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' ILE . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.904 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.904 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HB ' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.88 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.762 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.558 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' HD22 ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.794 HD12 HD23 ' A' ' 93' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.606 HD22 HD22 ' A' ' 48' ' ' LEU . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 90' ' ' LEU . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.555 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.754 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 60' ' ' VAL . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 58' ' ' ASP . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.614 HG11 HD22 ' A' ' 71' ' ' LEU . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.838 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD22 HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.68 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.008 0.432 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HA ' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.621 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' THR . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.723 HG21 ' HB1' ' A' ' 91' ' ' ALA . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.461 ' CE2' HD22 ' A' ' 172' ' ' LEU . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.643 HD22 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 102' ' ' VAL . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.867 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.867 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.464 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 160' ' ' SER . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.812 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 119' ' ' VAL . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.809 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 166' ' ' SER . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.821 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.88 HG22 ' HB3' ' A' ' 34' ' ' ALA . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.461 HD22 ' CE2' ' A' ' 104' ' ' PHE . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.762 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 16.9 t-160 -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.809 HG12 ' HB2' ' A' ' 160' ' ' SER . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.62 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.552 ' CB ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.758 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 18' ' ' ILE . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 30' ' ' LYS . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 29' ' ' VAL . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.755 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.53 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.672 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.853 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.915 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.656 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.525 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.717 ' HD2' HD12 ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.525 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 105' ' ' SER . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.656 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.686 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.672 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.649 HG21 ' HB1' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 HG12 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' HZ ' HD12 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.526 ' HA ' HG22 ' A' ' 87' ' ' VAL . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.46 0.042 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.832 HD22 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.867 HG12 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.917 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.48 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.484 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 165' ' ' ASN . 1.8 m120 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 156' ' ' TYR . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.917 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 158' ' ' LEU . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.903 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.585 ' HB2' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.778 ' HG2' HG22 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.605 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.657 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.832 ' HA ' HD22 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.657 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.605 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.425 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.755 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HG13 ' A' ' 9' ' ' ILE . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 18' ' ' ILE . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 171' ' ' ILE . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' OG ' ' A' ' 15' ' ' SER . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 18' ' ' ILE . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 32' ' ' LYS . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 31' ' ' ARG . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HG3' HD22 ' A' ' 23' ' ' LEU . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.785 ' HB3' HG23 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 73' ' ' TYR . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.586 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.752 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.617 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.647 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 59' ' ' ILE . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HG23 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.752 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.782 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.722 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.412 0.148 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.779 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.667 HG22 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.703 HG22 HG12 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CE2' HG12 ' A' ' 33' ' ' ILE . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.457 -0.076 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.645 HD13 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.733 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.71 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.733 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 7.8 p30 -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.91 ' HE2' ' HB1' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.721 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.818 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.502 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.461 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.544 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.684 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.91 ' HB1' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.23 0.042 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 70' ' ' ALA . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD23 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 18' ' ' ILE . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' C ' ' HE ' ' A' ' 31' ' ' ARG . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.961 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.876 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.61 ' O ' HD13 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.726 HD12 HD22 ' A' ' 49' ' ' ASN . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.726 HD22 HD12 ' A' ' 48' ' ' LEU . 16.8 p30 -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 61' ' ' LEU . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.543 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 50' ' ' THR . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.876 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 14' ' ' LEU . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.539 HD13 ' HE2' ' A' ' 73' ' ' TYR . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.729 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 105' ' ' SER . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.787 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.787 ' HE1' HD12 ' A' ' 90' ' ' LEU . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.789 HG22 HG12 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.658 HD23 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.502 ' HA ' HG22 ' A' ' 87' ' ' VAL . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.896 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.876 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.789 HG12 HG22 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' HG ' ' A' ' 100' ' ' LEU . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.877 ' H ' ' HD3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.75 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.896 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.7 m120 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 153' ' ' ASN . 1.3 m120 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.805 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.71 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.629 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.52 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.961 ' HB ' HD23 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.805 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.815 ' HA ' HD12 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.624 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.624 ' HB3' HD12 ' A' ' 9' ' ' ILE . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' ILE . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.653 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB3' HD11 ' A' ' 23' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.8 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.903 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.783 ' HB2' HD13 ' A' ' 158' ' ' LEU . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.679 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.82 HD13 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.903 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.517 ' HD2' ' C ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.646 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 90' ' ' LEU . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.529 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.711 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 119' ' ' VAL . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 172' ' ' LEU . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 86' ' ' ALA . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.652 HD11 HD22 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.814 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.814 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 140' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.816 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.4 m120 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.786 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.786 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.968 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.809 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.898 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.408 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 165' ' ' ASN . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' A' ' 174' ' ' ILE . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.968 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.457 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 23.2 m170 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.6 ' H ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 173' ' ' GLU . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.824 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HG3' HD11 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 106' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' HG22 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.701 ' HB2' HD22 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 127' ' ' ARG . 21.7 p30 -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 61' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 60' ' ' VAL . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 HG23 ' A' ' 59' ' ' ILE . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 40' ' ' GLU . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 62' ' ' PRO . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.926 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.906 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.581 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 2.0 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.891 HG22 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.891 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' HD21 ' A' ' 172' ' ' LEU . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.491 0.186 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.778 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.534 ' HA ' HD21 ' A' ' 49' ' ' ASN . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.516 ' HD2' ' HG ' ' A' ' 140' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.516 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.503 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 5.4 m120 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.935 HG22 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.72 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 1.7 t-20 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.421 ' H ' HD12 ' A' ' 154' ' ' LEU . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.935 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 147' ' ' ASN . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 166' ' ' SER . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.63 HD21 ' CE1' ' A' ' 104' ' ' PHE . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' A' ' 19' ' ' LEU . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.555 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 160' ' ' SER . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.957 HG22 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.438 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 18' ' ' ILE . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.674 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.907 HD13 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HD2' ' A' ' 32' ' ' LYS . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.907 ' HD3' HD13 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.655 HD21 HD23 ' A' ' 71' ' ' LEU . 55.4 m-80 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.893 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 47' ' ' ALA . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HB ' ' A' ' 46' ' ' THR . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD13 HD23 ' A' ' 93' ' ' LEU . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.542 HG21 HD21 ' A' ' 61' ' ' LEU . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 HG22 ' A' ' 60' ' ' VAL . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 59' ' ' ILE . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 50' ' ' THR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.893 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.655 HD23 HD21 ' A' ' 39' ' ' ASN . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' A' ' 108' ' ' TYR . 28.9 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.9 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.501 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HE1' HD12 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.716 HG21 ' HB1' ' A' ' 91' ' ' ALA . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HB ' HD21 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 172' ' ' LEU . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 142' ' ' PRO . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.622 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.434 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.716 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.501 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.716 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.602 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.7 m120 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 161' ' ' ARG . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.737 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.768 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.65 ' HB2' HD12 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.599 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.674 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.729 HG22 ' HB3' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.768 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.679 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.667 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.55 HG21 HD13 ' A' ' 61' ' ' LEU . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 130' ' ' GLN . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.843 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.667 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.772 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 8.1 t-160 -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 67' ' ' HIS . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.848 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.627 ' HZ1' ' HD1' ' A' ' 108' ' ' TYR . 23.4 ttmm . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 105' ' ' SER . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.684 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.775 HG22 HG12 ' A' ' 119' ' ' VAL . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 172' ' ' LEU . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.735 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.627 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 55.7 t80 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 102' ' ' VAL . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.643 HD13 ' HG ' ' A' ' 100' ' ' LEU . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.417 ' HB3' HH21 ' A' ' 53' ' ' ARG . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.59 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.1 m120 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.725 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.499 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.871 HG22 ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.725 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.605 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.714 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.875 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.742 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' ILE . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.778 ' H ' HG22 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.523 HD22 HG12 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.522 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.769 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 HD23 ' A' ' 61' ' ' LEU . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.646 ' HG2' HD11 ' A' ' 71' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.627 ' HD2' ' HG2' ' A' ' 64' ' ' LYS . 27.4 p-80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.627 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 71' ' ' LEU . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.646 HD11 ' HG2' ' A' ' 62' ' ' PRO . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.489 ' OE1' HG12 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.241 0.067 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 105' ' ' SER . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.692 HG22 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG22 HG12 ' A' ' 119' ' ' VAL . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.692 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HE1' HD21 ' A' ' 90' ' ' LEU . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.629 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.697 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.76 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.76 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.416 ' HB2' ' CE ' ' A' ' 132' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 103' ' ' LEU . 69.6 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.546 0.213 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.717 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.6 m120 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.522 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.838 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 119' ' ' VAL . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.838 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.889 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.522 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.645 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.555 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.558 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.593 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.889 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 1.006 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 32' ' ' LYS . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 23' ' ' LEU . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.708 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.438 HD22 ' HG ' ' A' ' 48' ' ' LEU . 15.4 p30 -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.586 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG3' ' OE1' ' A' ' 130' ' ' GLN . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 HG23 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.764 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.468 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.847 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD11 HD13 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.595 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.615 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 102' ' ' VAL . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.582 ' OH ' ' HG ' ' A' ' 61' ' ' LEU . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.515 HG21 ' HB1' ' A' ' 91' ' ' ALA . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD12 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.766 HG23 HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 87' ' ' VAL . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 t80 . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.766 HG12 HG23 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 132' ' ' MET . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 53' ' ' ARG . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.618 ' H ' ' HG3' ' A' ' 132' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.757 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.919 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 178' ' ' LYS . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.82 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.752 ' HG3' HG23 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.919 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.629 ' ND2' HG13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.776 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.776 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.835 HG22 ' HB3' ' A' ' 34' ' ' ALA . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.458 HD13 ' HE2' ' A' ' 104' ' ' PHE . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.687 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.569 ' HA ' HD23 ' A' ' 158' ' ' LEU . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.82 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.579 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.825 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.818 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HB3' HG13 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 54' ' ' SER . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.488 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.756 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.77 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 76' ' ' GLN . 60.4 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.003 0.43 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 103' ' ' LEU . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.728 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.721 HG21 ' HB1' ' A' ' 91' ' ' ALA . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 154' ' ' LEU . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 HG12 ' A' ' 119' ' ' VAL . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 103' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.491 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.402 ' N ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 6.5 m120 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.823 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.53 HD13 ' HG ' ' A' ' 100' ' ' LEU . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.983 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.983 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.731 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.823 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 154' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.548 ' HB3' HD11 ' A' ' 174' ' ' ILE . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.97 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.793 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.593 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.554 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 15.7 p30 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.607 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.825 HG22 ' HB3' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.97 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 14.1 m170 -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.642 0.258 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HB3' HG21 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.932 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.858 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.47 ' HG ' ' N ' ' A' ' 84' ' ' THR . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.858 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 43.0 tttm . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.583 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.996 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.656 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.676 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 119' ' ' VAL . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.996 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.583 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 . . . . . 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.797 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.644 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.0 t30 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 102' ' ' VAL . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 156' ' ' TYR . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.731 ' HD2' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.56 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.612 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.522 ' N ' HD13 ' A' ' 140' ' ' LEU . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.797 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.858 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.659 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.858 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.905 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 117' ' ' TRP . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.686 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.602 ' CA ' HG21 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.932 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.905 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 42.0 m170 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 160' ' ' SER . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HA ' HD12 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.695 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.51 -56.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -82.25 50.19 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.118 0.485 . . . . 0.0 111.694 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.26 137.37 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.505 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.02 44.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.885 0.374 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 42.3 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.616 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 44.87 1.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.409 . . . . 0.0 111.25 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.01 142.33 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -123.19 164.75 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.17 150.76 10.36 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.92 46.56 0.96 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.99 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.66 -32.95 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -74.34 -29.53 61.63 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD11 ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.67 161.66 30.38 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.393 0.616 . . . . 0.0 112.344 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 18' ' ' ILE . 15.5 m -153.93 157.54 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.931 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.565 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 4.6 p90 -54.78 -30.2 56.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.64 -39.63 67.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.731 0.301 . . . . 0.0 110.303 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 mp -63.96 -38.3 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 24.9 mt -63.34 -41.79 98.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.523 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 8.2 mtpm? -61.5 -37.28 83.11 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.6 m -68.17 -31.21 70.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.59 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.0 t -62.59 -49.64 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.192 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.74 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -78.72 -26.77 44.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.776 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' N ' HD22 ' A' ' 23' ' ' LEU . 33.3 tp10 -63.22 -44.98 93.76 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.185 -0.322 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.18 34.41 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.258 0.552 . . . . 0.0 110.162 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HG ' ' ND2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -121.36 46.21 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.713 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 144.87 4.7 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.832 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -78.44 43.66 0.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.408 0.623 . . . . 0.0 111.818 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.91 152.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.016 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -60.05 -46.62 88.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.302 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -110.04 146.25 35.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.609 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 89.7 mttt -142.15 125.65 16.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.197 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.3 mp -108.18 122.33 62.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -133.25 128.1 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.237 0.542 . . . . 0.0 110.775 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 57.2 t -127.79 143.08 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.206 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.07 85.57 0.15 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 45.2 t -89.77 116.87 31.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.808 0.337 . . . . 0.0 111.586 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' OD1' HD11 ' A' ' 14' ' ' LEU . 10.6 m-20 -79.24 90.11 4.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.0 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 61.7 m-80 -80.73 107.59 13.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.182 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -124.06 38.53 4.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.089 0.947 . . . . 0.0 108.477 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 158' ' ' LEU . 3.5 p -75.87 -34.34 60.02 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.51 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.811 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 85.49 37.56 9.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.269 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -138.22 145.01 40.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -89.9 126.37 35.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 18.0 m0 -107.02 156.58 18.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.232 0.539 . . . . 0.0 112.07 -178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 34.2 m -146.55 122.41 10.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.796 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' HIS . . . -54.94 120.63 7.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.409 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -101.36 -46.84 4.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.422 -178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -159.56 138.3 10.78 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 90' ' ' LEU . 4.8 p -142.36 125.06 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.612 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.53 141.45 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 111.068 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' HZ ' ' HE2' ' A' ' 73' ' ' TYR . 7.2 m-85 -103.5 142.3 34.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.118 0.485 . . . . 0.0 111.474 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -77.53 -32.4 53.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.591 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 24.9 m -133.98 -70.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.996 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 78' ' ' ASP . . . -76.44 -148.8 2.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.894 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 77' ' ' LYS . 14.8 t -165.61 -167.46 1.13 Allowed 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 122.177 -0.602 . . . . 0.0 109.688 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 p -159.96 -53.53 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -166.41 154.67 10.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.574 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 60' ' ' VAL . 9.0 tp -73.27 -33.7 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.555 0.217 . . . . 0.0 110.523 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 59' ' ' ILE . 14.5 m -139.24 139.15 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.681 0.277 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -132.54 164.21 45.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.148 -178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.01 147.82 18.53 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 123.303 2.669 . . . . 0.0 113.823 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 46' ' ' THR . 20.6 p-80 -119.48 51.29 1.17 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 35.2 mmtm -158.44 125.73 4.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.567 0.347 . . . . 0.0 111.235 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 61.5 t -135.84 78.88 47.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.67 168.62 23.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.833 2.355 . . . . 0.0 112.072 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.811 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 57.2 p-80 -66.45 138.59 57.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.21 36.85 23.15 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.266 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -145.11 135.01 23.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.387 0.613 . . . . 0.0 111.73 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.2 129.1 35.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.691 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.11 110.86 18.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.235 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.68 139.08 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.646 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 1.2 t80 -149.26 150.58 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 21.8 t-20 -154.61 141.92 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.45 160.6 27.32 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.383 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 85.7 mt-30 -145.19 46.6 1.32 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.941 0.37 . . . . 0.0 111.403 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.717 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 52.64 175.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.162 0.985 . . . . 0.0 113.515 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' N ' ' HA2' ' A' ' 55' ' ' GLY . 17.3 p-10 -69.77 -45.74 67.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.717 ' H ' ' HD3' ' A' ' 77' ' ' LYS . 21.4 tpt180 72.86 -46.93 0.66 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.374 1.07 . . . . 0.0 112.6 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.05 -61.91 6.64 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.156 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.53 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.323 2.682 . . . . 0.0 114.368 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 83' ' ' ALA . 5.3 p -77.55 -173.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.527 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.785 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -78.38 114.48 17.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -153.51 138.0 16.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.848 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -73.97 -137.45 0.4 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.951 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.62 ' H ' HG13 ' A' ' 106' ' ' VAL . . . -119.87 110.27 16.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.68 0.753 . . . . 0.0 111.357 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.4 t -131.97 132.05 61.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -174.87 168.85 41.64 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.84 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.98 130.64 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.525 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -112.24 138.07 49.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.9 125.33 20.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.707 0.765 . . . . 0.0 111.877 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 99' ' ' THR . 7.7 m-85 -121.28 142.86 49.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.5 139.11 39.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 98' ' ' ASN . 43.5 ttm -93.51 -29.17 15.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -167.35 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -89.33 -30.98 18.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.55 51.58 0.1 Allowed Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.152 -1.499 . . . . 0.0 113.945 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.4 m120 -131.5 136.4 47.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.2 m -132.02 120.4 22.36 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD13 ' CH2' ' A' ' 45' ' ' TRP . 4.1 tt -90.21 108.86 20.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.21 132.68 39.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.491 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.866 HG22 HG12 ' A' ' 119' ' ' VAL . 35.6 t -118.4 130.62 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.545 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 142' ' ' PRO . 64.5 tp -102.95 144.57 31.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.794 0.331 . . . . 0.0 111.561 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' HG23 ' A' ' 33' ' ' ILE . 28.1 t80 -133.63 140.06 46.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 5.7 t -156.02 132.11 9.95 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.617 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 86' ' ' ALA . 6.9 p -159.08 125.35 2.44 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.6 Cg_exo -72.92 145.69 40.72 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.574 2.85 . . . . 0.0 112.41 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.413 ' HB2' ' N ' ' A' ' 85' ' ' GLY . 14.3 t80 -84.26 40.12 0.75 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.044 0.45 . . . . 0.0 111.472 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -163.51 138.25 6.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -85.98 120.19 27.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 112' ' ' TRP . 54.0 t30 -160.76 -131.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.415 ' H ' ' ND2' ' A' ' 111' ' ' ASN . 16.5 m95 -87.68 -31.67 19.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.007 0.432 . . . . 0.0 111.08 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 12.5 m-85 -58.53 148.21 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.24 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.6 m -134.8 -179.89 5.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.669 0.271 . . . . 0.0 111.674 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 105' ' ' SER . 75.8 m-80 -70.02 150.12 46.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.534 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.933 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 10.2 m-90 -134.86 129.86 35.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.47 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 41.4 p-90 -137.6 138.04 39.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.447 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.808 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.3 t30 -148.57 117.23 6.62 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.003 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.866 HG12 HG22 ' A' ' 102' ' ' VAL . 6.4 m -101.5 133.33 45.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.063 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -162.44 151.28 15.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.939 0.399 . . . . 0.0 111.067 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.714 HG13 ' HB2' ' A' ' 156' ' ' TYR . 39.5 mm -85.44 130.85 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.06 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -125.4 128.47 48.18 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.99 144.88 56.47 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.856 -0.527 . . . . 0.0 110.593 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.84 74.78 0.11 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 114.383 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.28 127.78 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 69.99 129.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.537 0.684 . . . . 0.0 111.253 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 126.35 29.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.316 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.901 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 137.42 40.48 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 41.4 t0 -161.19 -159.42 0.65 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 45.1 mt-30 -58.15 -49.08 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.12 0.486 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -64.9 -20.05 66.24 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 22.1 mmt -76.15 -42.01 48.04 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.416 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.614 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 5.0 m-85 -84.67 -38.46 19.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.796 0.331 . . . . 0.0 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.94 -179.4 3.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 56.8 -56.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.137 1.775 . . . . 0.0 114.593 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -89.66 128.14 36.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -78.34 40.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.773 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.674 ' HB2' HD22 ' A' ' 136' ' ' LEU . 22.2 t80 -101.11 -41.62 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.753 0.311 . . . . 0.0 111.275 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 133' ' ' TYR . 10.4 p-10 -128.49 58.78 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.563 0.697 . . . . 0.0 111.591 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.38 70.33 1.36 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.3 p -153.38 76.94 6.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.661 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.933 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 4.7 Cg_endo -82.65 146.38 13.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.0 112.643 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.4 OUTLIER -85.01 136.91 33.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.189 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.23 123.03 24.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.31 142.16 27.84 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.746 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -160.2 142.14 12.85 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 122.601 0.36 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.5 m120 -47.19 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.322 0.649 . . . . 0.0 112.708 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.9 -151.33 11.07 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.311 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.945 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.1 p90 -167.06 140.57 3.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.896 0.379 . . . . 0.0 111.19 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.45 146.67 24.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.729 0.299 . . . . 0.0 111.414 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 161' ' ' ARG . 15.1 m -97.65 144.18 27.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.805 0.336 . . . . 0.0 111.513 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -171.5 144.16 1.88 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.333 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -68.3 139.18 55.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 111.421 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.3 pp -73.1 -31.47 64.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.91 -50.19 0.6 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.714 ' HB2' HG13 ' A' ' 121' ' ' ILE . 32.5 t80 -64.54 -43.74 93.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 110.642 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 170.84 -44.34 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.252 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 41' ' ' SER . 6.2 mp -65.8 165.52 12.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.952 0.406 . . . . 0.0 111.827 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -121.79 141.45 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.473 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 151' ' ' THR . 13.5 p -98.13 120.36 38.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.499 ' HG2' HG23 ' A' ' 151' ' ' THR . 19.6 mtp-105 -103.39 95.18 5.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.696 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.744 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.74 -158.43 28.47 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.043 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.945 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -175.15 -174.58 0.76 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.102 0.477 . . . . 0.0 110.074 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 115' ' ' ASN . 22.8 ttt -118.2 126.01 51.33 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.811 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 20.7 t30 -88.15 123.96 33.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 115' ' ' ASN . 5.8 p -82.36 -121.5 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.143 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 p 53.85 53.15 11.73 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.04 -78.17 0.8 Allowed Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.023 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.1 120.77 22.64 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -102.42 140.29 36.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.735 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.3 pt -134.84 129.31 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.687 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' A' ' 35' ' ' VAL . 32.4 tp -105.45 111.14 23.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 81.1 tt0 -116.4 75.85 0.99 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 26.0 pt -110.49 122.58 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.158 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.01 109.81 21.49 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.235 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 23.1 m -83.96 123.78 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.27 0.557 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.1 p -143.37 171.48 14.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.625 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -59.14 143.34 49.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.096 0.407 . . . . 0.0 111.791 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.17 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 121.47 25.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.048 0.451 . . . . 0.0 111.224 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.91 -49.14 11.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.88 132.63 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.372 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.0 131.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.024 0.828 . . . . 0.0 112.263 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.26 -136.76 4.42 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.38 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.37 135.65 24.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t -78.76 134.63 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.093 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.51 -174.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.945 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.19 167.74 15.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -76.66 44.41 2.01 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.927 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.87 -38.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.354 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' HB ' ' A' ' 9' ' ' ILE . 1.8 p -64.83 -37.64 88.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.316 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.007 HD21 ' HB3' ' A' ' 70' ' ' ALA . 2.3 pp -82.06 169.58 16.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.7 m -159.51 170.7 21.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.068 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 6.7 p90 -55.06 -28.21 50.6 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.52 0.513 . . . . 0.0 112.221 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.16 -38.46 66.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.175 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.2 mp -66.69 -39.75 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.7 -34.7 78.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.019 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -65.82 -34.83 79.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.2 m -70.67 -38.94 73.81 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.496 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' ILE . 77.9 t -62.05 -37.86 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.445 0.64 . . . . 0.0 109.331 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 169' ' ' HIS . 5.5 tt -70.22 -41.12 74.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.45 -40.97 96.72 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.227 0.33 . . . . 0.0 111.255 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.87 75.17 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.338 0.399 . . . . 0.0 111.713 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 4.2 mm? -80.78 44.9 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.59 63.49 3.71 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.794 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -135.09 -45.84 0.71 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.24 153.7 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -69.73 -37.92 76.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.276 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 22.1 mmt180 -135.3 145.31 47.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -161.19 153.41 20.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.916 0.389 . . . . 0.0 111.39 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 8.8 tt -122.3 127.71 75.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.723 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -100.1 129.21 46.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.624 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.2 t -101.23 146.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.784 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.81 69.89 0.24 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.399 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -89.14 112.38 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 110.672 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 24.3 m-20 -84.79 91.69 8.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.748 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 36.3 t-20 -70.31 108.15 4.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.88 40.36 3.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.308 0.575 . . . . 0.0 109.851 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 t -92.52 -76.93 0.45 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.785 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 137.91 52.61 0.06 OUTLIER Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HD2' ' HG3' ' A' ' 94' ' ' MET . 18.9 pttm -157.84 138.26 12.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.719 ' HB ' ' HD2' ' A' ' 64' ' ' LYS . 29.1 p -83.74 128.26 34.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 111.949 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.797 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 36.1 m0 -99.06 151.22 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.221 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 11.3 m -135.52 138.99 43.62 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -55.16 122.53 11.23 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.746 ' HG ' HD23 ' A' ' 93' ' ' LEU . 2.1 tm? -120.45 -57.73 1.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.625 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -159.17 144.54 16.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.194 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.432 ' O ' ' HD1' ' A' ' 51' ' ' TYR . 1.3 t -156.03 140.5 16.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -153.5 128.41 9.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.955 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.606 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 39.5 m-85 -119.21 120.6 37.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.83 ' HD2' ' HB2' ' A' ' 130' ' ' GLN . 74.1 mtp85 -81.11 -47.83 12.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.831 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 59.1 m -77.17 -53.09 8.19 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.25 -139.77 4.1 Favored Glycine 0 C--N 1.323 -0.165 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 143.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 0.0 112.179 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.782 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 24.7 m -86.9 -49.1 7.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.56 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -176.84 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.042 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt 60.99 -65.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.461 1.104 . . . . 0.0 113.203 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.58 148.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.458 0.647 . . . . 0.0 112.691 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 90' ' ' LEU . 2.0 pp -90.89 165.39 22.24 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.147 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HD22 ' A' ' 71' ' ' LEU . 81.1 Cg_exo -50.74 139.45 39.69 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 123.711 2.94 . . . . 0.0 113.93 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' THR . 89.8 m-70 -66.03 -35.7 81.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 14.0 tppt? -143.08 132.25 23.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 46.4 t -125.44 93.58 44.63 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -87.38 -171.79 0.78 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.188 2.592 . . . . 0.0 113.268 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 19.4 t-160 -76.77 125.86 29.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.036 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.96 50.47 4.88 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.176 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -148.19 128.89 14.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.057 0.456 . . . . 0.0 110.863 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.007 ' HB3' HD21 ' A' ' 14' ' ' LEU . . . -89.78 132.06 35.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.809 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 65' ' ' VAL . 96.2 mt -92.39 97.39 10.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.192 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.867 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -99.08 136.03 39.63 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 4.7 m-85 -149.87 177.75 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 4.6 p-10 -151.17 97.8 2.48 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.603 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -73.54 136.35 22.0 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.734 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -118.31 150.87 38.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.911 0.484 . . . . 0.0 110.032 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -80.36 -155.2 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.555 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.05 119.15 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.919 0.888 . . . . 0.0 111.507 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -170.42 -40.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.873 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.09 -63.62 0.07 OUTLIER Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.619 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.72 140.94 44.06 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.81 2.34 . . . . 0.0 112.069 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.52 19.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.8 0.81 . . . . 0.0 111.085 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.49 41.59 1.47 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.506 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 17.3 p -137.51 126.03 23.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.376 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.81 -68.88 1.05 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.83 105.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.334 0.588 . . . . 0.0 110.77 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.8 t -136.61 127.5 41.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.64 -179.25 48.42 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.475 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.24 136.97 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 124.034 0.491 . . . . 0.0 111.369 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.5 pt? -121.79 144.86 48.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -144.34 130.7 19.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.487 0.66 . . . . 0.0 112.025 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 62' ' ' PRO . 1.9 m-85 -111.97 143.02 43.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.312 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.746 HD23 ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.471 ' N ' HD13 ' A' ' 93' ' ' LEU . 30.9 ttm -81.81 -93.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.613 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.9 m -151.17 -45.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 0.0 110.675 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -89.68 33.25 0.85 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.253 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . 67.64 47.59 61.02 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.646 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -124.16 140.15 53.24 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -113.99 113.08 24.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.331 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.4 tt -88.43 112.99 23.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -100.45 142.56 31.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.323 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 17.2 t -129.71 134.63 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.57 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 9.0 tt -106.98 145.59 32.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' HE1' HD21 ' A' ' 90' ' ' LEU . 50.3 m-85 -137.92 141.15 40.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.981 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG22 ' A' ' 87' ' ' VAL . 23.0 t -151.73 122.8 7.64 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 111.794 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.442 HG12 ' ND2' ' A' ' 115' ' ' ASN . 3.0 m -148.1 83.67 7.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.39 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HG2' ' HB3' ' A' ' 113' ' ' TYR . 25.1 Cg_exo -64.78 154.19 73.93 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.356 2.704 . . . . 0.0 112.882 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -80.96 -170.74 2.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.957 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.3 t0 69.6 145.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.146 0.978 . . . . 0.0 111.14 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -84.23 42.03 0.86 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.399 0.619 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -114.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -153.49 37.97 0.48 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.111 0.481 . . . . 0.0 111.669 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 48.0 m-85 -81.07 129.02 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -89.88 153.03 20.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.297 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.525 ' OD1' ' HA ' ' A' ' 166' ' ' SER . 3.7 m120 -76.42 146.94 38.3 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 8.3 m-90 -134.97 139.63 45.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.77 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 59.4 p-90 -142.9 141.57 31.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.997 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 11.7 t-20 -152.93 115.91 4.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 112.159 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 4.4 m -102.63 131.71 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.197 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' NH1' ' HE2' ' A' ' 133' ' ' TYR . 33.4 ttm180 -157.52 146.43 19.67 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.101 0.477 . . . . 0.0 111.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 156' ' ' TYR . 11.6 mm -87.81 137.22 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 101' ' ' ALA . 7.6 m-85 -122.9 136.55 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -82.18 46.84 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.63 -47.37 0.94 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.476 0.951 . . . . 0.0 115.476 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG2' ' HG3' ' A' ' 123' ' ' LYS . 12.4 ptmm? -68.34 140.83 55.91 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 72.39 123.14 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.654 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -88.64 127.3 35.57 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.134 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 1.026 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.85 149.16 29.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.773 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.18 -153.93 0.43 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.83 ' HB2' ' HD2' ' A' ' 53' ' ' ARG . 4.7 tp60 -72.67 -50.15 26.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.057 0.39 . . . . 0.0 111.946 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.868 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 19.1 ptp180 -73.81 7.76 2.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.026 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 10.0 mmt -84.22 -42.75 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.135 -0.353 . . . . 0.0 111.83 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.507 ' HE2' ' NH1' ' A' ' 120' ' ' ARG . 10.4 m-85 -126.9 -46.68 1.54 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.686 ' HA ' HD22 ' A' ' 140' ' ' LEU . 9.7 mt-10 -61.68 -27.36 68.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.868 ' HB2' ' HA ' ' A' ' 131' ' ' ARG . 32.1 tt0 -65.49 -41.88 92.76 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.904 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 139' ' ' ASN . 6.2 mp -90.57 130.88 36.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.697 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -64.57 -42.7 95.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.533 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -78.65 -31.72 46.94 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 5.5 m120 -88.55 44.83 1.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.633 0.254 . . . . 0.0 111.535 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.861 ' HG ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 tp -151.54 138.83 19.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.642 0.258 . . . . 0.0 110.631 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.9 m -154.65 62.84 3.75 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.522 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.861 ' HD3' ' HG ' ' A' ' 140' ' ' LEU . 4.0 Cg_exo -77.43 143.09 21.58 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.616 2.21 . . . . 0.0 110.669 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.8 OUTLIER -95.1 135.91 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.451 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 38.3 ptt180 -80.39 127.06 31.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.78 135.83 16.44 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.216 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -160.29 141.03 11.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.2 m120 -51.5 97.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.708 0.63 . . . . 0.0 111.86 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.83 -133.15 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.328 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.63 136.4 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.989 0.516 . . . . 0.0 109.615 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.29 155.56 11.43 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 2.9 t -137.21 152.08 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.502 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.621 HH11 ' HB2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -166.47 146.78 6.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.484 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 159' ' ' LYS . 71.8 m-80 -61.98 126.52 27.64 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 3.0 pp -69.86 -34.63 73.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.548 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 151.12 -51.95 0.51 Allowed Glycine 0 C--O 1.227 -0.304 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.61 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.857 ' HB2' HG13 ' A' ' 121' ' ' ILE . 36.3 t80 -66.01 -41.5 90.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 165.32 -42.61 0.29 Allowed Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.924 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 2.6 mm? -65.48 150.77 47.8 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.608 0.363 . . . . 0.0 110.991 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 1.067 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 31.6 mtmm -100.73 160.96 13.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 151' ' ' THR . 23.6 p -126.26 106.29 9.43 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.792 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 16.6 ptm180 -109.69 124.14 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.26 -144.38 6.69 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.543 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.0 166.61 15.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.995 0.426 . . . . 0.0 111.32 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 26.0 ttt -137.19 119.65 15.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.583 ' HB3' HG12 ' A' ' 171' ' ' ILE . 17.3 t30 -79.75 126.1 30.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.525 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 16.9 p -85.07 -131.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.819 0.699 . . . . 0.0 112.125 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.9 m 62.59 -145.52 0.38 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.151 0.58 . . . . 0.0 111.409 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -83.31 -37.72 11.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.054 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.886 ' HB3' HD11 ' A' ' 23' ' ' LEU . 63.5 m170 -102.77 115.55 30.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -104.72 142.46 34.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.95 HG22 ' HB3' ' A' ' 34' ' ' ALA . 29.2 pt -142.33 126.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.945 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 39.7 tp -108.25 119.5 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 79.0 mt-10 -126.73 70.92 1.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.429 0.633 . . . . 0.0 110.757 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.632 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -103.07 126.98 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.2 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -99.94 116.69 32.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' LYS . 17.5 m -86.88 116.68 29.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.364 0.602 . . . . 0.0 109.416 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 p -134.52 -173.79 3.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.653 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.0 tppp? -68.22 139.9 56.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 112.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.067 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.997 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.396 0.617 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 121.23 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.953 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.64 132.68 41.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t 61.07 61.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.464 0.649 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.43 133.19 15.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.225 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.72 44.19 64.07 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.783 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.46 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.576 0.227 . . . . 0.0 111.156 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.35 137.62 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -133.85 162.26 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.818 0.342 . . . . 0.0 111.744 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.98 161.15 11.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.028 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.32 46.93 1.07 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.54 -28.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.705 0.402 . . . . 0.0 110.566 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 19.6 m -68.31 -42.09 79.91 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.736 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 70' ' ' ALA . 2.9 pp -76.24 171.6 14.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.139 0.495 . . . . 0.0 112.267 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.7 m -163.06 167.65 22.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.07 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -52.2 -33.31 40.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.262 0.351 . . . . 0.0 111.18 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.89 -40.67 75.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.9 mp -64.86 -40.45 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.62 -35.97 79.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.133 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.88 -32.58 74.18 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -71.51 -44.52 64.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.519 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 18' ' ' ILE . 69.8 t -61.65 -34.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 109.268 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.6 tm? -66.43 -36.36 82.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.629 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.1 -37.95 89.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.249 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.06 62.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.23 48.4 1.0 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.45 39.16 2.11 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.696 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -106.15 -51.65 2.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.071 0.462 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -95.94 162.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.797 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.19 -66.68 0.51 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.656 0.265 . . . . 0.0 111.233 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 168' ' ' GLY . 23.1 mmt85 -79.11 138.14 37.8 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HD2' HD13 ' A' ' 23' ' ' LEU . 37.9 mttm -128.78 139.83 52.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.273 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.8 mm -115.41 134.08 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -140.73 135.07 31.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.902 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 25.1 t -129.6 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.1 96.71 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 28.8 t -102.95 116.64 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.957 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 23.1 m-20 -83.29 89.32 6.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.5 m-80 -81.4 114.77 20.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.75 38.11 3.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.865 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 t -71.55 -21.16 61.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.534 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 85.11 -39.39 2.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HD2' ' HG2' ' A' ' 94' ' ' MET . 26.1 mtmm -78.81 136.68 37.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.095 0.558 . . . . 0.0 110.433 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 p -79.41 128.97 34.01 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.38 0.425 . . . . 0.0 111.612 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 26.1 m0 -90.7 145.34 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 0.0 111.201 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.6 m -123.71 128.92 50.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -59.25 116.35 3.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.792 0.33 . . . . 0.0 111.787 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -104.61 -58.07 1.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.844 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -168.92 140.69 2.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 p -129.41 120.49 25.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.407 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -134.18 129.01 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.96 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 44.5 m-85 -105.91 145.32 31.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -82.37 -47.48 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.921 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.4 m -110.34 -78.87 0.59 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 111.668 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.66 -134.02 2.41 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.008 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 52' ' ' PHE . 12.9 t -165.06 -172.59 2.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.6 t -166.27 -58.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.371 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -151.25 124.55 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.475 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 pt -83.42 -15.89 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 m -148.49 145.87 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 15.7 tp -90.62 142.58 28.06 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.608 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 61' ' ' LEU . 51.0 Cg_exo -37.95 -61.48 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.676 2.917 . . . . 0.0 113.686 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -177.98 -50.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 63.5 mttm -153.14 146.75 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.613 0.244 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 39.7 t -117.34 98.56 52.0 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 11.5 Cg_exo -77.35 -119.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.13 3.22 . . . . 0.0 113.62 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 31.9 p-80 -145.83 136.24 24.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.66 33.44 24.8 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 89.6 mttt -142.03 122.74 14.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' HD21 ' A' ' 14' ' ' LEU . . . -89.8 123.29 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.32 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 65' ' ' VAL . 8.3 mp -95.29 126.69 40.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.872 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.68 144.87 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 85.3 m-85 -140.89 160.64 39.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.891 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.6 p-10 -154.0 128.52 9.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -119.66 160.73 14.4 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.936 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -152.6 167.55 28.52 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.865 0.466 . . . . 0.0 110.885 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' NZ ' ' HG2' ' A' ' 79' ' ' ARG . 51.7 tttm -100.66 116.15 31.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.07 8.35 43.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.456 ' HG2' ' NZ ' ' A' ' 77' ' ' LYS . 77.9 mtm180 72.53 145.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.252 0.621 . . . . 0.0 111.319 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.96 -159.35 12.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.59 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.43 -44.72 4.3 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.88 2.386 . . . . 0.0 112.872 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 m -102.83 137.16 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.271 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.72 113.67 18.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.802 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -151.06 -176.61 5.61 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.3 -59.95 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.913 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.521 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 105' ' ' SER . 47.4 t -141.24 140.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . 179.28 159.34 23.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.871 -1.157 . . . . 0.0 114.252 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 HD13 ' A' ' 103' ' ' LEU . 59.9 t -121.61 124.12 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.105 0.562 . . . . 0.0 110.664 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -103.64 136.47 43.29 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -135.08 123.4 23.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.598 0.713 . . . . 0.0 111.401 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 90' ' ' LEU . 30.6 m-85 -129.05 150.65 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.358 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -77.14 139.77 40.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 43' ' ' LYS . 50.1 ttm -100.61 -24.93 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 t -163.09 -101.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 111.039 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.73 -30.29 18.14 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.8 37.23 0.09 OUTLIER Glycine 0 C--O 1.224 -0.526 0 C-N-CA 119.107 -1.52 . . . . 0.0 113.888 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -116.08 138.2 51.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 5.9 m -122.34 120.76 34.98 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.9 tt -89.01 118.71 28.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.44 130.01 55.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 110.996 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 119' ' ' VAL . 19.1 t -118.91 134.94 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.438 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 65.5 tp -110.42 141.6 43.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 0.0 112.147 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HE1' HD21 ' A' ' 90' ' ' LEU . 33.3 m-85 -132.67 141.96 48.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 87' ' ' VAL . 9.3 t -149.05 129.74 14.1 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 33' ' ' ILE . 96.3 t -141.32 118.9 7.72 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.5 Cg_endo -82.22 149.69 15.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.709 2.939 . . . . 0.0 112.83 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -93.49 42.43 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.619 0.723 . . . . 0.0 109.875 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -153.25 160.76 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.732 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -120.89 63.05 0.87 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 111.702 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -132.12 -130.93 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.006 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -64.13 -35.05 79.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.618 0.367 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -62.08 143.64 56.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -147.02 164.23 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.509 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 105' ' ' SER . 67.2 m-20 -65.82 165.28 13.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 11.1 m-90 -148.98 149.2 30.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 63.7 p-90 -146.99 143.62 28.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.828 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.847 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 49.7 t30 -158.12 118.08 3.29 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 102' ' ' VAL . 3.8 m -103.29 128.65 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.181 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -150.15 150.93 32.33 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.94 HG13 ' HB2' ' A' ' 156' ' ' TYR . 33.4 mm -98.11 128.11 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.589 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.08 123.61 49.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -79.27 50.6 1.09 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 56.21 -140.15 42.84 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.604 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt 69.24 -46.22 0.57 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.142 0.977 . . . . 0.0 112.315 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -139.22 134.08 32.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.392 . . . . 0.0 110.322 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.4 ttp-105 -83.12 134.75 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.033 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.99 45.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.506 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 132' ' ' MET . 53.5 t0 -158.28 168.79 26.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.673 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -45.8 -46.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.591 0.756 . . . . 0.0 112.329 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.56 9.83 25.23 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.598 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 94.7 mmm -89.61 -40.0 12.88 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 121.74 -0.6 . . . . 0.0 112.067 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -131.29 -41.76 1.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.51 -0.119 . . . . 0.0 111.128 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 140' ' ' LEU . 50.5 mt-10 -73.32 54.35 0.42 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.985 0.421 . . . . 0.0 111.416 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -140.05 -58.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.282 0.563 . . . . 0.0 110.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.786 ' HB2' HD22 ' A' ' 139' ' ' ASN . 98.5 mt -90.9 138.6 31.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -56.67 -36.0 69.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -82.18 47.86 1.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.786 HD22 ' HB2' ' A' ' 136' ' ' LEU . 38.7 m-80 -147.84 -38.43 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 134' ' ' GLU . 5.0 mp -87.65 133.85 33.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.851 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 40.7 t -151.86 61.52 4.23 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.895 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.3 Cg_endo -82.3 161.92 17.48 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.946 2.431 . . . . 0.0 111.9 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.488 ' CZ ' ' HE1' ' A' ' 150' ' ' HIS . 7.6 t80 -73.25 -111.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -170.33 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.95 125.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.409 0.523 . . . . 0.0 114.409 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.53 141.58 9.07 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.805 -0.821 . . . . 0.0 111.36 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.6 m120 -53.25 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.839 0.856 . . . . 0.0 112.563 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . 179.65 -147.38 7.52 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.991 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.984 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 3.1 p90 -169.26 134.07 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.927 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.488 ' HE1' ' CZ ' ' A' ' 143' ' ' PHE . 0.6 OUTLIER -153.1 151.7 30.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 112.011 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -88.48 142.28 27.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.788 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -165.84 136.23 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.298 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 2.5 p30 -64.25 141.7 58.68 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.613 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.477 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.9 pp -87.88 12.19 13.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.19 -55.81 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.655 -0.783 . . . . 0.0 114.629 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.94 ' HB2' HG13 ' A' ' 121' ' ' ILE . 29.9 t80 -63.85 -45.74 88.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.665 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.22 -40.59 0.18 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.815 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 177' ' ' THR . 70.0 mt -64.85 170.41 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.563 0.345 . . . . 0.0 110.95 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -132.93 141.87 48.59 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 174' ' ' ILE . 23.0 t -99.18 128.09 45.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.237 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -109.97 94.09 4.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 173.14 -159.59 29.92 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.509 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.984 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -174.93 171.12 3.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 0.0 110.873 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttt -108.53 122.36 46.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.203 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.819 ' HB3' HG13 ' A' ' 171' ' ' ILE . 16.8 t30 -82.11 125.96 31.48 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 p -98.63 -119.63 0.14 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.776 0.43 . . . . 0.0 111.751 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 67.5 m 70.83 -45.57 0.61 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . 176.14 -50.58 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -99.5 118.82 36.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -89.39 132.17 35.11 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 165' ' ' ASN . 6.5 pt -140.19 116.49 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.658 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.603 ' HB3' HG13 ' A' ' 35' ' ' VAL . 19.2 tp -104.63 117.24 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.627 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.9 mt-10 -119.1 83.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.695 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.647 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.6 pt -110.81 122.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.522 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -99.16 104.27 16.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.443 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 18.2 m -83.81 119.64 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 6.6 p -141.77 -168.41 2.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.018 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 140.77 44.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.454 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.525 -0.75 . . . . 0.0 111.836 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.464 0.173 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.89 43.85 26.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.204 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.06 124.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.811 0.815 . . . . 0.0 112.781 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -84.99 131.55 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.268 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.62 52.14 1.62 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.036 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.06 9.16 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.305 -0.474 . . . . 0.0 113.804 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.34 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.76 132.86 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 13' ' ' SER . 0.1 OUTLIER -147.67 -165.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.694 0.283 . . . . 0.0 111.227 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.9 149.15 37.22 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.294 0.638 . . . . 0.0 111.874 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.71 47.77 1.53 Allowed Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.347 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.54 -27.0 0.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.066 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.565 ' HB2' HG13 ' A' ' 9' ' ' ILE . 2.0 m -77.28 -29.33 53.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.526 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.5 mp -72.77 136.86 45.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 m -133.03 162.69 31.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.631 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -54.74 -28.83 51.27 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.034 0.445 . . . . 0.0 111.147 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.4 -42.65 82.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.54 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.33 -36.59 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.69 -38.75 92.31 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.19 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -68.0 -36.46 80.02 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.6 m -63.5 -49.24 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.171 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG11 HD11 ' A' ' 72' ' ' LEU . 65.2 t -64.78 -41.12 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.26 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.894 HD21 ' HB3' ' A' ' 169' ' ' HIS . 33.5 tp -58.52 -40.73 83.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.71 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.77 -27.12 61.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.017 0.376 . . . . 0.0 112.017 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -62.61 -30.04 71.05 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -129.68 100.96 5.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.535 0.683 . . . . 0.0 111.64 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.76 ' HA3' ' HE2' ' A' ' 32' ' ' LYS . . . -154.93 57.31 0.4 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.338 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.58 -36.78 43.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG21 ' H ' ' A' ' 77' ' ' LYS . 9.3 m -79.9 178.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -65.16 -30.55 71.48 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' HB2' ' HD2' ' A' ' 77' ' ' LYS . 34.2 mmt180 -133.82 139.97 46.61 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.289 -0.257 . . . . 0.0 110.546 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.76 ' HE2' ' HA3' ' A' ' 27' ' ' GLY . 16.4 ptpt -113.9 140.88 48.0 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.099 0.249 . . . . 0.0 110.944 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 5.0 mp -119.87 131.65 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -134.95 137.45 43.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.144 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 48.0 t -130.06 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 111.532 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.65 83.67 0.17 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.0 t -90.14 110.97 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.5 m-20 -81.32 89.65 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.132 0.492 . . . . 0.0 110.196 178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.518 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 31.4 t30 -77.38 120.51 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 177' ' ' THR . 38.8 mt-10 -136.79 39.38 2.59 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.579 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -72.98 -51.52 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.8 43.14 0.76 Allowed Glycine 0 N--CA 1.46 0.242 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.067 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 94' ' ' MET . 17.4 pttm -166.26 146.29 6.17 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.875 0.47 . . . . 0.0 109.874 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.3 p -85.51 126.5 33.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 111.402 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.795 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 20.1 m0 -94.83 143.0 26.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.084 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 6.8 t -124.68 128.33 48.65 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.46 115.89 2.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.721 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 93' ' ' LEU . 41.5 tp -101.55 -46.45 4.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -163.12 143.37 9.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 90' ' ' LEU . 1.7 p -145.36 126.16 14.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.989 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.95 144.54 31.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.461 . . . . 0.0 111.869 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 24.4 m-85 -112.83 134.32 54.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 15.1 mmm180 -74.25 -32.63 63.04 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.9 m -162.82 148.82 12.33 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.6 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 167.61 31.1 Favored Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.595 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -129.1 125.46 37.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 111.715 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -135.75 -85.97 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -145.13 128.32 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.98 -41.48 76.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.4 t -109.83 133.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.914 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 50' ' ' THR . 8.5 mp -113.92 166.7 10.84 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.254 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 96.1 Cg_exo -46.04 137.59 13.21 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.471 2.781 . . . . 0.0 114.106 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 46' ' ' THR . 73.8 m-70 -73.49 -34.35 65.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.495 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 48.9 mmtm -129.84 141.73 50.78 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 67.3 t -128.49 81.42 70.66 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 161.54 32.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.376 2.717 . . . . 0.0 112.969 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.41 137.86 57.16 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.27 36.13 13.32 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.463 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -148.08 130.94 16.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.166 0.507 . . . . 0.0 110.746 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -92.35 133.94 35.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.84 111.38 22.76 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.552 HD11 HG11 ' A' ' 22' ' ' VAL . 1.8 tm? -87.37 135.58 33.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.648 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -147.47 160.67 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 9.5 p-10 -165.09 149.93 9.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.87 167.03 33.64 Favored Glycine 0 C--O 1.235 0.168 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.225 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -126.35 170.18 12.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.271 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 1.146 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 36.5 mtpt -97.78 156.18 16.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.622 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.61 119.63 7.41 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 50.54 -84.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.564 1.146 . . . . 0.0 113.665 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.6 -59.42 0.24 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.393 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.12 -39.04 33.26 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.461 2.108 . . . . 0.0 113.007 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.87 143.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 121.74 0.781 . . . . 0.0 112.072 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HA ' ' CD2' ' A' ' 108' ' ' TYR . . . -79.46 57.54 2.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.636 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -136.87 130.51 31.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.758 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 1.146 ' HA2' ' HE3' ' A' ' 77' ' ' LYS . . . -97.66 -133.11 7.76 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.414 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.18 116.76 14.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.391 0.615 . . . . 0.0 110.949 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.12 127.26 51.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -153.95 151.18 22.93 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.93 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.525 HG21 ' CE ' ' A' ' 132' ' ' MET . 98.8 t -128.66 133.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG22 ' A' ' 50' ' ' THR . 1.0 OUTLIER -114.85 140.23 49.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.541 178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.68 121.8 17.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.33 0.586 . . . . 0.0 111.166 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' HE1' HD12 ' A' ' 90' ' ' LEU . 9.2 m-85 -121.64 141.12 51.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.422 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD23 HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -77.96 142.71 38.16 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.753 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . 37.4 mtm -136.65 25.43 3.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.668 0.667 . . . . 0.0 112.382 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' MET . 32.1 t 176.53 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.903 0.383 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.1 -21.23 24.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.566 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.49 48.02 0.04 OUTLIER Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.025 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -127.86 135.41 50.0 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.48 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 13.9 m -128.77 124.33 35.23 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.9 tt -88.28 115.89 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.54 133.1 49.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 HG12 ' A' ' 119' ' ' VAL . 30.9 t -125.56 126.62 70.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.679 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 6.0 tt -107.03 147.18 30.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 111.545 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.959 ' HE2' ' HG ' ' A' ' 172' ' ' LEU . 82.7 m-85 -137.08 146.75 45.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 12.8 t -153.36 123.33 6.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.141 0.496 . . . . 0.0 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.602 HG22 ' OD1' ' A' ' 115' ' ' ASN . 67.2 t -129.75 106.83 16.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' ' H ' ' A' ' 114' ' ' SER . 20.1 Cg_exo -67.49 -147.99 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.089 2.526 . . . . 0.0 114.965 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.713 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 71.2 t80 -150.67 164.88 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 54.66 144.73 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.109 1.364 . . . . 0.0 113.811 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 113' ' ' TYR . 0.7 OUTLIER -80.76 43.6 0.69 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -89.24 -58.62 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.432 0.158 . . . . 0.0 110.611 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.57 48.36 0.24 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.276 0.56 . . . . 0.0 109.898 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 110' ' ' TYR . 53.9 p90 -75.08 137.18 41.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.176 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.554 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 41.1 m -154.81 132.93 11.7 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.852 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.639 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 80.6 m-20 -75.25 143.45 43.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.411 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.489 ' HE3' ' HG ' ' A' ' 105' ' ' SER . 5.8 m-90 -131.93 137.79 48.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 110.975 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.6 p-90 -133.3 145.65 50.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.05 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 11.4 t30 -147.27 105.48 3.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 102' ' ' VAL . 21.8 m -103.3 125.53 57.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.051 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -165.32 147.02 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.548 . . . . 0.0 112.209 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 156' ' ' TYR . 40.1 mm -81.48 133.0 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.627 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.49 128.96 56.63 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -88.22 140.24 29.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.215 0.531 . . . . 0.0 112.102 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.5 -140.08 18.62 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.108 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -134.09 43.94 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.597 0.713 . . . . 0.0 109.89 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -83.95 115.68 22.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.22 130.11 42.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.35 143.32 30.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.926 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 130' ' ' GLN . 2.1 p30 -169.35 -138.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.519 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 53' ' ' ARG . 24.7 pt20 -63.09 -34.58 77.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.93 0.395 . . . . 0.0 111.483 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 131' ' ' ARG . 2.1 mmm180 -92.1 25.56 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.525 ' CE ' HG21 ' A' ' 89' ' ' VAL . 10.2 ptp -78.7 -25.01 44.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' HD1' ' C ' ' A' ' 139' ' ' ASN . 81.6 t80 -69.43 -178.72 1.46 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 34.3 tt0 -56.98 -44.2 82.44 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.505 ' H ' ' HD2' ' A' ' 133' ' ' TYR . 8.7 pt-20 -175.32 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 96.4 mt -85.77 -60.16 2.1 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' HB3' ' H ' ' A' ' 138' ' ' TYR . 3.7 m-85 -67.61 -161.42 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.56 ' C ' ' HB2' ' A' ' 133' ' ' TYR . 5.1 m-85 -90.05 -49.6 6.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.63 HD21 ' HB3' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -151.7 146.22 25.61 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.89 0.376 . . . . 0.0 111.507 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.6 43.97 1.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.122 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.641 ' H ' ' HD3' ' A' ' 142' ' ' PRO . 4.7 t -177.42 41.88 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.641 ' HD3' ' H ' ' A' ' 141' ' ' SER . 86.3 Cg_endo -87.48 132.06 3.0 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.546 1.498 . . . . 0.0 113.031 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -103.8 134.2 47.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -74.02 122.87 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.493 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.7 140.54 28.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.129 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -150.78 145.45 25.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -49.47 90.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.547 0.739 . . . . 0.0 111.748 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.82 -152.26 12.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.831 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 1.033 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.2 p90 -168.65 144.65 3.58 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.26 146.21 19.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.989 0.423 . . . . 0.0 111.404 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -90.92 141.83 28.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.606 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.68 146.99 5.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.376 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 71.4 m-80 -60.99 131.24 50.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.7 pp -79.63 -23.39 42.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.217 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.46 -52.6 0.56 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.345 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' ILE . 11.4 t80 -76.41 -49.48 16.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.111 0.481 . . . . 0.0 110.704 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -179.62 -41.45 0.07 OUTLIER Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.094 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.3 mm? -57.55 156.83 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 122.803 0.441 . . . . 0.0 111.356 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.7 mtmp? -123.21 138.64 54.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.162 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.682 ' HB3' HG12 ' A' ' 176' ' ' VAL . 27.4 p -103.1 119.34 38.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 161' ' ' ARG . 20.7 ptt-85 -102.21 94.93 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.781 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.85 -158.84 24.2 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 1.033 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.6 OUTLIER -170.76 -142.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.258 1.029 . . . . 0.0 111.796 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.639 ' HE2' ' HB3' ' A' ' 115' ' ' ASN . 22.9 ttt -152.31 121.26 6.59 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.67 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 14.4 t30 -84.68 125.59 32.63 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.5 m -101.55 -119.57 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.695 0.622 . . . . 0.0 111.201 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.5 m 71.55 -47.51 0.66 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.788 0.835 . . . . 0.0 111.914 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 31' ' ' ARG . . . -172.86 -54.18 0.05 OUTLIER Glycine 0 C--O 1.226 -0.356 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.894 ' HB3' HD21 ' A' ' 23' ' ' LEU . 55.4 m170 -95.11 129.47 42.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.44 129.04 42.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.67 ' CG1' ' HB3' ' A' ' 165' ' ' ASN . 19.7 pt -139.06 132.01 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.09 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.959 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 4.5 mm? -101.5 124.42 47.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.542 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 7.1 pt-20 -127.27 62.43 1.35 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.895 0.855 . . . . 0.0 109.283 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.781 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.6 pt -106.52 122.37 60.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.908 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.02 111.86 24.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.682 HG12 ' HB3' ' A' ' 160' ' ' SER . 29.4 m -88.73 126.87 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.035 0.445 . . . . 0.0 110.953 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 40' ' ' GLU . 22.2 p -143.41 179.72 6.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.433 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -65.29 140.37 58.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.454 -0.784 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.81 -56.27 0.62 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.026 0.93 . . . . 0.0 111.943 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.56 -49.34 12.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.0 t 71.52 -53.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.795 0.838 . . . . 0.0 111.806 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.29 134.23 33.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 111.52 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.48 -55.63 2.03 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.017 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.98 118.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.581 0.752 . . . . 0.0 112.972 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -88.04 138.17 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.426 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.863 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -94.58 161.7 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.332 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.66 154.48 17.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.914 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.38 48.86 1.22 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 121.911 0.729 . . . . 0.0 112.846 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.67 -36.97 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.246 0.546 . . . . 0.0 110.266 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.7 m -83.05 52.57 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.062 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 38' ' ' ASP . 1.3 pt? -144.52 169.19 18.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' HD13 ' A' ' 18' ' ' ILE . 20.2 m -158.11 158.67 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.697 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -54.06 -30.5 48.26 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.558 0.536 . . . . 0.0 111.96 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.33 -39.34 85.84 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 mp -63.86 -37.61 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.71 HD23 ' HB ' ' A' ' 171' ' ' ILE . 2.3 tp -64.37 -41.83 96.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -63.56 -35.31 80.07 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -68.74 -40.17 80.0 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.246 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 18' ' ' ILE . 99.0 t -61.25 -42.78 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.202 0.525 . . . . 0.0 109.774 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 9.3 tt -63.79 -44.68 92.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.119 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -64.61 -52.49 57.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.348 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -33.69 71.13 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HZ1' ' A' ' 32' ' ' LYS . 2.2 tm? -62.05 -35.16 77.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.774 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.31 138.53 2.96 Favored Glycine 0 C--O 1.236 0.27 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.948 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -82.23 52.9 2.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.373 0.606 . . . . 0.0 110.954 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.898 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.7 p -89.69 -159.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.526 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.898 ' H ' HG22 ' A' ' 29' ' ' VAL . 47.6 pttt -79.56 -146.28 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.953 0.406 . . . . 0.0 111.89 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -59.48 132.51 54.21 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 111.609 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HZ1' HD12 ' A' ' 26' ' ' LEU . 17.0 ptmt -149.75 151.0 32.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -112.88 121.47 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.85 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -104.08 109.88 21.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 40.4 t -92.21 143.7 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.56 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.14 72.72 0.24 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 47.2 t -89.59 114.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.555 0.217 . . . . 0.0 111.518 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' OD1' HD21 ' A' ' 14' ' ' LEU . 40.8 m-20 -81.56 92.94 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.657 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.85 103.88 13.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.793 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HG3' ' HA2' ' A' ' 68' ' ' GLY . 5.1 mp0 -128.87 79.85 1.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.229 0.537 . . . . 0.0 109.856 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -130.54 -30.86 1.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 93.85 53.32 1.8 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 110.997 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' HE1' ' A' ' 45' ' ' TRP . 24.4 pttm -151.22 136.94 17.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 p -89.31 142.54 27.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.911 0.386 . . . . 0.0 111.668 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.828 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 21.4 m0 -118.85 151.62 37.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.271 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.8 m -141.85 127.79 19.47 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -53.84 118.57 4.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -105.3 -47.13 4.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.872 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -163.37 131.74 3.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.974 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.69 HG21 HD21 ' A' ' 61' ' ' LEU . 6.9 p -135.6 117.57 15.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.76 142.71 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 45.6 m-85 -106.12 139.22 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.54 -33.45 58.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.275 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.6 m -131.21 -82.25 0.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.56 -141.53 0.56 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-N 116.418 -0.355 . . . . 0.0 113.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 52' ' ' PHE . 9.1 t -177.87 160.41 1.48 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.684 0.754 . . . . 0.0 111.649 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.8 t -118.82 -55.89 2.15 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.48 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.71 144.72 7.41 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG13 HG23 ' A' ' 60' ' ' VAL . 36.9 pt -74.93 -28.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 59' ' ' ILE . 58.3 t -132.68 131.85 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.044 0.45 . . . . 0.0 110.543 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 50' ' ' THR . 0.7 OUTLIER -132.35 159.19 73.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.057 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.32 134.41 25.49 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.231 2.621 . . . . 0.0 113.431 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 35.5 p-80 -92.64 47.1 1.27 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.195 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 54.3 pttt -166.7 126.78 1.57 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.1 t -134.1 82.38 48.34 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -72.41 178.25 6.38 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.999 2.466 . . . . 0.0 112.37 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.462 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 42.7 p-80 -79.81 136.68 36.77 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.611 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 83.31 46.89 5.95 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.894 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -152.4 135.24 15.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.499 0.666 . . . . 0.0 112.074 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.41 125.88 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.553 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 65' ' ' VAL . 6.9 mp -81.02 99.9 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 50.6 tp -90.55 127.81 36.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 80.8 m-85 -146.89 165.22 30.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.342 0.115 . . . . 0.0 111.079 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.2 p-10 -145.69 114.03 6.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.481 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -102.58 147.65 17.18 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.489 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.588 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 83.5 mt-30 -122.17 -171.46 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.55 0.34 . . . . 0.0 110.49 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.628 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 9.3 mptt -120.02 -155.77 0.64 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.268 . . . . 0.0 110.8 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 77' ' ' LYS . 3.3 m-20 -74.59 156.81 36.39 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -99.33 -34.94 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.78 -157.84 9.81 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.022 -0.608 . . . . 0.0 114.242 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.14 -43.59 3.07 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.019 2.479 . . . . 0.0 112.189 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.74 129.93 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.052 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.85 135.58 29.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.769 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -100.16 -46.29 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HG3' ' A' ' 77' ' ' LYS . . . 134.76 -130.34 5.47 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.83 120.65 8.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.202 1.001 . . . . 0.0 112.38 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.2 t -144.92 135.45 19.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.5 161.23 34.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.553 -1.308 . . . . 0.0 113.646 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.942 HG22 ' HG ' ' A' ' 103' ' ' LEU . 97.5 t -125.99 129.93 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.187 -0.506 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.1 pt? -112.09 136.51 51.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -138.28 125.78 21.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.492 0.663 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.614 ' HE1' HD12 ' A' ' 90' ' ' LEU . 12.4 m-85 -122.89 140.28 53.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.812 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -79.06 131.83 36.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 34.6 ttm -85.95 -86.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.601 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.7 t -154.2 -42.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.936 -0.478 . . . . 0.0 111.758 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -89.19 31.31 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.631 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.93 42.61 92.66 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.055 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -125.61 141.6 51.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.595 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 2.7 m -119.59 120.66 37.36 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.821 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 45' ' ' TRP . 4.8 tt -87.73 116.15 25.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.95 135.23 42.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.541 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 119' ' ' VAL . 23.6 t -125.44 133.23 69.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.942 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.7 mp -110.77 146.71 35.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.751 0.31 . . . . 0.0 111.791 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' HE1' HD21 ' A' ' 90' ' ' LEU . 41.0 m-85 -137.21 147.25 45.71 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 17.6 t -157.18 136.99 12.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.572 0.225 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 7.1 p -156.7 120.74 2.32 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.316 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 7.2 Cg_exo -76.04 152.48 36.08 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.876 3.051 . . . . 0.0 113.727 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -98.9 37.45 1.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.891 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -164.97 137.59 4.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.781 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -89.01 120.64 30.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.367 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.94 -123.53 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -105.15 42.77 1.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.015 0.825 . . . . 0.0 111.328 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -126.49 150.05 48.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.69 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.2 p -144.73 174.39 11.02 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' SER . 7.9 m120 -69.37 145.77 52.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.736 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 7.8 m-90 -132.32 139.07 48.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.01 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 51.7 p-90 -140.6 148.26 40.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.2 t30 -159.66 115.13 2.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.933 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 102' ' ' VAL . 13.5 m -102.25 130.35 52.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.934 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.666 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 19.0 tpt180 -161.78 147.31 13.43 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.426 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 100' ' ' LEU . 35.0 mm -79.93 128.08 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 4.9 m-85 -122.9 135.74 54.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.31 146.15 53.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.408 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.23 -152.12 1.02 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.054 -0.521 . . . . 0.0 114.274 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt 71.41 -39.1 0.44 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.656 0.782 . . . . 0.0 111.517 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 3.7 mmp_? -123.37 129.65 51.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -84.91 134.39 34.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -75.82 149.31 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 19.0 t70 -137.27 -151.56 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.484 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 20.0 pt20 -84.55 -42.88 15.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -92.78 17.44 10.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 16.8 mmt -81.61 -43.57 18.44 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.519 -0.738 . . . . 0.0 112.203 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.658 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 16.0 m-85 -124.63 40.05 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 110.486 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -100.52 -139.46 0.33 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 59.4 -107.84 0.36 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.134 0.574 . . . . 0.0 111.773 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.11 138.27 56.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.042 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.52 48.96 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.45 0.643 . . . . 0.0 111.912 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -125.48 -22.14 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.163 0.506 . . . . 0.0 110.011 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.607 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 6.4 m120 -88.03 -42.74 12.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.307 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 133' ' ' TYR . 65.8 mt -89.9 140.77 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.917 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 t -153.85 65.26 5.15 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.588 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.647 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 2.4 Cg_endo -79.76 147.64 19.54 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.098 2.532 . . . . 0.0 112.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 4.4 t80 -98.37 139.18 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.48 125.47 29.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 110.76 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.11 135.82 14.8 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.552 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -159.91 144.27 14.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.531 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.3 m120 -51.24 93.92 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.84 0.713 . . . . 0.0 112.118 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.21 -126.35 0.82 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.34 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.2 p90 -168.1 142.57 3.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.969 0.508 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.56 154.5 11.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.999 0.428 . . . . 0.0 112.142 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.69 HG22 ' HG2' ' A' ' 159' ' ' LYS . 2.9 m -126.56 147.24 49.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.599 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -151.0 130.66 13.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.018 0.437 . . . . 0.0 111.735 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.5 t-20 -74.81 135.58 41.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.642 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 158' ' ' LEU . 10.1 mt -70.79 -34.07 71.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.602 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.55 -48.2 0.97 Allowed Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -64.27 -51.29 64.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.219 0.533 . . . . 0.0 110.987 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.5 38.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 178' ' ' LYS . 62.1 mt -138.87 162.03 35.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.928 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.69 ' HG2' HG22 ' A' ' 151' ' ' THR . 8.0 ttpp -147.76 127.02 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 41.4 t -100.36 130.25 46.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.774 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.1 ptt-85 -124.34 128.15 48.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.058 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.97 -144.53 6.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.843 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 5.6 p90 -165.53 159.44 16.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.386 0.612 . . . . 0.0 112.118 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.0 ttt -127.22 115.78 19.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.244 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.617 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 11.2 t30 -80.48 129.9 34.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.659 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.464 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 54.7 p -105.42 -125.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.164 0.915 . . . . 0.0 111.418 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.0 m 70.75 -48.11 0.65 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.724 0.81 . . . . 0.0 112.642 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.32 -57.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -89.65 125.48 35.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -97.35 127.8 43.62 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.85 HG22 ' HB3' ' A' ' 34' ' ' ALA . 36.3 pt -136.37 124.32 34.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.35 118.2 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -123.09 82.77 2.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 13.3 pt -110.81 119.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.148 0.499 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -94.29 116.34 28.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.5 p -101.62 125.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.192 0.52 . . . . 0.0 111.767 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 41.6 p -127.32 178.54 5.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.217 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.808 ' HA ' HD23 ' A' ' 158' ' ' LEU . 34.6 ttpt -79.76 65.98 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.186 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.66 143.3 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.927 0.767 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 56.9 45.78 20.78 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.622 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.68 46.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.222 0.534 . . . . 0.0 110.668 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.8 61.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.05 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.79 -135.73 2.52 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.72 127.04 15.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 0.0 111.017 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.11 134.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -135.47 162.41 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 111.285 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 152.18 25.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.257 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -52.68 -31.93 38.71 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.789 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.12 65.78 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 m -80.18 -29.29 38.65 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.55 148.19 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.353 0.597 . . . . 0.0 112.159 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.598 ' H ' HG22 ' A' ' 18' ' ' ILE . 88.5 p -153.66 174.75 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.402 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 26.3 p90 -64.58 -20.24 66.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.41 -49.07 17.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.304 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 15' ' ' SER . 10.5 tp -64.51 -32.56 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.85 -35.8 79.18 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.401 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 62.3 mttm -66.96 -39.02 87.13 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.6 m -67.12 -41.46 86.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.644 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.4 t -62.66 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.374 0.606 . . . . 0.0 109.704 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 169' ' ' HIS . 45.3 tp -70.39 -40.21 74.08 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.779 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 56.2 mt-10 -66.99 -50.19 63.01 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.859 0.361 . . . . 0.0 111.207 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.11 67.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.716 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -71.95 -11.0 60.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.42 145.42 6.33 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.901 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -83.51 61.85 6.46 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -96.71 153.97 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -60.23 -45.26 93.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.823 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -130.17 129.55 43.6 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 29.1 mtpp -150.39 154.38 37.67 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.301 0.376 . . . . 0.0 110.296 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.0 pt -112.6 134.4 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -136.5 122.01 19.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 98.7 t -135.74 150.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -151.14 96.76 0.17 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.5 t -89.09 119.76 36.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.484 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -79.01 91.75 4.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.324 0.583 . . . . 0.0 110.134 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 28.5 t-20 -78.52 119.11 21.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.347 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 7.4 tp10 -141.87 39.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 11.3 t -79.16 -20.43 48.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.467 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.51 46.75 8.57 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.843 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HE2' ' OG ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -168.09 135.15 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.509 0.324 . . . . 0.0 110.268 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -74.98 130.04 38.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.078 0.466 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.632 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.3 m0 -90.48 160.2 16.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 21.6 m -141.53 118.17 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.213 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 112.26 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 111.511 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.05 -52.08 3.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 127' ' ' ARG . 11.6 p-10 -161.77 143.3 11.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.592 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.581 HG21 HD13 ' A' ' 61' ' ' LEU . 16.5 p -142.47 128.83 20.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -141.85 149.04 39.78 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 111.853 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.1 114.37 15.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 130' ' ' GLN . 9.1 ptm180 -71.28 -32.68 68.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.655 ' HB3' ' H ' ' A' ' 87' ' ' VAL . 8.6 t -101.77 -99.79 0.27 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.319 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.09 -133.63 0.34 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.581 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -167.34 -176.41 3.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.956 0.407 . . . . 0.0 110.228 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -131.06 -62.64 0.88 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.616 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -174.76 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp 53.5 -52.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 126.03 1.732 . . . . 0.0 114.421 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.72 147.57 13.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.98 -0.45 . . . . 0.0 110.661 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD13 HG21 ' A' ' 50' ' ' THR . 6.9 mp -121.51 168.95 10.01 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 86.7 Cg_exo -47.25 139.06 16.6 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.425 2.75 . . . . 0.0 113.485 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' THR . 38.0 t-80 -73.49 -38.66 65.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.591 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 12.0 ptmm? -140.33 140.24 35.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 99.5 t -121.28 110.13 34.54 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 10.6 Cg_endo -92.34 162.59 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.714 2.943 . . . . 0.0 112.33 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.91 142.38 56.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.072 0.463 . . . . 0.0 111.853 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.86 35.64 24.27 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.726 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 56.2 mttm -150.23 138.61 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 133.92 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.479 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 65' ' ' VAL . 6.3 mp -78.72 111.72 15.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.005 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.69 126.24 30.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.928 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 55.9 t80 -136.8 142.57 42.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.996 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -168.06 143.12 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.708 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 33' ' ' ILE . . . -165.83 -170.7 31.1 Favored Glycine 0 C--O 1.241 0.554 0 C-N-CA 119.802 -1.189 . . . . 0.0 113.765 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -164.58 168.92 17.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 110.521 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -84.16 143.54 29.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 111.492 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.03 157.99 21.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.484 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 137.35 57.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.111 0.481 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . -177.7 147.98 8.44 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.078 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 3.1 Cg_exo -75.39 41.9 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.125 2.55 . . . . 0.0 112.691 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 m -151.46 146.19 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.021 0.528 . . . . 0.0 110.134 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.69 112.27 16.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 3.1 p -144.81 134.05 22.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 106' ' ' VAL . . . -91.29 -129.95 4.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.579 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.4 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.772 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' H ' ' HB3' ' A' ' 54' ' ' SER . 18.7 t -131.14 133.54 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.72 160.44 31.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.188 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 103' ' ' LEU . 98.1 t -124.55 129.18 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.972 0.415 . . . . 0.0 111.46 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD21 ' HE1' ' A' ' 104' ' ' PHE . 1.2 pt? -110.54 140.6 44.67 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -137.76 127.87 25.94 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.575 0.702 . . . . 0.0 111.781 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' THR . 5.4 m-85 -123.73 145.47 48.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.29 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 132.94 38.9 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 100' ' ' LEU . 64.4 mmm -84.59 -60.2 2.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.402 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 t -177.27 -55.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 111.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -89.41 38.95 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.257 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.49 39.2 87.14 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.503 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -118.66 144.15 46.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.9 m -124.43 115.38 20.84 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.547 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 5.8 tt -87.24 117.16 25.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -104.23 139.99 38.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 119' ' ' VAL . 22.0 t -126.01 132.42 70.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.427 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 2.9 tm? -109.45 144.77 37.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.53 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.627 ' H ' HD22 ' A' ' 103' ' ' LEU . 88.2 m-85 -138.27 142.6 39.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.172 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 23.1 t -148.29 126.4 12.11 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.569 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 77.8 t -136.55 118.17 11.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.234 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -75.9 138.25 20.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.2 2.6 . . . . 0.0 112.616 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -102.91 41.73 1.22 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.893 0.854 . . . . 0.0 109.924 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -128.27 -134.4 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.182 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 11.1 m-85 -71.89 139.92 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.693 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -71.75 43.31 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 110' ' ' TYR . 22.0 m95 -102.98 -39.84 6.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.651 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -78.15 135.85 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.8 m -89.08 154.39 20.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.957 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' HG22 ' A' ' 106' ' ' VAL . 81.9 m-20 -63.69 155.16 30.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.216 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 25.3 m-90 -128.06 131.02 49.13 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.084 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.719 ' HZ2' ' HD2' ' A' ' 150' ' ' HIS . 35.1 p-90 -136.64 143.83 43.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.846 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.7 t30 -156.88 118.93 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 102' ' ' VAL . 18.6 m -102.44 134.73 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.953 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -163.88 140.58 6.8 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.163 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 156' ' ' TYR . 64.7 mt -91.12 134.64 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.683 . . . . 0.0 112.453 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -117.47 133.05 56.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.085 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.01 130.25 34.65 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.325 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -177.66 52.75 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.361 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 3.5 mppt? -76.42 130.59 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -131.86 -35.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HA ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 ttt85 58.17 50.18 10.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.611 0.719 . . . . 0.0 109.769 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.514 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -71.0 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.001 -1.0 . . . . 0.0 113.63 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.68 -124.17 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.053 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' A' ' 131' ' ' ARG . 1.8 pm0 -86.26 -40.04 15.95 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.635 -0.666 . . . . 0.0 112.743 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -70.13 -39.58 75.34 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 52.3 tpp -55.45 -45.26 76.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 6.1 m-85 -74.25 -37.71 63.7 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -73.33 -38.4 65.79 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.07 -48.35 81.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.083 0.468 . . . . 0.0 111.919 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.39 122.88 34.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.939 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.74 -43.74 98.26 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -91.71 46.6 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.418 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.52 -44.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -89.2 133.78 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.342 0.591 . . . . 0.0 111.05 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -168.13 56.75 0.33 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.266 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.87 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -68.84 141.11 48.12 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.372 2.048 . . . . 0.0 113.018 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 30.5 t80 -92.85 137.11 32.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -73.79 128.37 35.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.21 139.83 30.03 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.818 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.24 136.36 19.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.559 0.219 . . . . 0.0 110.531 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.2 m120 -56.63 -9.2 0.69 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.539 0.736 . . . . 0.0 112.843 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -123.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -143.37 144.16 31.95 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.719 ' HD2' ' HZ2' ' A' ' 117' ' ' TRP . 67.8 t60 -147.4 141.58 26.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 161' ' ' ARG . 4.5 m -144.28 146.36 32.58 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 179.78 148.81 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.506 0.322 . . . . 0.0 111.266 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 3.9 t30 -69.9 129.56 39.83 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 158' ' ' LEU . 4.3 pp -66.27 -30.86 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.416 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.99 -54.02 0.54 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.583 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.745 ' HB2' HD12 ' A' ' 121' ' ' ILE . 13.4 t80 -67.97 -42.89 80.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.97 -32.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.175 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.6 mm? -71.56 150.98 44.23 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.505 0.322 . . . . 0.0 110.227 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 7.0 mtmp? -118.12 137.59 52.84 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.663 ' HB3' HG12 ' A' ' 176' ' ' VAL . 26.1 p -103.86 130.04 51.39 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.044 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.794 ' HB3' HG23 ' A' ' 151' ' ' THR . 18.7 ptt-85 -130.72 129.6 42.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.969 0.414 . . . . 0.0 109.887 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 174.61 -139.24 4.78 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.454 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -174.02 156.35 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.965 0.412 . . . . 0.0 110.967 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.4 ttt -124.55 111.98 16.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.415 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.609 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 16.3 t30 -79.04 127.87 32.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.582 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.5 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 24.4 p -97.45 -112.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.185 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.6 p 64.59 -54.32 0.28 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.217 1.407 . . . . 0.0 113.427 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.01 -45.28 0.03 OUTLIER Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.567 ' HB3' HD21 ' A' ' 23' ' ' LEU . 56.8 m170 -106.7 122.89 47.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 33' ' ' ILE . . . -88.87 128.42 35.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 34' ' ' ALA . 27.3 pt -135.08 117.1 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.862 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.688 ' HB3' HG13 ' A' ' 35' ' ' VAL . 24.3 tp -103.53 118.07 35.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.32 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.424 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 74.5 mt-10 -116.75 63.75 0.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.363 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.496 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 4.9 tp -100.57 122.86 53.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 160' ' ' SER . 10.7 m170 -103.88 132.85 49.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 160' ' ' SER . 18.0 m -107.41 119.24 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.208 0.528 . . . . 0.0 111.062 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.4 p -139.38 -167.45 2.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.142 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.63 142.18 51.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.59 0.233 . . . . 0.0 111.377 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.406 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.318 0.118 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.05 -58.79 0.56 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.81 0.844 . . . . 0.0 112.072 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.04 127.75 34.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.953 0.406 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.07 138.79 18.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.83 42.61 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.56 -140.55 3.63 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.558 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.24 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 111.734 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -79.78 145.56 9.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.092 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -89.03 164.39 2.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.874 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.98 152.63 15.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.77 46.75 1.16 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.775 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.27 -28.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.6 m -85.89 16.04 4.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -101.69 161.09 13.91 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.975 -0.453 . . . . 0.0 111.029 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 18' ' ' ILE . 39.8 p -161.7 161.31 29.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.307 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -63.53 -26.07 68.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.298 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 9.5 t70 -77.3 -42.17 37.89 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.637 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.2 tp -62.57 -33.97 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 171' ' ' ILE . 1.9 mp -63.82 -44.45 93.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.172 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 17' ' ' ASP . 47.9 mttm -59.5 -41.93 91.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -60.91 -30.84 70.43 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.393 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 18' ' ' ILE . 92.6 t -64.14 -48.97 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.321 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 32' ' ' LYS . 1.8 mm? -58.89 -38.22 78.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.934 0.397 . . . . 0.0 111.279 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.71 -32.66 73.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.78 98.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.409 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 74' ' ' ASN . 3.0 mm? -63.93 -47.52 80.19 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.914 0.387 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.48 147.7 4.84 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.969 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -66.95 90.54 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.009 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.7 t -129.58 157.83 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.662 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.0 -39.75 93.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.27 146.61 43.2 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HE2' ' CB ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -176.64 142.49 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.917 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 23.3 pt -110.78 141.18 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.807 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -139.43 135.28 33.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.737 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 38.9 t -124.01 145.83 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.68 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.33 75.0 0.22 Allowed Glycine 0 C--N 1.331 0.283 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.6 t -87.32 114.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.187 0.517 . . . . 0.0 111.152 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.0 t0 -78.98 88.64 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.683 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -78.08 102.46 7.48 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.258 0.551 . . . . 0.0 112.071 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' HB3' HG22 ' A' ' 177' ' ' THR . 8.7 tp10 -131.68 84.94 2.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.682 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -141.88 -31.62 0.55 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.463 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 99.05 37.84 4.0 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.521 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.4 pttm -133.0 125.42 29.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 p -83.23 128.72 34.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 35.5 m0 -97.72 164.32 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.247 0.546 . . . . 0.0 112.301 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.4 m -144.28 100.2 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.435 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 63' ' ' HIS . . . -50.08 119.37 3.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 93' ' ' LEU . 60.7 tp -81.15 -56.35 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.374 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.468 HD21 ' HA ' ' A' ' 127' ' ' ARG . 20.0 p30 -176.28 149.71 0.87 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.539 HG21 HD21 ' A' ' 61' ' ' LEU . 4.6 p -118.42 128.78 54.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -133.44 123.61 25.61 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 28.6 m-85 -116.01 117.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.181 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 2.5 tpm_? -77.87 -42.56 33.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.917 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.607 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 47.9 t -80.85 -86.34 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.707 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -88.1 -139.35 6.45 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.419 -0.419 . . . . 0.0 113.145 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 t -165.64 -173.85 2.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.305 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -167.9 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -173.78 175.04 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.134 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -112.01 -26.0 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.723 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 59' ' ' ILE . 64.2 t -139.12 135.03 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.299 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 1.1 pt? -148.45 176.22 2.34 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.339 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 63.8 Cg_exo -40.84 132.61 2.71 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.266 2.644 . . . . 0.0 113.204 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' ND1' ' HB3' ' A' ' 47' ' ' ALA . 95.2 m-70 -92.27 -47.86 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 11.2 ptmm? -80.18 127.68 32.62 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 96.6 t -120.55 98.01 48.44 Favored Pre-proline 0 N--CA 1.463 0.199 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.56 173.53 12.19 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.115 2.543 . . . . 0.0 112.629 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.63 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 50.7 p-80 -75.74 139.74 42.04 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.148 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 40' ' ' GLU . . . 78.45 43.67 12.22 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.176 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 84.8 mttt -152.08 133.28 14.38 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.01 0.433 . . . . 0.0 111.009 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -92.59 130.54 38.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.257 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.694 HD21 HG22 ' A' ' 65' ' ' VAL . 89.7 mt -81.68 107.25 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -89.17 133.82 34.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.833 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.3 t80 -150.26 160.27 43.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.587 HD22 HD21 ' A' ' 26' ' ' LEU . 14.4 p-10 -167.07 144.72 4.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.897 0.479 . . . . 0.0 110.039 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -154.11 177.81 31.33 Favored Glycine 0 C--O 1.237 0.33 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.008 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -133.05 -171.52 2.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.227 0.211 . . . . 0.0 110.973 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 8.2 mttp -75.64 -176.59 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.107 0.479 . . . . 0.0 112.064 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.07 -40.61 78.36 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -146.9 -47.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.681 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.04 -63.28 0.61 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.141 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.17 -30.38 46.5 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.779 2.32 . . . . 0.0 112.476 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 83' ' ' ALA . 8.8 p -85.2 -179.96 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.358 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.725 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -80.47 -152.5 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.73 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.607 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 36.1 p 52.79 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.243 1.417 . . . . 0.0 113.101 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -92.09 -65.38 1.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -169.39 123.66 0.81 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.253 0.527 . . . . 0.0 112.261 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 105' ' ' SER . 58.5 t -150.07 129.77 3.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -176.08 -178.38 45.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.508 -1.329 . . . . 0.0 113.25 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.844 HG22 ' HG ' ' A' ' 103' ' ' LEU . 48.6 t -136.57 137.35 47.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.358 -0.421 . . . . 0.0 111.237 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -110.93 147.59 34.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -141.58 126.53 18.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.049 0.452 . . . . 0.0 112.183 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -130.19 143.9 51.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.804 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 48' ' ' LEU . 2.9 mm? -79.0 139.98 38.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.4 ttm -98.87 -54.71 2.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.4 t -164.55 -70.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.33 48.18 1.58 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.588 0.709 . . . . 0.0 110.558 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.79 32.35 80.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.669 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 5.7 m120 -92.16 130.62 37.83 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.579 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 18.5 m -109.67 114.31 27.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.439 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.5 tt -88.19 118.22 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -109.49 135.35 50.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.724 ' HB ' HD21 ' A' ' 90' ' ' LEU . 39.5 t -126.31 131.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.063 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.844 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -106.68 147.14 29.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' HE1' HD21 ' A' ' 90' ' ' LEU . 78.3 m-85 -138.4 145.3 40.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.896 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.2 t -150.23 119.59 6.87 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 59.0 t -134.01 119.41 14.63 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.573 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.8 Cg_exo -77.3 -169.92 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.155 2.57 . . . . 0.0 113.335 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HE1' ' HE2' ' A' ' 77' ' ' LYS . 27.4 t80 -122.45 -174.94 3.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.847 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' N ' ' CG ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -61.15 -23.68 65.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.462 0.705 . . . . 0.0 112.55 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -69.48 -34.82 74.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.716 0.293 . . . . 0.0 111.507 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -137.38 103.03 4.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -74.87 54.99 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.249 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.498 ' HD2' ' HH2' ' A' ' 116' ' ' TRP . 3.3 m-85 -77.94 168.24 20.22 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.792 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -88.5 149.83 23.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' SER . 82.5 m-20 -66.27 155.78 36.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.021 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.868 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 13.0 m-90 -134.3 144.1 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 62.5 p-90 -145.85 142.65 29.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.627 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.8 t30 -152.79 113.79 4.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 102' ' ' VAL . 16.0 m -101.92 134.68 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.742 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -166.6 146.46 5.82 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.639 HD13 ' HG ' ' A' ' 100' ' ' LEU . 12.7 mm -87.74 126.02 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.169 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.23 107.61 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.4 OUTLIER -79.21 120.45 23.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.09 90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.463 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -137.12 -47.68 0.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.676 0.238 . . . . 0.0 111.513 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' HD21 ' A' ' 48' ' ' LEU . 53.5 mmm-85 61.52 101.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.173 0.589 . . . . 0.0 112.548 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.468 ' HA ' HD21 ' A' ' 49' ' ' ASN . 81.9 mtp180 70.56 125.11 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB1' ' HE1' ' A' ' 133' ' ' TYR . . . -157.13 166.34 33.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.747 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.82 169.26 9.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -57.73 -26.31 61.62 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.179 0.299 . . . . 0.0 111.17 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.62 -37.25 73.79 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.004 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -71.81 -36.74 70.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.176 0.513 . . . . 0.0 110.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 38.4 m-85 -107.49 43.2 1.21 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.465 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 140' ' ' LEU . 58.0 tt0 -87.45 -59.1 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.54 42.77 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 139' ' ' ASN . 84.6 mt -66.01 -45.61 80.91 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.273 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -173.36 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.73 43.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.725 0.774 . . . . 0.0 109.612 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 136' ' ' LEU . 5.4 m120 -91.93 -35.26 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 142' ' ' PRO . 6.5 tt -88.66 119.47 29.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.272 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.9 p -167.82 68.35 0.84 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.868 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 3.2 Cg_endo -83.95 147.0 11.76 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.118 2.545 . . . . 0.0 112.111 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -88.48 141.39 28.57 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -73.05 123.34 23.35 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.25 131.99 10.84 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.688 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.507 ' H ' ' HE2' ' A' ' 163' ' ' PHE . 38.4 t70 -163.49 130.65 3.42 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 109.964 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.464 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 1.6 m120 -28.86 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.441 1.096 . . . . 0.0 113.541 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.78 -154.47 12.4 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.922 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.8 p90 -174.48 143.84 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -163.92 173.58 12.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.675 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.856 HG22 ' HG3' ' A' ' 161' ' ' ARG . 1.9 p -91.35 152.18 20.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.168 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -153.23 123.52 7.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -77.41 126.62 31.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.71 -38.57 83.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.634 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.04 -42.68 1.23 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.686 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.61 47.83 1.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 82.56 -51.83 4.59 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.223 -0.513 . . . . 0.0 114.167 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 158' ' ' LEU . 2.7 mm? -56.69 149.82 17.11 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 117.227 0.514 . . . . 0.0 111.73 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.714 ' HE3' ' HB1' ' A' ' 179' ' ' ALA . 6.1 mtmp? -135.12 143.78 46.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.402 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 23.5 p -100.44 127.35 46.8 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.148 0.499 . . . . 0.0 111.488 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.856 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.6 mpt_? -104.19 107.57 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 170.04 -150.21 14.34 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.036 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.922 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 1.7 t80 -173.24 -141.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.938 0.399 . . . . 0.0 111.78 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.437 ' H ' ' HD2' ' A' ' 163' ' ' PHE . 17.7 ttt -157.56 123.41 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.749 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.691 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 19.6 t30 -88.52 142.04 28.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.4 t -99.8 -127.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.759 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 m 62.4 46.31 5.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.138 0.494 . . . . 0.0 111.855 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.9 -50.25 4.1 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.79 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 m170 -100.36 113.98 27.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -88.94 132.35 34.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' A' ' 34' ' ' ALA . 27.6 pt -133.41 120.88 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.955 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.476 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 20.4 tp -93.66 110.05 21.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 95.6 mt-10 -116.24 64.17 0.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.109 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.649 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.9 pt -105.07 117.8 51.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.07 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 m170 -97.22 108.1 20.76 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 2.7 p -85.87 122.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.325 0.583 . . . . 0.0 110.473 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.9 p -145.85 -154.91 0.57 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.441 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.454 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.31 143.57 50.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.714 ' HB1' ' HE3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.629 -0.701 . . . . 0.0 111.826 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.08 43.13 21.35 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.368 0.418 . . . . 0.0 111.819 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.86 125.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.485 0.714 . . . . 0.0 112.019 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.3 136.67 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.325 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.45 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.603 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.85 -135.1 2.73 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.299 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.8 34.78 21.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.38 0.672 . . . . 0.0 112.213 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 t -138.4 71.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 109.537 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.802 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -105.22 167.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.387 -178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.14 147.73 15.58 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.5 48.77 0.98 Allowed Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.057 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.65 -30.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.1 m -73.05 -26.06 61.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 14' ' ' LEU . 2.3 pt? -71.28 176.94 4.16 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 97.4 p -167.59 174.73 7.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.946 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 13.4 p90 -63.72 -24.08 67.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.36 -48.47 22.88 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' VAL . 11.1 tp -61.71 -30.81 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.4 -36.75 83.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.237 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 68.1 mttm -65.13 -39.18 92.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -65.77 -37.36 86.11 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.366 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 18' ' ' ILE . 84.0 t -61.47 -36.12 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.485 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -80.58 -45.08 17.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.435 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.29 -28.88 69.51 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.045 0.216 . . . . 0.0 111.318 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.57 -31.04 61.86 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.669 0.388 . . . . 0.0 111.864 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.826 ' HG ' ' HE2' ' A' ' 32' ' ' LYS . 2.2 pt? -138.84 45.4 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.339 0.59 . . . . 0.0 111.389 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.94 52.63 3.65 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.724 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.41 -48.4 15.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.024 0.44 . . . . 0.0 111.09 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' GLN . 18.4 m -86.75 156.6 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.702 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -61.49 -47.98 83.16 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -109.88 135.67 50.4 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.68 0.276 . . . . 0.0 111.609 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.826 ' HE2' ' HG ' ' A' ' 26' ' ' LEU . 29.7 mtpp -149.07 143.82 26.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -118.42 117.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.203 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -103.26 120.01 39.95 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 45.5 t -104.57 142.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.105 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.44 79.66 0.2 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 174' ' ' ILE . 39.9 t -88.76 112.26 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 19.1 m-20 -83.22 89.71 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.395 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 25.2 t-20 -77.9 129.62 35.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.742 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 177' ' ' THR . 14.4 tp10 -141.12 43.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 158' ' ' LEU . 36.1 t -84.75 -33.65 23.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.358 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' ' HB3' ' A' ' 67' ' ' HIS . . . 101.14 -40.49 2.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.127 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.673 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.4 pttm -78.82 127.85 32.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 129.96 39.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 29.2 m0 -94.97 157.73 15.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.701 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 30.3 m -136.91 128.37 28.42 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 118.71 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 112.13 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -102.65 -49.81 3.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.94 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -166.7 138.37 3.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 61' ' ' LEU . 13.8 p -139.77 122.93 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.046 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.88 144.24 31.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.63 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 21.9 m-85 -115.32 146.26 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.444 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 3.7 tpm_? -76.24 -38.94 55.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.125 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -142.55 -63.76 0.42 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.015 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.738 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -65.41 135.74 36.52 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.078 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.5 p -97.45 122.24 40.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.562 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 27.7 t -105.77 -56.07 2.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -174.84 144.2 0.78 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.4 mp -75.17 -35.26 33.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.05 170.99 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.311 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 50' ' ' THR . 0.9 OUTLIER -170.34 162.74 6.21 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 Cg_endo -54.71 131.88 48.41 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.052 2.501 . . . . 0.0 112.396 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.7 p-80 -94.38 38.9 1.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.902 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 mttm -154.99 121.53 5.35 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.919 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 89.4 t -124.67 89.89 51.7 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 1.5 Cg_endo -87.61 163.72 7.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.303 2.668 . . . . 0.0 111.97 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.581 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -69.72 148.49 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 111.713 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.83 35.27 51.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 9.3 mtpm? -145.72 131.34 18.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 111.334 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.69 131.35 35.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 HG13 ' A' ' 65' ' ' VAL . 3.2 mm? -90.27 101.23 13.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.11 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -86.54 134.33 33.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.326 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.811 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 92.9 m-85 -146.95 162.87 37.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t-20 -153.96 133.36 12.74 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -134.59 155.1 21.76 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.672 -0.775 . . . . 0.0 114.199 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG2' HG21 ' A' ' 29' ' ' VAL . 27.0 mt-30 -120.91 -139.69 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.427 0.691 . . . . 0.0 109.947 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.664 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 22.2 ptmt -147.48 140.36 24.95 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.922 0.328 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -87.78 16.98 5.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.693 0.283 . . . . 0.0 111.645 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 66.34 148.29 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.417 0.627 . . . . 0.0 112.399 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.06 154.71 15.48 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.243 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.68 -42.23 40.88 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.941 2.427 . . . . 0.0 112.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 p -77.45 160.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.936 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -78.66 104.47 9.29 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.249 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 p -141.31 135.73 30.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' LYS . . . -104.05 -66.61 0.71 Allowed Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.738 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -165.55 116.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.0 110.759 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 53' ' ' ARG . 43.0 t -130.59 135.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -172.14 158.34 28.83 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.653 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.754 HG22 ' HG ' ' A' ' 103' ' ' LEU . 60.8 t -123.82 127.36 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.332 -0.434 . . . . 0.0 111.457 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -109.59 139.74 44.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -140.23 130.0 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.359 0.6 . . . . 0.0 111.64 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.661 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.6 m-85 -126.75 146.73 50.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.101 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' N ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -79.1 133.25 36.77 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.673 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 32.3 ttm -81.42 -57.03 3.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -171.31 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.11 -48.58 7.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.933 0.397 . . . . 0.0 111.373 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.53 44.61 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -124.42 127.47 47.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.743 HG22 ' HB1' ' A' ' 91' ' ' ALA . 12.5 m -106.37 116.32 31.73 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.976 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 5.1 tt -88.24 124.01 33.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -111.03 136.25 50.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.651 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 119' ' ' VAL . 21.6 t -120.93 130.18 74.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.05 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.3 mp -102.92 145.91 29.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.6 m-85 -136.54 141.45 43.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.0 t -149.67 129.95 13.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 33' ' ' ILE . 91.5 t -138.51 125.86 13.39 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.274 0.359 . . . . 0.0 110.88 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.2 Cg_exo -82.81 156.47 15.68 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.961 3.107 . . . . 0.0 113.539 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -109.87 130.87 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.583 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 54.67 -44.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.855 1.662 . . . . 0.0 115.398 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -59.09 125.67 24.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.99 0.813 . . . . 0.0 111.451 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -84.23 -30.43 25.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -60.37 -37.58 81.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -80.57 139.81 36.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.937 0.399 . . . . 0.0 111.523 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -116.51 169.06 9.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.4 159.26 32.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 14.4 m-90 -141.31 135.71 30.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 23.8 p-90 -137.37 143.63 42.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.08 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.841 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 15.9 t-20 -155.71 122.36 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.258 0.551 . . . . 0.0 112.172 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 102' ' ' VAL . 4.5 m -103.65 123.27 57.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -148.9 148.87 30.34 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 154' ' ' LEU . 3.8 mp -93.88 135.87 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.367 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -125.75 -164.02 1.27 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.813 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -107.75 147.98 30.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -75.16 49.33 2.21 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.539 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -146.74 134.67 21.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.86 137.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.706 0.628 . . . . 0.0 111.098 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.588 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -76.96 131.78 38.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.12 138.43 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.102 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 2.9 p30 -158.19 -154.08 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.845 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 130' ' ' GLN . 3.5 pm0 -66.24 -36.49 83.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 tpt -62.12 -39.94 94.23 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.175 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.447 ' CE2' HD21 ' A' ' 103' ' ' LEU . 9.3 m-85 -84.31 -48.13 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.482 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -86.3 50.71 2.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.931 0.395 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.542 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 4.3 tp10 -90.09 -139.04 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.542 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 84.4 mt -80.25 -44.11 20.23 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.056 0.455 . . . . 0.0 110.951 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -84.93 152.2 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.115 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -72.24 67.38 0.68 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.123 0.487 . . . . 0.0 111.293 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.8 52.39 2.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.217 0.532 . . . . 0.0 110.969 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.19 113.12 4.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.5 m -158.24 61.95 2.22 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.863 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 60.2 Cg_endo -72.05 149.59 52.86 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.01 1.807 . . . . 0.0 112.96 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.2 OUTLIER -83.35 133.61 34.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.474 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -69.72 115.13 8.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.439 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.518 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -81.8 128.89 8.71 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.253 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.36 145.28 8.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.687 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.2 m120 -39.88 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.28 126.26 0.88 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.188 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.3 p90 -80.62 139.44 36.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.615 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.48 146.87 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.517 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.798 HG23 ' HB2' ' A' ' 161' ' ' ARG . 0.2 OUTLIER -109.91 145.11 37.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.276 -177.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' NH1' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -163.71 140.89 7.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.687 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 5.3 m120 -68.02 137.81 55.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 121' ' ' ILE . 2.5 pp -73.07 -34.39 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.562 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 154' ' ' LEU . . . 149.33 -55.95 0.48 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.275 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 154' ' ' LEU . 15.4 t80 -61.95 -40.43 95.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.7 0.286 . . . . 0.0 111.516 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.33 -38.78 0.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 154' ' ' LEU . 53.2 mt -61.68 162.45 8.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.221 0.534 . . . . 0.0 111.419 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 2.9 ttmp? -132.56 134.05 44.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.498 -0.773 . . . . 0.0 108.933 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.433 ' OG ' HG12 ' A' ' 176' ' ' VAL . 1.1 m -108.44 127.4 53.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.798 ' HB2' HG23 ' A' ' 151' ' ' THR . 64.2 ttt-85 -112.97 119.58 38.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . -151.23 166.95 30.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 118.593 -1.765 . . . . 0.0 115.404 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -128.56 119.99 25.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.201 -0.999 . . . . 0.0 109.727 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.518 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 19.1 ttt -111.64 133.19 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.687 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 10.0 t30 -111.8 138.51 48.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.2 p -98.69 -125.41 0.15 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.345 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.7 m 61.0 48.25 6.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 112.351 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.76 -59.11 2.57 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.935 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -89.72 106.27 18.35 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . . . -86.64 137.21 32.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.0 pt -138.31 129.15 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.435 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.97 119.1 32.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 111.696 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -112.88 62.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.371 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.608 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 tp -88.08 120.05 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.232 0.539 . . . . 0.0 110.553 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 30.1 m170 -104.43 120.23 40.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -97.96 120.27 47.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 40' ' ' GLU . 25.3 p -141.51 -167.64 2.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.412 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -74.23 140.76 45.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.19 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.539 ' HA ' ' HZ2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.623 0.249 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.16 -48.82 8.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.176 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 66.93 -44.89 0.45 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.383 1.073 . . . . 0.0 113.053 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.89 38.45 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.411 1.084 . . . . 0.0 113.022 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.5 141.72 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.82 130.82 2.15 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 67.12 117.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.601 0.76 . . . . 0.0 112.951 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m -147.1 150.21 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.507 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 32.9 mm -93.37 144.29 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.637 0.256 . . . . 0.0 111.511 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.1 29.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.77 -17.54 1.22 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.103 -0.57 . . . . 0.0 114.405 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 8.42 2.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.364 0.582 . . . . 0.0 112.14 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -110.03 47.06 0.97 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.225 0.536 . . . . 0.0 110.808 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -147.45 162.96 37.98 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.1 m -158.48 161.65 37.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.406 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 9.4 p90 -53.06 -29.42 30.05 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.369 0.418 . . . . 0.0 112.027 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.38 -41.63 89.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.0 mp -63.72 -39.0 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.42 -35.88 82.35 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.64 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -63.46 -36.87 85.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -68.99 -43.09 75.57 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' ILE . 70.3 t -59.36 -34.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.932 0.872 . . . . 0.0 109.487 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.904 HD12 ' HE2' ' A' ' 32' ' ' LYS . 49.9 tp -73.75 -42.85 60.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.642 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.18 -49.28 72.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.032 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.47 73.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.059 0.457 . . . . 0.0 111.965 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 48.05 1.22 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.088 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.15 112.65 3.49 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.096 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -164.23 -44.25 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -108.75 154.59 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.535 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -63.07 -29.3 70.71 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 108' ' ' TYR . 22.7 ptt-85 -134.75 146.24 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.904 ' HE2' HD12 ' A' ' 23' ' ' LEU . 23.4 ttpt -155.42 148.12 24.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HB ' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -110.34 129.55 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.761 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.88 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -114.69 126.74 55.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.618 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 54.3 t -100.4 145.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.91 85.12 0.12 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.629 -0.589 . . . . 0.0 111.629 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 40.7 t -108.28 116.83 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.457 0.646 . . . . 0.0 111.078 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.762 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 17.7 m-20 -83.61 91.98 7.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.771 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.558 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 48.4 t-20 -75.02 100.58 4.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 111.196 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.621 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tt0 -128.44 38.93 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.005 0.907 . . . . 0.0 108.75 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.6 ' HA ' HD22 ' A' ' 158' ' ' LEU . 45.6 t -95.92 -20.2 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.532 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 83.33 37.61 12.11 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.26 126.32 44.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.885 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 94' ' ' MET . 1.3 p -79.61 142.36 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.563 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 18.4 m0 -120.56 141.37 50.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.804 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -137.84 104.16 5.2 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -43.96 117.12 1.12 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.794 HD12 HD23 ' A' ' 93' ' ' LEU . 3.9 tt -100.58 -50.52 3.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.606 HD22 HD22 ' A' ' 48' ' ' LEU . 19.7 p30 -162.27 144.75 11.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 90' ' ' LEU . 17.7 p -148.67 127.28 12.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.97 146.3 33.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 34.2 m-85 -106.94 125.88 51.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HD3' ' HB3' ' A' ' 130' ' ' GLN . 66.9 mtm180 -70.64 -27.52 64.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.555 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 14.7 m -154.98 134.84 12.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.268 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.98 -159.23 47.25 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.391 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 t -170.79 150.86 3.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.396 0.617 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.754 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 8.4 t -94.76 -56.84 2.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.675 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 60' ' ' VAL . 29.5 t70 -175.27 38.58 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp 53.19 -53.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 126.336 1.854 . . . . 0.0 114.306 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 58' ' ' ASP . 14.6 p -107.52 161.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -152.53 165.37 17.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 122.489 -0.132 . . . . 0.0 111.266 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 73.5 Cg_exo -42.49 136.51 4.19 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.765 2.977 . . . . 0.0 112.931 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -87.76 -20.91 25.51 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 24.3 pttm -141.75 147.42 37.33 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.614 HG11 HD22 ' A' ' 71' ' ' LEU . 21.2 t -133.39 79.69 59.96 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.25 161.08 41.27 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.095 2.53 . . . . 0.0 112.701 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.838 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 49.6 p-80 -57.05 138.36 54.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.031 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 38.65 11.57 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.895 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -150.55 133.64 16.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 111.4 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . . . -96.72 124.32 40.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.485 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD22 HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -90.61 115.72 27.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.039 0.447 . . . . 0.0 110.425 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.68 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.29 145.5 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.201 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 87.9 m-85 -148.58 172.2 14.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.638 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -161.64 115.66 1.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.168 0.509 . . . . 0.0 110.552 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -109.91 145.36 16.98 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.152 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.2 177.75 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.367 0.267 . . . . 0.0 110.738 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -73.47 159.11 33.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.999 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 138.24 18.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.09 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -75.55 -22.05 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.736 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.69 -164.81 8.09 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.099 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 -46.07 5.58 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.05 2.5 . . . . 0.0 112.126 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.44 149.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.678 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.84 113.85 7.66 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.384 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 7.4 m -95.62 -54.73 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.217 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . 159.9 -120.84 0.99 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.736 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.44 101.34 3.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.435 0.636 . . . . 0.0 110.744 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 23.8 t -131.88 133.63 60.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -168.82 160.92 34.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.989 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.4 t -123.44 136.79 58.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 123.386 0.674 . . . . 0.0 110.119 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HA ' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.36 136.87 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -136.1 119.82 17.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.545 0.688 . . . . 0.0 111.019 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.621 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 3.5 m-85 -123.68 142.02 51.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.895 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -76.84 137.74 39.38 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' THR . 34.3 ttm -92.51 -38.85 11.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.1 t -156.3 -69.81 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.182 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.35 -38.37 4.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA2' HD21 ' A' ' 93' ' ' LEU . . . -174.43 45.39 0.14 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.315 -1.421 . . . . 0.0 113.356 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -129.3 141.07 51.2 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.723 HG21 ' HB1' ' A' ' 91' ' ' ALA . 90.6 m -132.48 124.49 28.66 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.7 109.83 20.46 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.81 136.19 34.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.35 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 119' ' ' VAL . 21.9 t -134.02 140.66 45.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.123 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 4.1 pp -126.06 145.82 50.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.461 ' CE2' HD22 ' A' ' 172' ' ' LEU . 84.0 m-85 -131.88 146.02 51.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.818 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 7.8 t -149.82 131.11 14.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 33' ' ' ILE . 96.1 t -135.58 119.81 13.15 Favored Pre-proline 0 C--O 1.236 0.357 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.7 Cg_exo -78.64 165.22 25.12 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.828 3.019 . . . . 0.0 113.212 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 31' ' ' ARG . 38.9 t80 -80.6 151.89 28.84 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 -27.22 11.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -64.0 -27.6 69.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.601 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' TYR . 6.8 m120 -119.95 98.44 6.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -69.84 56.36 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.102 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 4.1 m-85 -93.34 164.98 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.749 0.309 . . . . 0.0 110.525 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.5 p -86.0 163.74 17.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.643 HD22 ' HA ' ' A' ' 166' ' ' SER . 13.0 p30 -71.8 170.25 14.02 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 12.8 m-90 -141.38 132.93 26.97 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 11.9 p-90 -148.1 140.09 24.04 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.245 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.8 t30 -155.45 122.16 5.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.768 0.318 . . . . 0.0 111.705 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 102' ' ' VAL . 16.1 m -102.01 140.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.464 178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 31.0 ttm180 -165.94 138.12 3.96 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.32 -0.238 . . . . 0.0 110.513 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.8 mp -81.32 131.26 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.233 0.539 . . . . 0.0 111.482 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 9.2 m-85 -124.13 -179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.318 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -88.24 150.81 23.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.06 66.22 1.49 Allowed Glycine 0 C--O 1.229 -0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.32 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -82.94 -125.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 48' ' ' LEU . 62.0 mmt-85 -149.58 -49.71 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 122.069 -0.394 . . . . 0.0 111.316 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -85.97 123.92 31.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.641 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.66 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.976 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 130' ' ' GLN . 35.8 t70 176.05 -147.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.867 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 2.5 pt20 -62.17 -40.56 96.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.518 0.599 . . . . 0.0 110.913 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.867 ' HD3' ' HG3' ' A' ' 130' ' ' GLN . 0.2 OUTLIER -61.14 -20.54 62.8 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.3 tpt -76.24 -33.71 59.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.645 0.259 . . . . 0.0 111.687 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -92.29 -42.09 10.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.894 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -60.88 164.06 5.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.029 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.31 -51.09 0.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 112.278 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' HB2' HD22 ' A' ' 139' ' ' ASN . 92.4 mt -85.03 116.04 23.19 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.701 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -77.03 37.1 0.18 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -146.88 32.95 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.469 0.652 . . . . 0.0 109.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' A' ' 136' ' ' LEU . 64.4 m-20 -143.28 -43.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.778 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 ' HD3' ' A' ' 142' ' ' PRO . 1.8 tm? -87.1 120.98 28.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 110.382 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t -173.95 70.51 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.316 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.674 ' HD3' HD13 ' A' ' 140' ' ' LEU . 12.9 Cg_exo -70.21 152.23 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.832 2.354 . . . . 0.0 112.123 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 29.5 t80 -68.86 -24.71 64.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 86.6 mtt-85 77.61 6.1 2.92 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.964 0.506 . . . . 0.0 110.817 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.47 144.02 0.04 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -171.48 126.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.449 -0.442 . . . . 0.0 110.179 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -66.14 3.57 0.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.841 -178.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.05 -123.35 0.02 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.529 ' HE3' ' HD2' ' A' ' 163' ' ' PHE . 74.2 t-105 -170.97 131.58 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.464 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -154.19 158.5 40.42 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.655 -0.818 . . . . 0.0 112.614 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 160' ' ' SER . 8.6 m -122.96 148.19 45.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.132 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -162.79 129.58 3.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.146 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.812 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -69.49 138.74 53.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.729 0.299 . . . . 0.0 111.287 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 119' ' ' VAL . 2.9 pp -158.94 -28.75 0.07 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.58 49.7 0.8 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.01 -0.615 . . . . 0.0 113.599 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.7 t80 52.31 41.76 30.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.868 0.842 . . . . 0.0 108.955 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 130.14 -38.68 1.93 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.011 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 178' ' ' LYS . 8.0 mp -73.66 -176.61 2.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 8.2 mtmp? -140.24 157.34 45.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 112.496 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.809 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.0 t -105.87 132.74 51.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.707 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -119.98 121.78 39.7 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 172.88 -149.56 11.51 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.107 -1.521 . . . . 0.0 114.177 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.529 ' HD2' ' HE3' ' A' ' 149' ' ' TRP . 34.9 p90 -168.12 -166.99 0.77 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 110.642 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 171' ' ' ILE . 24.6 ttt -157.72 121.84 4.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.913 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.59 ' HB3' HG12 ' A' ' 171' ' ' ILE . 26.7 t30 -76.46 134.4 39.55 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 115' ' ' ASN . 4.5 p -82.78 -133.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.157 0.91 . . . . 0.0 112.043 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 166' ' ' SER . 21.9 m 61.94 -149.04 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.62 -39.96 7.45 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.821 ' HB3' HD21 ' A' ' 23' ' ' LEU . 45.7 m170 -91.51 96.77 10.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.52 138.33 31.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.066 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.88 HG22 ' HB3' ' A' ' 34' ' ' ALA . 28.1 pt -141.71 125.65 16.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.691 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.461 HD22 ' CE2' ' A' ' 104' ' ' PHE . 25.9 tp -101.85 120.12 39.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 87.9 tt0 -122.91 78.56 1.56 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 31.4 pt -114.87 123.51 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.762 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 16.9 t-160 -105.3 110.91 23.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.999 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.809 HG12 ' HB2' ' A' ' 160' ' ' SER . 35.0 m -86.52 122.98 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.259 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.621 HG22 ' HB3' ' A' ' 40' ' ' GLU . 21.0 p -148.75 -172.9 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.478 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.62 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -55.43 141.29 37.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.552 ' CB ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.665 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.542 0.21 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 139.16 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.771 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 4' ' ' VAL . 66.1 m-20 69.68 -46.55 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.853 0.861 . . . . 0.0 112.641 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 5' ' ' ALA . 3.8 p 50.98 -152.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.318 1.047 . . . . 0.0 111.117 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 4' ' ' VAL . . . 67.94 -64.35 0.29 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.72 0.808 . . . . 0.0 112.105 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.03 49.13 0.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.15 138.08 31.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.535 -0.333 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.52 135.14 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.918 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.758 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -90.44 164.65 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 112.116 -178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.26 161.52 30.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.318 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.85 51.75 0.71 Allowed Glycine 0 N--CA 1.463 0.498 0 O-C-N 123.615 0.572 . . . . 0.0 112.52 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.83 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 15.5 m -82.63 -12.57 57.56 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.1 pt? -71.74 146.85 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.941 0.4 . . . . 0.0 111.604 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 m -161.61 156.9 23.85 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.956 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -49.84 -39.48 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.478 0.486 . . . . 0.0 111.387 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -60.87 -46.22 91.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 18' ' ' ILE . 3.4 mp -62.67 -42.84 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.0 mt -63.13 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.973 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.02 -38.03 89.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 m -67.65 -42.01 82.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.917 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.09 -42.91 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.505 0.669 . . . . 0.0 109.5 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 34' ' ' ALA . 1.1 tm? -66.01 -31.3 72.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.637 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.35 -53.86 17.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.73 50.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -58.42 -42.13 86.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.576 0.351 . . . . 0.0 111.781 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.07 150.2 5.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.253 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -79.23 47.61 0.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.296 0.238 . . . . 0.0 111.381 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 30' ' ' LYS . 7.4 p -110.6 171.03 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 0.0 111.346 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 29' ' ' VAL . 99.8 mttt -63.99 -71.76 0.16 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' NE ' ' HD1' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -96.19 146.79 24.39 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.462 -0.149 . . . . 0.0 111.013 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 26' ' ' LEU . 47.6 mtmt -153.4 140.45 19.32 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.585 0.553 . . . . 0.0 109.858 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 106' ' ' VAL . 5.6 mm -107.61 129.58 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -134.43 109.88 9.04 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 59.6 t -107.49 140.55 25.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.016 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -145.36 81.71 0.21 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 57.8 t -87.98 114.65 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.272 -0.546 . . . . 0.0 112.083 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.755 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.2 t0 -80.19 95.72 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.064 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -91.63 112.58 24.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 177' ' ' THR . 16.5 tp10 -126.17 44.2 2.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.53 ' OG ' ' HE2' ' A' ' 43' ' ' LYS . 3.6 t -72.0 -24.46 61.57 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.627 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.65 39.61 24.76 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.435 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.672 ' HD2' ' CG ' ' A' ' 94' ' ' MET . 4.1 pttm -169.65 138.16 1.84 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.781 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 p -80.86 129.69 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.876 0.37 . . . . 0.0 111.832 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.853 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 39.5 m0 -89.76 140.89 29.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.078 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -110.88 135.55 51.25 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.915 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -65.37 116.21 6.45 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.125 -0.359 . . . . 0.0 111.496 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HG ' ' NH1' ' A' ' 127' ' ' ARG . 25.5 tp -100.43 -61.9 1.31 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -176.37 146.53 0.63 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.212 0.53 . . . . 0.0 111.31 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.7 p -129.17 126.91 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.3 124.51 23.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.363 0.601 . . . . 0.0 112.525 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.656 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 30.9 m-85 -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -79.38 -38.35 35.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.349 0.595 . . . . 0.0 110.944 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.525 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 15.7 t -91.02 -97.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.849 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -70.05 -157.92 2.02 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 114.439 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.4 p -133.21 169.78 16.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.5 -0.35 . . . . 0.0 111.424 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -170.32 -146.0 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.287 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.62 134.06 36.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.048 0.452 . . . . 0.0 110.432 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.7 mp -81.11 -34.19 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.967 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.07 144.64 27.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.708 0.766 . . . . 0.0 112.438 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.6 tp -74.07 140.67 77.17 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.043 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.717 ' HD2' HD12 ' A' ' 61' ' ' LEU . 21.1 Cg_exo -35.47 -54.63 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.138 3.226 . . . . 0.0 113.915 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -179.99 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 111.096 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 28.0 mttp -154.12 142.08 20.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.201 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 98.8 t -107.27 96.75 16.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 3.0 Cg_exo -77.42 174.16 13.15 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.53 2.153 . . . . 0.0 111.672 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -81.27 140.68 34.71 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.364 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 69' ' ' LYS . . . 84.94 38.49 9.27 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.9 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 76.9 mttt -153.7 130.29 10.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.232 0.539 . . . . 0.0 111.478 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -91.8 126.76 37.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.74 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -87.43 134.19 33.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.676 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -105.47 125.87 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.729 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 6.1 m-85 -131.33 152.31 50.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.813 0.339 . . . . 0.0 111.57 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 74.3 m-80 -138.38 151.51 47.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.948 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.55 146.1 15.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.676 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -111.35 160.64 16.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 47.7 mttt -64.42 -57.06 10.36 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.1 t70 -163.62 -136.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.961 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 10.0 mpt_? -85.8 -31.31 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.191 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.71 -136.96 2.13 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.665 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.46 121.71 9.2 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.415 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 83' ' ' ALA . 7.4 p -174.46 179.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.666 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -86.79 178.94 6.85 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.525 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 60.1 p 58.37 165.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.86 0.838 . . . . 0.0 111.969 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -128.98 -53.31 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.684 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -172.26 128.77 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.024 0.44 . . . . 0.0 110.733 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 105' ' ' SER . 92.4 t -151.1 121.68 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.656 ' HA3' ' HA ' ' A' ' 52' ' ' PHE . . . -178.43 -172.64 43.03 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.397 -1.382 . . . . 0.0 113.384 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -136.56 133.87 49.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.833 -0.683 . . . . 0.0 112.143 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -106.84 142.4 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.71 125.95 21.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.424 0.63 . . . . 0.0 111.348 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.686 ' CE1' ' HB2' ' A' ' 61' ' ' LEU . 37.9 m-85 -130.84 150.75 51.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.512 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -77.82 137.38 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.672 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 24.9 ttm -88.71 -38.4 14.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 t -169.26 -51.81 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.565 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -120.92 -45.38 2.38 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.43 36.79 0.11 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.115 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -119.24 142.58 47.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.649 HG21 ' HB1' ' A' ' 91' ' ' ALA . 26.8 m -125.25 127.02 46.07 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -92.71 111.48 23.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -97.98 139.33 33.97 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 HG12 ' A' ' 119' ' ' VAL . 39.9 t -127.98 127.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.216 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 57.5 tp -98.09 145.2 26.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.024 0.44 . . . . 0.0 111.84 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' HZ ' HD12 ' A' ' 33' ' ' ILE . 22.7 t80 -142.52 142.6 32.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.532 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.526 ' HA ' HG22 ' A' ' 87' ' ' VAL . 11.4 t -153.95 115.86 4.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.952 -0.113 . . . . 0.0 110.867 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -131.65 120.36 17.64 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 121.477 0.656 . . . . 0.0 111.281 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.6 Cg_endo -85.28 177.25 5.27 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.274 3.316 . . . . 0.0 112.53 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HD1' ' NE ' ' A' ' 31' ' ' ARG . 17.7 t80 -95.21 47.98 1.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t70 66.4 104.89 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.681 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.814 ' HB2' ' HB2' ' A' ' 113' ' ' TYR . 17.3 m-85 -128.93 144.27 51.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -54.61 -24.7 22.51 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.461 ' HD1' ' CD1' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -145.32 50.04 1.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 112.386 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.814 ' HB2' ' HB2' ' A' ' 110' ' ' TYR . 29.7 m-85 -137.25 142.82 42.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.784 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.6 m -137.61 156.96 47.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.651 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.832 HD22 ' HA ' ' A' ' 166' ' ' SER . 64.8 m-20 -59.01 140.12 56.08 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.577 0.548 . . . . 0.0 110.998 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 7.7 m-90 -121.35 146.27 47.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.812 0.339 . . . . 0.0 110.848 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.7 p-90 -146.32 151.69 37.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 32.6 t30 -164.5 116.0 1.26 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.867 HG12 HG22 ' A' ' 102' ' ' VAL . 4.2 m -102.81 139.12 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -166.69 150.24 6.99 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.917 HG13 ' HB2' ' A' ' 156' ' ' TYR . 14.1 mm -91.48 136.39 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.248 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.2 137.08 54.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -79.82 44.6 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.107 0.48 . . . . 0.0 111.822 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.86 -145.07 15.96 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.138 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 72.28 -40.95 0.49 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.97 0.908 . . . . 0.0 113.074 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -133.43 136.37 45.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.759 0.314 . . . . 0.0 110.69 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' NH1' ' HG ' ' A' ' 48' ' ' LEU . 94.8 mtt-85 -79.58 140.32 37.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.52 146.18 34.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 130' ' ' GLN . 45.1 t0 -161.05 -160.36 0.73 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.48 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 11.4 mm100 -65.91 -42.66 89.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.834 0.349 . . . . 0.0 111.08 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.38 -19.25 55.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 tpt -87.96 -34.82 17.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 140' ' ' LEU . 16.6 t80 -79.94 -51.68 8.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.339 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.407 ' HG3' ' CD2' ' A' ' 133' ' ' TYR . 94.6 mt-10 -94.29 167.94 11.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.65 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 69.87 -68.45 0.2 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.367 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.5 135.95 33.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -76.78 124.2 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.654 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -167.91 -45.19 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 133' ' ' TYR . 14.1 p30 -139.13 27.58 2.35 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.041 0.448 . . . . 0.0 111.963 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.484 ' HA ' ' CE1' ' A' ' 133' ' ' TYR . 1.3 tt -88.93 66.67 7.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.196 0.522 . . . . 0.0 110.187 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 7.9 t -158.41 64.78 2.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.619 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 6.0 Cg_exo -76.96 150.42 29.98 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 122.845 2.364 . . . . 0.0 111.853 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 144.8 24.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -80.58 135.57 36.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.77 9.57 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.388 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -138.17 138.66 38.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 165' ' ' ASN . 1.8 m120 -58.14 89.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.838 0.455 . . . . 0.0 111.96 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 163' ' ' PHE . . . -168.0 -137.47 2.25 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.118 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 1.5 p90 -166.64 133.93 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.109 0.481 . . . . 0.0 111.034 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.48 149.91 20.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.856 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 161' ' ' ARG . 11.5 p -97.37 143.98 27.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.585 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 42.4 ttm-85 -165.7 130.53 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.254 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -64.73 143.26 58.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.404 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 156' ' ' TYR . 2.4 pp -76.46 -29.59 57.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.54 -54.86 0.5 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.378 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.917 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.0 t80 -64.58 -49.42 71.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.908 0.385 . . . . 0.0 110.699 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . -178.9 -41.05 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.553 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 158' ' ' LEU . 5.6 mp -61.98 158.45 16.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.256 0.551 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.903 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 6.6 ttpm? -128.48 140.11 51.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.175 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.585 ' HB2' HG12 ' A' ' 176' ' ' VAL . 18.0 t -101.32 143.81 30.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.778 ' HG2' HG22 ' A' ' 151' ' ' THR . 43.5 mtp85 -121.62 105.66 10.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 169.53 -148.74 12.3 Favored Glycine 0 C--N 1.312 -0.764 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.708 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -172.09 -162.33 0.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.285 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.605 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -140.95 117.61 10.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.657 ' HB3' HG12 ' A' ' 171' ' ' ILE . 10.7 t-20 -79.74 121.01 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.832 ' HA ' HD22 ' A' ' 115' ' ' ASN . 14.0 p -80.95 -127.11 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.771 0.669 . . . . 0.0 112.274 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 51.1 m 63.1 -151.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.5 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.68 -36.24 9.58 Favored Glycine 0 N--CA 1.462 0.382 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -102.09 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -102.83 141.52 35.5 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.657 HG12 ' HB3' ' A' ' 165' ' ' ASN . 29.9 pt -135.53 134.39 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.605 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 11.0 mt -107.04 115.68 30.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.386 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.425 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 56.1 tt0 -127.61 78.45 1.82 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.562 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 18.5 pt -116.62 115.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.078 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.755 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 m170 -90.8 108.12 19.63 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.432 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 160' ' ' SER . 31.6 m -88.56 119.53 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.367 0.604 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 40' ' ' GLU . 76.9 p -143.0 -162.85 1.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.611 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -67.04 147.84 52.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.891 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.659 0.266 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.84 -42.65 13.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.875 0.369 . . . . 0.0 110.646 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -86.74 136.93 32.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.6 t 69.73 -57.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.451 0.7 . . . . 0.0 112.602 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.31 140.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.469 0.708 . . . . 0.0 111.943 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.65 132.64 1.67 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.056 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.4 41.85 0.8 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 111.902 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 m -145.65 144.96 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.274 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -136.78 178.78 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 0.0 111.391 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.14 151.8 30.25 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.045 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' N ' ' HA ' ' A' ' 69' ' ' LYS . . . -72.39 50.24 1.33 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.587 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.84 -29.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.083 -0.559 . . . . 0.0 111.082 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HG13 ' A' ' 9' ' ' ILE . 13.4 m -72.34 -25.64 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.075 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 70' ' ' ALA . 6.9 mp -67.88 145.71 54.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.746 0.307 . . . . 0.0 111.595 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 18' ' ' ILE . 9.8 p -165.07 166.86 18.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.507 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 171' ' ' ILE . 58.2 t80 -58.82 -34.63 71.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.41 -43.86 63.28 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.728 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 ' OG ' ' A' ' 15' ' ' SER . 1.6 mp -63.96 -37.88 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 171' ' ' ILE . 49.0 mt -65.88 -35.54 80.93 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.247 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 10.1 mtpm? -64.12 -41.03 97.39 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -63.56 -41.21 98.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.97 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 18' ' ' ILE . 79.7 t -62.77 -39.01 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.725 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD22 ' HG3' ' A' ' 32' ' ' LYS . 81.0 mt -67.12 -35.44 79.74 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.188 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 5.7 mm-40 -60.87 -38.88 87.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.09 88.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.862 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.59 47.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.688 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.39 29.91 3.49 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.278 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.19 -46.27 10.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.35 154.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.233 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -63.19 -42.05 99.29 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.449 0.468 . . . . 0.0 110.704 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 31' ' ' ARG . 19.9 mmt85 -89.13 137.58 32.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HG3' HD22 ' A' ' 23' ' ' LEU . 13.9 ptpt -149.27 141.26 23.81 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.971 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 104' ' ' PHE . 5.2 mp -118.88 136.45 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.612 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.785 ' HB3' HG23 ' A' ' 171' ' ' ILE . . . -134.15 119.66 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.206 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 73' ' ' TYR . 69.7 t -102.02 145.74 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.04 74.0 0.22 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 36.7 t -88.75 114.42 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.069 0.461 . . . . 0.0 110.917 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.63 93.52 5.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.586 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 10.3 m-80 -80.08 108.59 13.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.442 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 177' ' ' THR . 10.4 tp10 -134.58 86.16 2.24 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.453 0.644 . . . . 0.0 109.39 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -145.83 -10.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.133 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.752 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 69.58 48.12 45.5 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 22.9 pttm -137.55 129.36 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.046 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.8 p -88.78 133.08 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.868 0.366 . . . . 0.0 111.88 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.646 ' HE1' ' HG3' ' A' ' 43' ' ' LYS . 27.0 m0 -105.63 156.87 17.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.809 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 m -147.39 121.87 9.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 118.58 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.205 0.526 . . . . 0.0 112.168 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 93' ' ' LEU . 29.1 tp -107.41 -45.8 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.595 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -162.66 126.25 2.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.025 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 61' ' ' LEU . 19.8 p -138.21 122.04 17.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.85 137.25 18.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.421 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 9.7 m-85 -98.33 144.27 27.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.296 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -83.05 -29.37 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.755 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.617 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 50.1 m -129.49 -80.26 0.56 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 -144.64 3.75 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.266 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 t -170.92 152.35 3.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 111.365 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.647 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 18.7 p -82.32 -66.89 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 59' ' ' ILE . 44.0 t0 -165.34 37.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.668 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 60' ' ' VAL . 10.8 tp 58.27 -47.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 125.868 1.667 . . . . 0.0 114.048 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG23 HG23 ' A' ' 59' ' ' ILE . 27.8 t -113.07 145.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.089 -0.382 . . . . 0.0 110.289 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 50' ' ' THR . 0.8 OUTLIER -138.02 163.42 47.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.255 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.55 135.62 61.98 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.417 2.745 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -94.09 -37.18 11.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.3 tttm -104.71 130.31 52.78 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.1 t -133.53 111.57 12.66 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.019 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 8.2 Cg_endo -91.13 -126.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.864 3.043 . . . . 0.0 113.188 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.752 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 46.3 p-80 -123.29 143.04 50.33 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.727 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.88 55.95 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.629 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' ' N ' ' A' ' 11' ' ' GLY . 57.0 mtpt -148.74 127.43 12.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.05 0.452 . . . . 0.0 110.574 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.782 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.37 111.65 19.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.58 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.722 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -111.33 125.96 54.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.475 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' A' ' 35' ' ' VAL . 50.2 p90 -151.63 131.16 13.01 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.323 0.583 . . . . 0.0 112.329 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.8 p-10 -88.23 151.14 22.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.677 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -123.72 142.81 14.56 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.306 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.67 165.61 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.735 0.414 . . . . 0.0 110.073 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -83.16 -141.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.219 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 71.54 142.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.729 0.812 . . . . 0.0 111.704 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 54' ' ' SER . 20.7 tpt180 -171.42 -42.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.42 -140.02 4.82 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.627 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.46 -41.59 11.53 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.194 2.596 . . . . 0.0 113.296 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 m -81.64 128.25 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.96 126.09 30.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.399 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 p -144.07 148.67 35.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.679 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.97 -131.43 0.36 Allowed Glycine 0 C--O 1.229 -0.175 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 104' ' ' PHE . . . -124.65 119.94 30.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.229 0.538 . . . . 0.0 111.223 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 45.2 t -142.91 134.04 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . -174.72 174.65 46.73 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.014 -1.565 . . . . 0.0 114.127 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.2 t -137.82 135.62 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.667 -0.767 . . . . 0.0 110.643 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.4 pt? -126.12 135.38 51.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 99' ' ' THR . . . -138.69 128.02 24.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.388 0.613 . . . . 0.0 111.273 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.779 ' HE1' HD12 ' A' ' 90' ' ' LEU . 18.2 m-85 -122.83 142.64 50.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.656 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -80.06 132.97 36.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 35.0 ttm -85.61 -92.16 0.09 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.172 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -150.71 -40.95 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.042 -0.411 . . . . 0.0 111.009 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.62 32.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.91 46.27 92.0 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.647 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -128.97 135.8 49.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.667 HG22 ' HB1' ' A' ' 91' ' ' ALA . 1.3 m -110.76 117.31 33.1 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.182 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.3 tt -87.07 120.3 28.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -106.88 135.89 47.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.24 0.543 . . . . 0.0 111.767 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.703 HG22 HG12 ' A' ' 119' ' ' VAL . 47.6 t -123.4 140.81 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.875 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 8.6 tt -124.76 145.7 49.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.071 0.462 . . . . 0.0 111.813 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CE2' HG12 ' A' ' 33' ' ' ILE . 31.2 t80 -136.76 144.86 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.484 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB3' ' HE3' ' A' ' 116' ' ' TRP . 2.3 t -155.74 123.37 5.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.173 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 13.0 p -143.69 122.4 7.18 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.354 0.597 . . . . 0.0 110.844 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo -76.49 133.86 14.83 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.384 2.723 . . . . 0.0 113.559 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -86.47 43.27 1.06 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 113' ' ' TYR . 2.1 p30 -123.46 173.62 7.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -117.93 58.63 0.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.103 0.477 . . . . 0.0 111.72 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.403 ' H ' ' HD2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -149.75 -123.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.176 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -75.62 48.55 0.46 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 107' ' ' PRO . 22.6 p90 -78.36 135.0 37.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.3 m -148.2 143.44 27.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.818 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -80.59 140.67 35.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 9.7 m-90 -128.39 132.62 48.52 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 67.4 p-90 -135.55 147.9 48.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.275 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 34.0 t30 -155.42 109.61 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.651 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 102' ' ' VAL . 17.3 m -103.82 129.77 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.96 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -153.57 152.81 31.33 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 111.609 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.645 HD13 ' HG ' ' A' ' 100' ' ' LEU . 22.1 mm -89.72 132.36 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.037 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -123.22 179.01 4.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.38 147.85 34.3 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.476 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.08 58.62 2.28 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.94 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -128.38 -28.89 2.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 3.1 tpm_? -145.45 135.73 23.98 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -81.21 136.6 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.072 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.699 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -80.05 128.36 33.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.733 ' H ' ' HB2' ' A' ' 132' ' ' MET . 0.5 OUTLIER -126.02 -160.39 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -66.88 -45.32 78.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.316 . . . . 0.0 111.791 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.71 ' HD2' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -88.3 16.91 5.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.733 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -82.05 -55.53 4.51 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.608 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 10.5 p90 -78.68 -38.81 38.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG3' ' CD1' ' A' ' 133' ' ' TYR . 36.0 mt-10 -88.3 43.38 1.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -94.31 -134.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.29 -39.54 16.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 109.944 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.55 141.59 34.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -76.07 57.82 1.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.24 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.42 48.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 3.3 pp -143.1 145.02 32.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.7 t -167.63 66.74 0.8 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.342 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 52.8 Cg_endo -71.08 130.49 17.8 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.296 1.997 . . . . 0.0 112.01 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 5.9 t80 -93.11 135.21 34.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.435 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.53 114.85 13.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.665 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.62 130.71 10.35 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.68 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 1.4 m-20 -156.38 146.51 21.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -37.34 99.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.357 1.036 . . . . 0.0 112.864 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.11 -130.02 1.12 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.644 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 11.3 t90 -173.09 139.44 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.46 150.94 9.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.5 m -121.92 142.07 50.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.664 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -155.64 138.26 15.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 7.8 p30 -68.71 139.15 55.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.776 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mt -67.79 -37.78 82.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.059 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.97 -42.16 1.31 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -69.16 -46.48 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 173.66 -36.86 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.962 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 177' ' ' THR . 6.4 mp -73.51 -177.65 2.74 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.91 ' HE2' ' HB1' ' A' ' 179' ' ' ALA . 67.5 mttm -143.35 149.74 38.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.44 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 176' ' ' VAL . 45.8 t -108.24 125.7 51.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.418 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.721 ' HB3' HG23 ' A' ' 151' ' ' THR . 22.2 ptt-85 -124.08 125.59 44.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.555 0.693 . . . . 0.0 110.654 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.6 -144.06 6.71 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.212 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 23.3 p90 -160.69 158.38 28.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.08 0.467 . . . . 0.0 111.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.502 ' SD ' ' HG ' ' A' ' 172' ' ' LEU . 2.9 tpt -116.59 117.82 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.501 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.818 ' HB3' HG13 ' A' ' 171' ' ' ILE . 31.9 t30 -78.95 125.83 29.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 146' ' ' ASP . 10.0 p -105.99 -130.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.067 0.854 . . . . 0.0 111.205 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' A' ' 166' ' ' SER . 30.3 m 70.61 -42.6 0.53 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.868 0.867 . . . . 0.0 112.889 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.77 -44.45 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -99.82 123.29 43.92 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -91.62 124.33 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.818 HG13 ' HB3' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -136.0 112.13 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.621 178.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.502 ' HG ' ' SD ' ' A' ' 164' ' ' MET . 17.1 mt -90.78 121.48 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.085 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.461 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 29.1 mt-10 -123.71 54.76 1.29 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.806 0.812 . . . . 0.0 109.457 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.544 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 11.0 pt -95.66 124.06 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -107.49 116.59 32.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.565 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 160' ' ' SER . 29.0 m -88.19 119.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 109.956 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.684 HG22 ' HB3' ' A' ' 40' ' ' GLU . 18.8 p -145.77 -161.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.67 144.53 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 111.59 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.91 ' HB1' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.74 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.87 -62.96 0.33 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.713 0.805 . . . . 0.0 112.509 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -75.1 135.59 41.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.205 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.3 t 73.52 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.931 0.77 . . . . 0.0 112.225 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.88 40.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.315 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.56 55.68 4.7 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.732 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.084 0.469 . . . . 0.0 111.425 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 m -147.83 141.09 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.845 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -136.49 157.45 37.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.856 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.39 171.81 9.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.318 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . -74.89 46.07 1.72 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.77 43.76 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.142 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 31.6 t -144.97 -39.81 0.25 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 70' ' ' ALA . 3.0 pp -75.87 170.44 16.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -165.02 163.51 20.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.897 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -50.69 -31.22 15.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -68.35 -46.87 68.97 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 109.86 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 mp -58.52 -40.63 79.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD23 ' HB ' ' A' ' 171' ' ' ILE . 5.8 mp -62.29 -43.47 98.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.951 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -60.16 -40.36 89.63 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.226 0.536 . . . . 0.0 109.567 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.0 m -60.55 -38.1 83.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.763 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 18' ' ' ILE . 88.8 t -61.53 -45.21 99.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.685 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 2.3 mm? -60.86 -35.25 76.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.26 -50.07 73.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.1 89.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.734 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.52 37.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.42 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 26.5 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.48 -39.75 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.496 0.665 . . . . 0.0 110.35 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HB ' ' HZ1' ' A' ' 32' ' ' LYS . 7.0 t -113.49 149.75 15.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' C ' ' HE ' ' A' ' 31' ' ' ARG . 99.2 mttt -59.63 -56.32 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' HB2' ' HD3' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -103.46 155.46 18.49 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 3.7 ttmp? -167.18 147.24 5.42 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.165 0.507 . . . . 0.0 111.444 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.9 pt -98.36 129.76 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.098 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.961 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -123.58 106.77 10.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.642 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 86.0 t -98.23 144.91 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.201 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.93 70.7 0.24 Allowed Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 71' ' ' LEU . 61.1 t -90.13 119.7 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.11 93.28 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.394 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -72.29 123.09 22.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.758 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -148.43 102.36 3.32 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 2.2 t -166.44 -24.16 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.244 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 88.97 49.99 3.4 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.466 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 19.4 pttm -144.34 140.06 28.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -100.19 125.8 46.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.251 0.548 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.876 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 35.5 m0 -97.32 134.24 40.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.732 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.61 ' O ' HD13 ' A' ' 93' ' ' LEU . 20.9 m -126.05 134.25 51.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 118.83 9.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.068 0.461 . . . . 0.0 111.884 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.726 HD12 HD22 ' A' ' 49' ' ' ASN . 1.5 tm? -103.23 -46.43 4.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.891 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.726 HD22 HD12 ' A' ' 48' ' ' LEU . 16.8 p30 -164.26 145.52 8.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 61' ' ' LEU . 14.8 p -144.47 126.22 15.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.914 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -138.37 134.02 33.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -107.3 136.73 46.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 130' ' ' GLN . 81.4 mtm180 -96.03 -22.47 17.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.246 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 t -134.96 -57.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.784 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.79 -148.99 18.88 Favored Glycine 0 C--O 1.23 -0.104 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.419 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -173.34 179.82 2.08 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 m -148.84 -76.84 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' VAL . 5.8 t0 -166.25 40.57 0.06 Allowed 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 60' ' ' VAL . 33.5 pt 49.73 -65.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.543 ' H ' HG13 ' A' ' 59' ' ' ILE . 29.8 m -89.04 141.98 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 50' ' ' THR . 9.3 mp -116.32 159.36 40.13 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.11 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD2' ' HE1' ' A' ' 73' ' ' TYR . 58.0 Cg_exo -41.71 157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.697 3.598 . . . . 0.0 115.147 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -73.8 -110.89 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.876 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 58.5 mtmt -78.99 136.49 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.752 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 30.8 t -119.58 85.47 32.48 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.209 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 -173.94 2.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.262 2.641 . . . . 0.0 112.925 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 44.2 p-80 -71.13 140.66 50.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.192 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.46 39.84 49.33 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.022 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -142.13 126.84 18.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 110.785 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 14' ' ' LEU . . . -89.47 129.56 35.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.871 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.539 HD13 ' HE2' ' A' ' 73' ' ' TYR . 1.3 pp -99.05 118.7 36.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.161 0.505 . . . . 0.0 110.216 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 5.8 mp -106.49 137.2 44.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.731 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.729 ' HE1' ' HD2' ' A' ' 62' ' ' PRO . 94.7 m-85 -145.43 138.66 26.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.21 0.529 . . . . 0.0 110.788 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 13.7 p-10 -131.77 136.26 47.42 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -139.87 154.57 23.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.247 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -95.95 148.18 22.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.547 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 19.2 pttp -89.09 -46.51 8.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 111.027 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' N ' ' HG3' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -90.41 140.27 29.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.557 0.694 . . . . 0.0 111.692 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -105.81 -36.19 7.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.603 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' ' 81' ' ' PRO . . . -174.44 -127.31 0.99 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.79 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 18.8 Cg_endo -59.53 -40.8 62.78 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.059 2.506 . . . . 0.0 112.444 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.9 m -76.22 125.25 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.384 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.8 130.27 34.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.0 p -148.81 165.55 31.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.842 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 77' ' ' LYS . . . -105.44 -134.86 8.05 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.59 86.17 2.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.559 0.695 . . . . 0.0 110.952 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 105' ' ' SER . 28.5 t -124.6 130.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.78 177.8 45.93 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.986 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.86 141.18 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 123.081 0.552 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.787 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.3 pt? -130.37 141.25 50.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.33 126.31 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 0.0 111.598 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.787 ' HE1' HD12 ' A' ' 90' ' ' LEU . 4.5 m-85 -115.22 141.59 47.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.1 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.72 140.89 36.81 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.864 177.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 14.5 tpp -89.12 -48.94 7.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 m -150.9 -69.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.296 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -86.02 -53.27 5.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 0.0 109.566 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.77 29.23 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.271 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 78.3 m-20 -91.82 126.33 36.87 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.03 115.32 30.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' ' 121' ' ' ILE . 5.9 tt -87.0 109.53 19.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.14 143.68 26.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.492 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.789 HG22 HG12 ' A' ' 119' ' ' VAL . 38.9 t -129.41 135.69 61.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.401 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.658 HD23 ' HB3' ' A' ' 142' ' ' PRO . 56.0 tp -112.66 148.89 33.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.684 0.278 . . . . 0.0 111.635 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -144.4 149.76 36.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.502 ' HA ' HG22 ' A' ' 87' ' ' VAL . 16.8 t -155.09 124.7 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.4 t -136.01 124.77 15.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 15.7 Cg_exo -69.02 148.25 69.41 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.598 2.865 . . . . 0.0 112.343 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -110.52 38.04 2.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -147.94 -136.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -64.16 140.05 58.83 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.401 0.62 . . . . 0.0 112.125 -179.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -70.76 40.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 110' ' ' TYR . 15.1 m95 -90.03 -46.29 8.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.98 0.419 . . . . 0.0 110.432 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE1' ' HE1' ' A' ' 110' ' ' TYR . 6.6 m-85 -75.99 144.14 41.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.5 p -96.07 151.51 19.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.504 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -63.88 152.48 39.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.867 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.896 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 16.1 m-90 -130.15 140.28 50.79 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 30.2 p-90 -148.87 143.19 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.639 0.257 . . . . 0.0 110.332 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.876 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 39.6 t30 -158.58 124.12 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.8 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.789 HG12 HG22 ' A' ' 102' ' ' VAL . 13.3 m -102.33 144.29 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.437 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.77 143.24 6.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.612 HD13 ' HG ' ' A' ' 100' ' ' LEU . 9.0 mm -82.57 136.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.256 0.55 . . . . 0.0 111.957 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.34 150.47 40.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.299 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.06 129.37 55.93 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.952 -0.468 . . . . 0.0 111.013 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.36 146.0 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.39 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -75.28 44.44 0.25 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.958 0.409 . . . . 0.0 110.737 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 127' ' ' ARG . 6.7 tmm_? -96.56 119.24 34.68 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.877 ' H ' ' HD3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -62.54 136.55 57.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.044 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.07 162.63 13.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.908 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -162.82 -179.14 6.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.586 ' HG3' HH11 ' A' ' 53' ' ' ARG . 47.4 tt0 -55.85 -46.73 78.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.57 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -66.86 -8.08 26.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.56 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 37.1 tpp -87.5 -31.99 19.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.75 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 5.2 m-85 -87.74 -41.34 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -79.1 111.81 15.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.633 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 -171.59 3.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 136' ' ' LEU . 3.2 mm? -82.25 -29.41 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -81.9 -98.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.761 0.315 . . . . 0.0 111.405 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -172.19 120.91 0.44 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.965 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 133' ' ' TYR . 59.9 t30 -147.06 -34.63 0.26 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 110.432 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -88.15 137.14 32.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.156 0.503 . . . . 0.0 109.713 178.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -166.1 64.44 0.89 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.347 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.896 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 63.4 Cg_endo -73.01 141.93 33.79 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.314 2.01 . . . . 0.0 112.506 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.44 141.29 28.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -75.28 126.4 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.883 0.373 . . . . 0.0 110.492 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 164' ' ' MET . . . -77.87 137.64 20.33 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.865 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -165.27 137.56 4.29 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 166' ' ' SER . 1.7 m120 -49.25 97.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.671 0.607 . . . . 0.0 111.444 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.17 -125.94 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.221 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 3.4 t90 -179.14 135.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 154.71 20.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.2 m -109.82 151.72 26.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.325 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -158.29 141.42 14.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.013 0.435 . . . . 0.0 111.657 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 153' ' ' ASN . 1.3 m120 -78.77 133.12 37.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.318 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.76 -40.33 41.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.597 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 136.2 -47.33 0.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.766 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -71.65 -34.59 69.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 110.835 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.24 -36.99 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.3 mm? -60.3 157.57 13.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.893 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 179' ' ' ALA . 59.4 mttp -139.01 139.87 37.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.261 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 151' ' ' THR . 33.8 t -94.69 135.18 36.46 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.363 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -129.81 108.25 10.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.805 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 178.85 -154.57 14.45 Favored Glycine 0 CA--C 1.501 -0.801 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.271 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.71 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 43.9 p90 -158.14 165.32 35.27 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.485 0.659 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 145' ' ' GLY . 13.0 ttt -120.61 120.75 36.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.425 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.629 ' HB3' ' CG1' ' A' ' 171' ' ' ILE . 9.4 t30 -92.95 137.02 32.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.507 0.194 . . . . 0.0 110.922 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.52 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 23.3 p -104.25 -135.23 0.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t 68.68 46.21 0.97 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.382 0.611 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 -57.61 4.75 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 113.604 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.516 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 51.9 m170 -89.79 122.92 33.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.8 126.31 43.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.961 ' HB ' HD23 ' A' ' 19' ' ' LEU . 27.9 pt -134.08 140.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.812 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 56.7 mt -108.14 112.81 25.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -107.12 51.63 0.74 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.805 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 19.0 pt -103.07 126.33 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.759 0.79 . . . . 0.0 112.345 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -109.12 123.06 48.59 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.2 m -96.33 120.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 41.5 p -124.67 170.62 10.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.815 ' HA ' HD12 ' A' ' 158' ' ' LEU . 47.4 pttt -74.39 64.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.23 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.61 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.77 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.628 0.252 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.27 133.27 34.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.526 0.203 . . . . 0.0 110.749 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -138.28 155.09 48.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.973 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m 44.47 48.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.581 1.153 . . . . 0.0 113.427 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.68 54.71 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.51 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.38 -136.77 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.139 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.94 130.43 12.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.81 0.305 . . . . 0.0 110.843 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.6 t -135.58 129.79 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.664 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.624 HD12 ' HB3' ' A' ' 14' ' ' LEU . 16.6 pt -140.57 136.01 35.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.91 157.57 37.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -69.37 44.87 0.46 Allowed Glycine 0 C--N 1.334 0.423 0 O-C-N 123.771 0.669 . . . . 0.0 113.966 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.69 -46.82 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.151 0.501 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.7 m -71.29 -24.65 62.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.488 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.624 ' HB3' HD12 ' A' ' 9' ' ' ILE . 3.6 pp -63.06 160.17 15.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.389 0.614 . . . . 0.0 112.495 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 18' ' ' ILE . 31.6 m -162.53 158.76 23.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -60.25 -28.46 68.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.704 0.288 . . . . 0.0 111.618 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.56 -42.81 61.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.189 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.8 tp -66.32 -32.05 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 171' ' ' ILE . 18.4 tp -67.14 -37.7 84.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -68.82 -33.95 74.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.504 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.2 m -67.62 -38.59 84.11 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.437 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' ILE . 89.9 t -61.7 -42.87 95.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.138 0.494 . . . . 0.0 109.983 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.653 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -68.53 -37.46 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.336 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.38 -51.98 45.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.674 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.2 12.83 5.91 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -78.46 -41.82 31.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.56 141.66 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.479 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -66.57 98.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.303 0.573 . . . . 0.0 111.376 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.78 155.63 30.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.466 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 97.0 mttt -60.32 -44.48 95.44 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 34.9 mmt180 -139.54 152.06 46.6 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB3' HD11 ' A' ' 23' ' ' LEU . 30.7 ttmt -165.61 153.08 10.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.9 mp -125.19 129.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.8 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -112.42 120.18 40.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.191 0.519 . . . . 0.0 109.951 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 49.6 t -105.51 144.68 14.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.817 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -159.28 78.97 0.17 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 49.9 t -90.03 112.23 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 110.968 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 175' ' ' HIS . 1.2 m-20 -77.13 95.51 4.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.227 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 28.2 m-80 -78.36 93.95 4.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.47 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.903 ' HG2' ' HA2' ' A' ' 68' ' ' GLY . 37.5 mt-10 -120.97 39.08 3.89 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.345 0.593 . . . . 0.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.783 ' HB2' HD13 ' A' ' 158' ' ' LEU . 40.0 t -90.54 -38.03 13.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 108.18 41.26 1.55 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.806 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HD3' ' SD ' ' A' ' 94' ' ' MET . 0.5 OUTLIER -142.67 124.14 14.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -75.62 144.42 41.76 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.679 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.9 m0 -112.23 146.39 38.23 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 93' ' ' LEU . 6.6 m -126.73 138.32 53.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 120.47 11.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 93' ' ' LEU . 39.9 tp -119.24 -51.51 2.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -166.64 149.16 6.61 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -149.19 120.34 7.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.871 178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -143.42 139.07 29.77 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 1.2 p90 -85.78 154.51 21.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -98.5 -22.64 15.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.869 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 67.4 m -151.92 -63.27 0.17 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.479 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' A' ' 86' ' ' ALA . . . -76.16 -136.22 0.62 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.249 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -156.61 175.98 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 12.5 p -164.17 -80.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -144.56 141.52 29.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.449 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.6 mp -79.47 -41.27 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.98 130.68 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.526 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.82 HD13 ' H ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -94.47 156.84 38.16 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.499 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 10.2 Cg_endo -52.43 160.26 3.74 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.674 2.916 . . . . 0.0 113.565 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -143.87 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -64.9 139.22 58.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 54.5 t -112.34 103.44 55.4 Favored Pre-proline 0 C--N 1.339 0.134 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -161.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.998 2.466 . . . . 0.0 112.351 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 3.6 p80 -91.05 137.3 32.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.19 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.903 ' HA2' ' HG2' ' A' ' 40' ' ' GLU . . . 78.63 45.06 9.84 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -157.38 136.33 11.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.787 0.294 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -97.2 139.04 33.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 4.2 pp -89.15 130.32 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 mp -103.24 139.03 39.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.336 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -149.26 160.68 43.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 42.8 t30 -147.14 143.24 28.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -133.49 161.7 24.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.287 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -138.33 151.46 47.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.517 ' HD2' ' C ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -87.47 -9.6 54.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 1.1 m-20 -56.89 116.55 3.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -155.47 -50.32 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.552 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.07 11.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.93 -36.88 5.52 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.11 2.54 . . . . 0.0 112.991 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -56.76 124.74 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.412 0.625 . . . . 0.0 112.586 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.54 121.65 27.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.7 OUTLIER -152.41 -47.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.91 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.99 -131.55 10.7 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.646 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . . . -144.39 109.4 5.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.727 0.764 . . . . 0.0 112.022 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 11.3 t -121.17 135.08 62.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -158.05 153.14 24.35 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.575 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 59.5 t -126.71 129.59 71.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.1 pt? -107.23 144.1 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -142.0 125.45 16.67 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 90' ' ' LEU . 1.5 m-85 -120.95 144.9 48.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.198 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.529 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -79.53 129.15 34.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.711 ' SD ' ' HD3' ' A' ' 43' ' ' LYS . 51.0 tpp -75.12 -68.44 0.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -155.7 -55.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.416 -0.802 . . . . 0.0 111.913 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -88.54 -49.86 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 0.0 111.083 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.28 39.99 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.724 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -106.64 141.21 38.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -117.74 107.73 14.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.603 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 121' ' ' ILE . 4.7 tt -88.43 115.24 25.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -108.1 141.36 39.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.139 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 119' ' ' VAL . 40.0 t -128.66 129.02 68.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.983 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 51.8 tp -100.63 147.68 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 172' ' ' LEU . 92.7 m-85 -142.58 144.7 32.99 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 25.0 t -152.4 113.08 4.13 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.986 0.179 . . . . 0.0 111.009 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 86' ' ' ALA . 1.6 p -100.38 134.11 20.94 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 10.2 Cg_exo -72.24 138.33 30.22 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.261 2.641 . . . . 0.0 113.76 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -90.47 -139.72 0.15 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.37 43.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.93 -0.481 . . . . 0.0 111.34 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' HE1' ' HA ' ' A' ' 113' ' ' TYR . 1.0 OUTLIER -112.86 156.28 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.092 -0.38 . . . . 0.0 110.851 179.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -61.76 -44.77 96.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.199 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -78.14 57.19 1.77 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.524 ' HA ' ' HE1' ' A' ' 110' ' ' TYR . 3.7 p90 -82.26 129.71 34.92 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.1 m -168.76 131.87 1.39 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.859 0.464 . . . . 0.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' SER . 59.6 m-80 -78.86 138.22 38.05 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.1 m0 -130.69 135.19 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.039 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 54.4 p-90 -133.33 144.29 49.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.7 t30 -151.63 110.81 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.813 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 102' ' ' VAL . 16.2 m -101.73 135.24 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.744 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.05 138.74 5.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.815 0.34 . . . . 0.0 111.165 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.652 HD11 HD22 ' A' ' 154' ' ' LEU . 3.2 mp -94.29 124.01 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.18 153.58 19.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -95.99 48.76 1.12 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.406 0.622 . . . . 0.0 109.913 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.62 -133.43 52.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.949 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 71.99 -46.24 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.774 0.829 . . . . 0.0 112.991 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -145.18 144.16 30.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.541 0.21 . . . . 0.0 111.199 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -73.11 133.16 44.04 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.252 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.814 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -73.36 132.0 42.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.162 0.506 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.57 -155.79 0.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.264 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -42.96 78.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.731 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.73 -28.56 68.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.556 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.814 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 24.0 mmt -68.48 -41.44 80.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 0.0 111.585 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 9.1 m-85 -79.54 -42.39 25.22 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.73 48.43 1.59 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 139' ' ' ASN . 25.0 mt-10 -81.47 -122.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.586 0.231 . . . . 0.0 110.976 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -71.56 -61.15 1.88 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -176.53 -50.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.09 53.1 0.94 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.419 ' CG ' ' HB2' ' A' ' 135' ' ' GLU . 7.8 m120 -133.24 -49.75 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.669 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 140' ' ' LEU . 2.8 pp -97.71 133.96 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.855 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -160.72 65.62 2.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.816 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 38.8 Cg_endo -68.33 136.92 38.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.456 2.104 . . . . 0.0 112.947 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 0.1 OUTLIER -93.13 133.53 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.516 0.198 . . . . 0.0 110.623 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -72.14 120.14 17.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HB3' ' A' ' 164' ' ' MET . . . -87.74 136.98 14.22 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.316 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -157.92 149.83 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.4 m120 -44.61 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.336 0.654 . . . . 0.0 112.724 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.06 -146.06 4.73 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.624 -0.591 . . . . 0.0 111.624 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 37.1 t90 -173.59 121.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.271 0.535 . . . . 0.0 109.787 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 151.17 29.95 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 161' ' ' ARG . 2.4 m -98.46 149.01 23.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.364 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -148.54 139.83 23.33 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.742 0.417 . . . . 0.0 110.498 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.786 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 16.3 t-20 -73.64 133.54 43.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 121' ' ' ILE . 1.6 mt -78.37 -27.62 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.61 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 111.8 -42.2 2.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.831 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.44 -41.84 88.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.256 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 169.93 -39.69 0.2 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.667 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 158' ' ' LEU . 1.7 pt? -80.92 -171.39 3.16 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.786 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 8.0 mtmp? -145.1 139.81 27.6 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 t -96.16 124.46 40.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 151' ' ' THR . 16.0 ptp180 -118.81 116.65 26.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 111.361 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.968 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.7 -155.88 27.46 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.809 ' HD1' ' H ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -174.52 149.87 1.33 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.872 0.836 . . . . 0.0 110.95 179.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.809 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 7.6 tpt -82.99 124.95 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.898 ' HB3' HG13 ' A' ' 171' ' ' ILE . 17.7 t30 -89.92 132.03 35.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.594 0.235 . . . . 0.0 110.721 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.408 ' H ' ' ND2' ' A' ' 147' ' ' ASN . 21.8 p -96.98 -131.39 0.19 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.716 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.0 t 68.54 55.14 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.749 0.785 . . . . 0.0 111.061 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.8 -59.26 3.83 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.071 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -101.1 130.45 47.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 165' ' ' ASN . . . -98.99 138.24 36.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 165' ' ' ASN . 1.1 pt -140.85 123.81 16.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' A' ' 174' ' ' ILE . 33.6 tp -92.19 112.45 24.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 111.409 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -108.46 58.16 0.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.612 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.968 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 16.8 tt -116.8 124.44 72.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.418 0.627 . . . . 0.0 109.429 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.457 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 23.2 m170 -110.66 127.03 55.11 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' A' ' 158' ' ' LEU . 29.7 m -90.14 122.96 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.275 0.56 . . . . 0.0 111.325 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 158' ' ' LEU . 2.2 p -141.25 170.82 15.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.41 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -55.84 140.82 41.1 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.845 0.355 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.392 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.787 0.327 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.94 45.24 1.14 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.268 0.556 . . . . 0.0 110.158 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -88.85 122.24 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.389 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.42 -54.3 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.99 0.424 . . . . 0.0 110.551 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.316 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.46 48.51 10.56 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.699 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.63 44.95 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -144.74 58.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.262 0.553 . . . . 0.0 110.772 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -87.62 157.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.239 0.542 . . . . 0.0 112.38 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.18 161.05 11.75 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.32 44.28 1.37 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.04 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.33 -31.04 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 11.9 m -73.1 -26.79 61.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.338 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.3 pt? -61.62 159.55 13.05 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.6 ' H ' HG22 ' A' ' 18' ' ' ILE . 33.2 p -162.11 165.59 26.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.073 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.32 -22.96 66.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.975 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.71 -46.75 24.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 15' ' ' SER . 11.3 tp -64.75 -34.71 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 173' ' ' GLU . 15.6 mt -69.35 -35.64 76.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.526 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -69.02 -33.36 73.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -72.9 -39.66 66.18 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.68 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 18' ' ' ILE . 74.7 t -66.09 -35.25 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 32' ' ' LYS . 26.7 tp -70.77 -33.5 70.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.372 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.43 -43.12 98.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.38 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.82 75.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.037 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 38.32 0.54 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.044 0.449 . . . . 0.0 110.954 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.04 39.48 2.6 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.881 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -99.26 -48.62 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.441 0.639 . . . . 0.0 110.052 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 m -93.08 153.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.091 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -61.07 -56.23 23.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.824 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 40.1 mtm-85 -94.71 136.08 35.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.632 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HG3' HD11 ' A' ' 23' ' ' LEU . 20.5 pttm -152.22 135.43 15.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.609 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 106' ' ' VAL . 42.1 mm -120.27 104.64 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -91.04 94.75 9.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.651 0.739 . . . . 0.0 110.505 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 50.2 t -91.54 144.94 8.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.12 90.68 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.5 t -91.07 109.37 20.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.43 . . . . 0.0 111.137 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 8.4 t0 -81.76 88.83 6.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.532 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.9 m-80 -84.73 109.9 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' HG22 ' A' ' 177' ' ' THR . 23.4 tt0 -133.67 42.78 2.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.913 0.863 . . . . 0.0 109.437 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 t -68.96 -39.24 79.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.55 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.63 2.73 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.442 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 5.0 pttm -165.55 135.5 3.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.837 0.455 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 p -73.39 142.01 46.99 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 28.8 m0 -105.19 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.365 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 1.8 m -152.46 124.36 7.96 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.26 111.74 1.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.701 ' HB2' HD22 ' A' ' 93' ' ' LEU . 59.9 tp -89.66 -54.78 3.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.909 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 127' ' ' ARG . 21.7 p30 -172.43 147.82 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.573 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 61' ' ' LEU . 7.0 p -135.26 129.8 34.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.081 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -143.38 141.11 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 111.476 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 17.3 m-85 -119.06 138.99 52.48 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.199 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -79.54 -45.02 20.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.644 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 40.4 t -98.0 -100.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.466 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.2 -138.07 0.96 Allowed Glycine 0 C--O 1.222 -0.618 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.993 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -171.29 149.68 2.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.429 0.633 . . . . 0.0 110.823 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 7.9 t -102.19 -38.19 7.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.109 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -171.51 148.02 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 60' ' ' VAL . 7.9 tp -78.44 -35.2 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 111.002 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 HG23 ' A' ' 59' ' ' ILE . 46.6 t -133.87 124.97 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.172 0.511 . . . . 0.0 109.874 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.0 mp -105.4 169.28 7.23 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.503 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 4.8 Cg_endo -47.3 146.1 7.36 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.088 3.192 . . . . 0.0 113.442 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' THR . 97.0 m-70 -70.96 -32.33 69.17 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -145.63 144.72 30.61 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 88.7 t -113.56 102.63 55.02 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.36 152.39 13.76 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.322 2.681 . . . . 0.0 112.492 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.96 140.51 58.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 40' ' ' GLU . . . 79.96 36.54 24.77 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.741 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -150.14 133.63 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.404 0.621 . . . . 0.0 110.934 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -94.4 132.28 39.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.743 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 62' ' ' PRO . 15.6 tp -101.23 128.19 47.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.934 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.926 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -93.84 148.54 22.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.237 0.541 . . . . 0.0 111.926 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.906 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 12.5 m-85 -139.34 151.84 46.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 11.6 p-10 -137.78 98.62 3.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 109.665 178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -87.18 133.23 11.66 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.376 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -137.54 146.98 44.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.93 0.492 . . . . 0.0 110.339 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HB3' HH21 ' A' ' 31' ' ' ARG . 59.6 tptt -93.35 115.1 27.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.065 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -145.54 62.91 1.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.71 0.767 . . . . 0.0 109.342 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -98.44 -40.63 8.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.744 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.39 -143.34 8.05 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.052 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.29 -38.24 15.86 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.303 2.669 . . . . 0.0 112.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.8 131.11 34.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.555 0.693 . . . . 0.0 111.853 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.79 136.62 37.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.594 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.581 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 2.0 m -130.48 -47.86 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.275 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 136.39 -132.37 6.06 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.81 118.92 10.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.181 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 48.1 t -140.8 129.24 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -167.53 168.59 40.66 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.666 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.891 HG22 ' HG ' ' A' ' 103' ' ' LEU . 65.8 t -132.06 132.85 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.364 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -107.82 141.06 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -134.86 121.05 20.07 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.525 0.678 . . . . 0.0 111.282 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 16.2 m-85 -130.0 149.19 51.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.181 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' A' ' 48' ' ' LEU . 1.7 mm? -76.84 147.11 37.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.171 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 41.6 ttm -107.21 -37.98 6.11 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -163.18 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -88.8 -51.43 5.65 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.09 0.471 . . . . 0.0 110.981 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.5 37.17 0.1 OUTLIER Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -99.7 132.45 45.04 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 15.7 m -119.63 115.28 23.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 5.0 tt -88.37 123.02 32.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -107.67 135.75 48.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.324 0.583 . . . . 0.0 111.506 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 119' ' ' VAL . 25.9 t -126.86 127.9 70.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.306 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.891 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.5 mp -105.15 143.85 32.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' HD21 ' A' ' 172' ' ' LEU . 22.8 m-85 -139.21 142.54 37.87 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.0 t -154.17 131.42 11.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.241 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 33' ' ' ILE . 7.3 p -144.48 121.07 6.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 9.8 Cg_endo -89.66 152.77 5.17 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.312 2.675 . . . . 0.0 114.144 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.61 ' HB3' ' HE1' ' A' ' 110' ' ' TYR . 11.0 t80 -82.07 59.58 4.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 62.87 39.1 10.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.61 ' HE1' ' HB3' ' A' ' 108' ' ' TYR . 27.2 m-85 -89.96 144.67 25.71 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.701 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.75 -43.79 35.74 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.46 0.475 . . . . 0.0 111.615 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.64 ' HD1' ' HD1' ' A' ' 113' ' ' TYR . 1.4 p90 -75.62 -38.46 58.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.657 ' HB3' ' HB3' ' A' ' 107' ' ' PRO . 2.2 m-85 -79.15 149.07 32.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 110.752 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -145.75 155.42 42.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.215 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 73.7 m-20 -62.87 141.58 58.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.35 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.6 m-90 -144.77 141.89 29.57 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 112.312 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 56.2 p-90 -148.02 134.81 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.131 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.778 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 50.5 t30 -154.65 116.64 4.2 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.967 -0.458 . . . . 0.0 111.885 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 102' ' ' VAL . 2.8 m -102.93 130.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.428 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -166.76 146.15 5.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 111.364 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 mp -91.91 140.48 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.108 0.48 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -114.0 132.13 56.1 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.277 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -89.35 126.97 35.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.954 0.407 . . . . 0.0 111.916 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.45 141.81 11.9 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.955 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -74.03 87.88 1.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.018 0.437 . . . . 0.0 111.247 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -134.93 136.07 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.534 ' HA ' HD21 ' A' ' 49' ' ' ASN . 82.7 mtp180 -72.83 123.19 22.87 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.133 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.36 145.75 25.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.187 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.78 -161.09 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -62.31 -41.69 98.73 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 122.733 0.413 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -59.98 -31.2 69.68 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.3 ttm -70.83 -21.04 62.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 7.9 m-85 -60.19 -51.99 67.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -94.7 32.68 1.57 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.19 -59.15 2.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.345 . . . . 0.0 111.507 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 95.8 mt -89.68 -96.45 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.912 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -162.34 -58.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.733 0.302 . . . . 0.0 110.572 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -89.02 44.11 1.19 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 82.2 m-20 -100.43 -38.72 8.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.136 0.493 . . . . 0.0 110.757 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.516 ' HG ' ' HD2' ' A' ' 133' ' ' TYR . 2.4 tt -89.2 64.58 7.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.485 0.659 . . . . 0.0 109.946 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 63.5 m -133.82 59.64 40.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.843 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.0 Cg_exo -75.67 152.72 38.05 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.917 2.411 . . . . 0.0 111.601 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 15.0 t80 -91.99 135.02 34.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.5 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 98.7 mtt180 -72.97 129.0 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.838 0.351 . . . . 0.0 111.302 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.45 131.53 10.77 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.035 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.503 ' O ' ' HE2' ' A' ' 163' ' ' PHE . 35.6 p-10 -158.04 112.3 2.56 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.006 0.431 . . . . 0.0 111.124 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 165' ' ' ASN . 5.4 m120 -0.21 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 163' ' ' PHE . . . -174.67 -157.62 16.6 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.619 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.906 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 2.0 p90 -169.86 137.8 1.71 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.833 0.316 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.73 163.46 26.8 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.935 HG22 ' HG3' ' A' ' 161' ' ' ARG . 5.0 p -89.61 144.41 26.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.735 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -159.01 137.01 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.725 0.298 . . . . 0.0 110.872 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.72 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 1.7 t-20 -69.91 127.96 34.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.967 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 158' ' ' LEU . 3.9 pp -74.66 -23.77 58.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.325 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.75 -58.04 0.57 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.991 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.421 ' H ' HD12 ' A' ' 154' ' ' LEU . 20.4 t80 -69.27 -43.51 73.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 111.895 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 175.02 -44.94 0.13 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.954 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 154' ' ' LEU . 2.7 mm? -59.48 151.33 24.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.841 0.456 . . . . 0.0 110.872 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 153' ' ' ASN . 7.6 mtmp? -124.34 145.92 49.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.132 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 176' ' ' VAL . 41.5 t -101.45 127.12 48.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.935 ' HG3' HG22 ' A' ' 151' ' ' THR . 1.5 mpt_? -103.29 92.75 4.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.5 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.57 -160.05 27.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.309 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.906 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 9.0 t80 177.3 167.28 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.435 0.636 . . . . 0.0 111.097 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 15.5 ttt -86.97 135.54 33.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.93 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 147' ' ' ASN . 44.8 t30 -135.08 56.72 1.83 Allowed 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 68.6 p -144.62 118.71 9.44 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 m -84.89 -36.49 21.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.381 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.4 -33.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -154.69 111.97 3.37 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.068 0.947 . . . . 0.0 108.505 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 166' ' ' SER . . . -170.76 -129.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 34' ' ' ALA . 42.2 pt -135.3 175.93 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.619 0.724 . . . . 0.0 112.741 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.63 HD21 ' CE1' ' A' ' 104' ' ' PHE . 9.1 tp -161.84 112.2 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.812 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' A' ' 19' ' ' LEU . 45.4 mt-10 -119.36 127.62 53.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.007 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.555 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 7.0 pt -142.39 107.72 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.326 0.584 . . . . 0.0 110.067 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 17.6 m170 -91.48 105.72 17.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.526 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' A' ' 160' ' ' SER . 16.8 m -91.13 117.17 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 110.881 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.957 HG22 ' HB3' ' A' ' 40' ' ' GLU . 31.8 p -144.06 -155.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' H ' ' HB ' ' A' ' 177' ' ' THR . 0.0 OUTLIER -71.87 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.398 0.618 . . . . 0.0 111.977 -179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 157' ' ' GLY . . . . . . . . 0 C--O 1.242 0.694 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.53 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.059 0.022 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.86 128.75 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.379 1.05 . . . . 0.0 112.677 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -75.34 132.84 41.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.544 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.48 -55.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.055 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.66 144.4 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.234 0.614 . . . . 0.0 111.472 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.73 47.93 4.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.812 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.91 136.57 38.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.5 127.92 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.631 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -104.15 -150.59 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.976 -179.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' H ' ' HB ' ' A' ' 9' ' ' ILE . 36.3 t70 -85.5 153.28 22.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.746 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.76 48.39 1.29 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.184 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 -29.62 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.192 0.52 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 9' ' ' ILE . 29.4 t -76.91 -25.49 53.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.009 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 70' ' ' ALA . 7.3 mp -67.49 143.1 56.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.634 0.73 . . . . 0.0 112.73 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 18' ' ' ILE . 34.4 m -160.93 158.85 28.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.086 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' A' ' 163' ' ' PHE . 9.0 m-85 -56.63 -32.8 65.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.96 0.41 . . . . 0.0 110.653 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.74 -43.79 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.064 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' VAL . 10.5 tp -65.47 -32.58 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 34' ' ' ALA . 48.6 mt -67.89 -42.29 81.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -67.87 -34.8 77.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.014 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 18' ' ' ILE . 38.5 t -60.0 -43.6 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.296 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.674 ' HG ' ' HB3' ' A' ' 169' ' ' HIS . 3.1 mm? -71.98 -30.75 65.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 111.072 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -73.24 -42.07 62.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -27.43 54.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.907 HD13 ' HD3' ' A' ' 32' ' ' LYS . 19.1 mt -59.69 -70.62 0.15 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.576 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.36 -55.03 2.81 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.948 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.5 -46.37 86.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 0.0 111.525 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HD2' ' A' ' 32' ' ' LYS . 2.5 t -81.76 146.44 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.886 0.374 . . . . 0.0 110.043 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -84.5 -46.34 11.72 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.964 -178.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 29.4 mmt180 -133.39 136.52 45.34 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.907 ' HD3' HD13 ' A' ' 26' ' ' LEU . 23.9 mtpp -151.26 153.38 34.77 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.637 0.256 . . . . 0.0 110.896 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 12.1 tt -107.35 115.47 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.18 0.514 . . . . 0.0 111.824 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -90.2 106.81 18.74 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.651 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -95.33 135.58 28.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.855 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -150.4 124.18 1.69 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 30.0 t -135.74 114.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.281 -0.541 . . . . 0.0 111.466 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.93 91.08 5.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.888 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.655 HD21 HD23 ' A' ' 71' ' ' LEU . 55.4 m-80 -73.62 100.57 3.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.324 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 3.6 tp10 -123.13 79.7 1.69 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 110.837 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' OG ' ' HD3' ' A' ' 43' ' ' LYS . 12.9 t -142.34 -22.78 0.68 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.893 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 83.4 9.9 82.86 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.856 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 18.3 pttm -90.72 125.8 35.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -80.74 127.6 32.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 26.1 m0 -108.16 149.58 28.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.2 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 47' ' ' ALA . 5.7 m -118.5 -110.52 0.35 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' H ' ' HB ' ' A' ' 46' ' ' THR . . . -167.56 128.37 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.016 -0.427 . . . . 0.0 110.723 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD13 HD23 ' A' ' 93' ' ' LEU . 61.2 tp -108.29 -56.11 2.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -173.23 144.72 1.23 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.153 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.542 HG21 HD21 ' A' ' 61' ' ' LEU . 1.3 p -127.13 114.42 17.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.89 146.08 42.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.441 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 26.9 m-85 -129.9 138.19 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.762 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' CD ' ' A' ' 130' ' ' GLN . 40.9 ttm180 -77.21 -37.01 54.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.836 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 34.8 t -102.94 -111.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.53 -134.23 0.13 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.77 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.4 t -163.41 156.06 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.168 0.509 . . . . 0.0 111.121 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 22.9 t -121.33 -45.7 2.32 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.42 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.06 130.58 2.65 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.611 HG13 HG22 ' A' ' 60' ' ' VAL . 34.1 pt -82.92 -41.37 17.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 59' ' ' ILE . 3.9 m -135.22 65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.714 0.768 . . . . 0.0 111.346 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 50' ' ' THR . 1.2 pp -64.96 163.17 31.74 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.577 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.12 145.56 25.51 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.525 2.817 . . . . 0.0 113.003 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -108.07 57.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.352 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 40.6 mttm -164.1 117.5 1.43 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 44.9 t -137.41 86.55 19.24 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 5.5 Cg_exo -81.72 -135.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.609 2.873 . . . . 0.0 114.989 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.893 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 21.1 t-80 -99.24 137.31 37.94 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.431 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.15 52.48 52.5 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 114.654 0.622 . . . . 0.0 114.654 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -144.73 125.21 13.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.624 0.712 . . . . 0.0 110.464 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 14' ' ' LEU . . . -92.09 128.4 37.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.228 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.655 HD23 HD21 ' A' ' 39' ' ' ASN . 4.6 pp -89.94 141.78 28.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.3 tt -131.42 130.28 42.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.682 0.277 . . . . 0.0 110.741 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -147.05 147.19 30.38 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 75.6 m-80 -128.72 104.37 7.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.829 0.347 . . . . 0.0 110.618 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -77.11 151.26 38.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.177 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 16.2 pt20 -149.39 150.93 33.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.989 0.424 . . . . 0.0 111.406 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 83' ' ' ALA . 28.9 tttm -83.49 136.0 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.822 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.23 107.35 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.904 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.469 ' NH2' ' O ' ' A' ' 53' ' ' ARG . 91.7 mtt180 -156.77 -63.51 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.294 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.13 -57.32 0.47 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.452 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.68 -136.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.382 2.721 . . . . 0.0 114.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.16 145.99 8.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 122.158 0.98 . . . . 0.0 112.744 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.961 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . . . -82.38 108.64 15.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.835 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.9 m -109.63 -39.06 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 111.127 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -125.95 7.97 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.154 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.19 122.48 20.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.305 0.552 . . . . 0.0 111.524 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 29.7 t -144.86 130.92 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.501 ' HA2' ' OE1' ' A' ' 130' ' ' GLN . . . -173.16 -178.68 43.32 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.615 -1.279 . . . . 0.0 114.238 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.62 132.83 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.258 0.623 . . . . 0.0 110.847 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -109.93 142.64 40.99 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -140.83 120.97 13.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.377 0.608 . . . . 0.0 112.076 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' HE1' HD12 ' A' ' 90' ' ' LEU . 5.1 m-85 -118.28 144.53 45.74 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.465 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -77.91 135.21 37.83 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 25.4 tpp -92.01 -28.78 16.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.931 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 t -172.71 -93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.465 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -87.6 -38.32 16.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.663 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.6 40.92 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.136 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 14.9 t-20 -110.29 144.39 39.07 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.716 HG21 ' HB1' ' A' ' 91' ' ' ALA . 87.9 m -146.93 126.64 13.41 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.574 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.2 tt -89.81 108.22 19.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.05 134.41 34.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.814 0.34 . . . . 0.0 110.792 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HB ' HD21 ' A' ' 90' ' ' LEU . 21.4 t -129.51 132.86 66.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.507 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 60.9 tp -101.39 144.95 29.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.23 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 172' ' ' LEU . 62.3 m-85 -142.22 141.54 32.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.649 0.593 . . . . 0.0 109.78 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 16.7 t -153.05 133.58 13.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.689 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.3 p -149.69 124.94 4.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 121.154 0.502 . . . . 0.0 109.701 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo -78.76 149.19 23.16 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 123.835 3.023 . . . . 0.0 113.285 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 77' ' ' LYS . 4.1 t80 -104.61 127.78 52.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 69.74 -49.77 0.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.93 114.97 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 111.285 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.77 -26.53 40.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.866 0.365 . . . . 0.0 111.454 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -61.82 -42.06 98.56 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.441 ' O ' ' HG2' ' A' ' 107' ' ' PRO . 7.5 m-85 -70.89 138.91 50.58 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.92 0.391 . . . . 0.0 111.23 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.2 p -100.51 170.25 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.087 0.47 . . . . 0.0 112.0 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.71 176.99 9.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 142' ' ' PRO . 8.2 m-90 -157.48 135.21 10.69 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.622 ' HD1' ' SD ' ' A' ' 164' ' ' MET . 16.7 p-90 -145.08 144.41 30.94 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -156.74 116.43 3.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 102' ' ' VAL . 19.2 m -101.89 136.3 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.789 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 29.8 ttm180 -167.23 141.86 3.88 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.729 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 ' HG ' ' A' ' 100' ' ' LEU . 30.2 mm -79.87 134.48 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.905 0.383 . . . . 0.0 111.303 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.434 ' HE1' ' HB3' ' A' ' 120' ' ' ARG . 5.9 m-85 -123.63 52.77 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.395 0.617 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 87.8 tttt -65.32 129.85 41.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.51 -92.2 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.288 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -172.15 -39.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.829 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -72.6 136.58 45.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.232 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -85.01 140.01 31.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.716 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -81.21 158.42 24.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.557 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -160.56 -157.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.1 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.501 ' OE1' ' HA2' ' A' ' 88' ' ' GLY . 4.2 mm100 -77.97 -23.68 48.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -86.64 -37.3 18.17 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.439 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.716 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 86.6 mmm -51.44 -40.61 59.75 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.624 ' HA ' ' HB3' ' A' ' 139' ' ' ASN . 4.7 m-85 -67.83 -45.36 74.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.2 -34.42 63.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.369 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -62.72 -53.34 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.045 0.45 . . . . 0.0 112.077 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.508 HD23 ' ND2' ' A' ' 139' ' ' ASN . 30.2 tp -90.94 134.41 34.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.988 0.423 . . . . 0.0 111.383 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -61.29 -44.05 97.87 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.656 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -85.69 39.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.624 ' HB3' ' HA ' ' A' ' 133' ' ' TYR . 1.8 m120 -126.11 -44.6 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.117 -0.364 . . . . 0.0 111.36 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.46 ' CD1' ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -89.2 131.35 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.297 0.57 . . . . 0.0 110.933 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 t -175.13 68.61 0.27 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.0 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' TRP . 4.0 Cg_exo -75.08 142.2 27.32 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.972 2.448 . . . . 0.0 112.766 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' ARG . 30.7 t80 -71.5 -11.6 60.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.602 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 99.7 mtt180 73.7 -6.14 1.86 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.968 0.507 . . . . 0.0 112.013 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.99 127.24 0.01 OUTLIER Glycine 0 N--CA 1.462 0.418 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -171.59 137.51 1.05 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.71 -0.877 . . . . 0.0 109.853 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.7 m120 -45.66 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.218 0.948 . . . . 0.0 112.212 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.79 124.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 163' ' ' PHE . 1.2 p90 -89.42 140.48 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 111.087 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 161' ' ' ARG . 0.6 OUTLIER -165.22 165.17 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.826 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 161' ' ' ARG . 8.8 t -120.38 160.82 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 111.105 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -160.98 130.17 4.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.13 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 17.6 p-10 -65.32 138.61 58.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.839 0.352 . . . . 0.0 111.198 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.58 -40.57 63.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.635 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.52 -45.09 1.12 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.076 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -67.87 -55.43 12.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.533 0.682 . . . . 0.0 110.179 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.17 42.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 178' ' ' LYS . 42.6 mt -143.56 167.17 22.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 153' ' ' ASN . 9.2 ptpp? -138.54 139.75 38.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 151' ' ' THR . 6.5 m -110.48 114.22 27.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.737 ' HB3' ' HB ' ' A' ' 151' ' ' THR . 0.2 OUTLIER -109.62 124.71 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.768 ' HA3' HG22 ' A' ' 174' ' ' ILE . . . -159.18 175.42 36.12 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.611 -1.28 . . . . 0.0 114.277 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 149' ' ' TRP . 62.8 t80 -133.29 129.88 38.19 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.089 0.556 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.65 ' HB2' HD12 ' A' ' 172' ' ' LEU . 18.0 ttt -117.93 139.33 51.3 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.298 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.599 ' HB3' HG13 ' A' ' 171' ' ' ILE . 11.1 t30 -118.43 130.58 56.05 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.6 p -81.82 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 71.0 m 65.74 -151.48 0.24 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.771 0.428 . . . . 0.0 111.295 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -48.31 5.37 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.862 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.674 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 54.3 m170 -88.87 108.09 19.35 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.11 137.85 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.729 HG22 ' HB3' ' A' ' 34' ' ' ALA . 15.0 pt -140.72 137.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.092 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 164' ' ' MET . 2.2 tp -141.65 113.0 7.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.445 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -117.46 96.25 5.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.272 0.558 . . . . 0.0 109.524 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.768 HG22 ' HA3' ' A' ' 162' ' ' GLY . 28.0 pt -110.97 128.37 67.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.505 0.669 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -106.12 114.16 28.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.763 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 39' ' ' ASN . 25.2 m -92.91 124.92 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 40' ' ' GLU . 34.7 p -138.15 -176.86 4.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.57 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 158' ' ' LEU . 59.0 pttt -66.26 139.31 58.07 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.84 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 121.616 0.722 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.86 47.54 1.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.093 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 55.4 43.12 29.31 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t 72.01 -47.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 -41.26 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.4 -150.34 12.7 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.628 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 139.35 43.44 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.069 0.461 . . . . 0.0 111.458 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -152.29 140.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.847 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.79 165.1 24.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.408 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.16 148.15 27.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.553 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.46 51.44 0.63 Allowed Glycine 0 C--N 1.333 0.402 0 O-C-N 124.175 0.922 . . . . 0.0 113.552 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.15 -30.93 0.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.983 0.42 . . . . 0.0 111.165 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -72.66 -27.41 62.1 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -67.35 160.82 26.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m -154.2 163.2 40.5 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.58 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 173' ' ' GLU . 16.4 m-85 -53.64 -34.91 60.21 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.483 0.489 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.32 -46.48 86.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -60.35 -40.8 85.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.75 -38.78 92.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.073 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.83 -34.55 78.41 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.2 m -68.18 -48.35 65.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.607 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.55 -36.81 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.72 0.772 . . . . 0.0 109.543 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 169' ' ' HIS . 15.7 tp -63.28 -47.83 80.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.335 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 3.9 tp10 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.596 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.62 62.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.593 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.74 58.03 2.68 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.16 0.505 . . . . 0.0 110.181 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.9 49.33 4.06 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.97 -56.74 2.0 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.533 0.682 . . . . 0.0 109.732 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.7 158.49 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.941 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -64.39 -63.51 1.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.418 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.2 146.31 35.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -132.71 139.5 47.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 4.4 mp -120.14 128.61 75.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 111.34 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -133.61 139.15 46.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.866 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 172' ' ' LEU . 59.5 t -142.11 144.08 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.975 0.417 . . . . 0.0 111.764 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.61 114.39 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 44.6 t -114.79 119.36 61.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.752 0.311 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-20 -81.59 93.77 6.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -77.94 96.33 5.01 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.47 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -117.69 67.58 0.75 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.16 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -122.01 -43.85 2.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.777 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.772 ' HA2' ' HB2' ' A' ' 67' ' ' HIS . . . 104.79 30.78 4.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.679 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 16.1 pttm -119.67 126.22 50.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 p -87.14 123.52 32.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.452 0.644 . . . . 0.0 111.298 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.3 m0 -94.23 163.97 13.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.562 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 20.9 m -142.32 129.19 20.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.667 ' H ' ' HA ' ' A' ' 63' ' ' HIS . . . -60.61 114.28 2.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.816 0.341 . . . . 0.0 111.749 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.3 tp -93.52 -51.57 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.44 . . . . 0.0 110.569 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -173.51 160.67 3.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.247 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.55 HG21 HD13 ' A' ' 61' ' ' LEU . 1.8 p -152.7 122.22 6.81 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.393 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.53 135.01 24.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.229 0.538 . . . . 0.0 111.977 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD2' ' HA3' ' A' ' 88' ' ' GLY . 7.9 m-85 -116.69 144.25 44.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.303 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 130' ' ' GLN . 28.2 ttm180 -78.1 -47.22 18.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.595 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -104.43 -90.15 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.872 0.368 . . . . 0.0 111.572 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 86' ' ' ALA . . . -73.23 -157.03 3.98 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.945 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 t -170.33 147.22 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.714 0.769 . . . . 0.0 112.009 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 21.7 t -95.75 -45.44 7.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.938 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -173.84 155.07 2.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.661 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.843 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -87.44 -20.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.654 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.72 151.02 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.665 0.269 . . . . 0.0 110.435 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -145.05 152.95 52.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.23 122.99 12.63 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.916 2.411 . . . . 0.0 112.488 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.667 ' HA ' ' H ' ' A' ' 47' ' ' ALA . 16.1 p80 -77.05 48.36 0.59 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 51.7 tttm -171.36 123.55 0.57 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 59.2 t -132.78 102.76 13.46 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -82.81 -144.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.338 2.692 . . . . 0.0 114.502 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.772 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . 8.1 t-160 -109.94 131.69 54.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.757 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 67' ' ' HIS . . . 76.13 43.49 21.17 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.748 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -146.1 130.29 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.828 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -88.27 128.47 35.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.318 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 71' ' ' LEU . 3.9 pp -83.98 127.16 33.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.81 144.62 27.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.848 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.52 148.17 29.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.291 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 12.7 p-10 -159.67 117.22 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -105.01 143.15 15.6 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.621 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -117.49 149.54 40.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.715 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 23.4 ttmm -68.25 145.71 54.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.976 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.67 -61.53 2.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.193 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.0 tpt85 -142.46 -62.39 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.076 -0.39 . . . . 0.0 111.399 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.715 ' HA2' ' HD3' ' A' ' 77' ' ' LYS . . . 155.22 -59.52 0.38 Allowed Glycine 0 C--O 1.225 -0.41 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.977 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.55 -37.76 63.46 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.414 2.742 . . . . 0.0 114.14 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 m -61.96 142.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.18 0.514 . . . . 0.0 111.163 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HA ' ' HB3' ' A' ' 108' ' ' TYR . . . -77.49 39.3 0.26 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.371 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -147.72 143.59 27.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.502 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' LYS . . . -100.24 -50.88 1.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.972 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' H ' ' A' ' 55' ' ' GLY . . . -164.22 114.26 1.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.053 0.454 . . . . 0.0 110.647 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 105' ' ' SER . 42.1 t -136.91 130.01 45.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 52' ' ' PHE . . . -172.13 -175.76 40.49 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.655 -1.259 . . . . 0.0 113.498 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 103' ' ' LEU . 64.0 t -138.08 141.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.029 -0.586 . . . . 0.0 111.503 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 ' HE1' ' A' ' 92' ' ' TYR . 1.2 pt? -119.7 145.98 46.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.2 128.75 18.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.305 0.574 . . . . 0.0 111.497 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.684 ' HE1' HD12 ' A' ' 90' ' ' LEU . 10.9 m-85 -130.75 153.87 48.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 3.7 mp -78.38 138.14 38.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 40.8 tpp -86.49 -35.11 19.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.69 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.6 t -171.29 -72.11 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.129 0.49 . . . . 0.0 110.868 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -90.43 -50.12 6.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.397 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -175.76 23.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 94' ' ' MET . 5.9 m120 -86.8 149.74 24.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.679 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 14.8 m -128.38 119.14 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HG ' HD13 ' A' ' 121' ' ' ILE . 4.6 tt -89.52 106.88 18.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.3 136.91 32.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.419 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.775 HG22 HG12 ' A' ' 119' ' ' VAL . 26.6 t -131.52 133.3 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.393 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.8 mp -109.88 150.07 28.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.612 0.244 . . . . 0.0 111.595 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 172' ' ' LEU . 89.3 m-85 -140.14 148.13 41.2 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.735 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 11.5 t -155.81 131.53 9.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.007 0.432 . . . . 0.0 111.513 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 96.3 t -141.42 114.42 6.79 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.17 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 113' ' ' TYR . 2.8 Cg_exo -78.68 163.27 26.66 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.687 -178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.627 ' HD1' ' HZ1' ' A' ' 77' ' ' LYS . 55.7 t80 -99.16 164.84 11.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.169 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.3 t0 71.88 148.16 0.08 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.463 0.705 . . . . 0.0 111.127 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.72 116.32 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.957 0.408 . . . . 0.0 111.119 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -162.47 -142.43 0.07 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.55 41.19 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.625 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.859 ' HB2' ' HG2' ' A' ' 107' ' ' PRO . 42.8 p90 -77.46 149.21 35.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.533 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.4 m -140.19 145.76 37.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.375 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.06 154.1 41.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.023 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 105' ' ' SER . 10.1 m-90 -132.76 138.49 47.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 61.4 p-90 -148.33 144.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.246 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 47.4 t30 -154.54 116.5 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 102' ' ' VAL . 11.3 m -102.7 135.91 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.921 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 139' ' ' ASN . 19.4 tpt180 -162.69 143.63 9.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.643 HD13 ' HG ' ' A' ' 100' ' ' LEU . 5.2 mm -87.87 143.93 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.61 141.9 51.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -92.89 46.96 1.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.174 -0.329 . . . . 0.0 111.364 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.77 -154.31 35.85 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.614 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 68.87 -47.04 0.56 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.608 0.763 . . . . 0.0 112.576 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -112.04 134.58 53.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -86.96 131.02 34.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 132' ' ' MET . . . -79.98 141.14 36.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.3 t0 -155.53 -160.93 1.09 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.417 ' HB3' HH21 ' A' ' 53' ' ' ARG . 96.6 mm-40 -67.63 -33.15 74.39 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.953 0.406 . . . . 0.0 110.577 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -85.9 13.77 6.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.149 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.59 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 8.2 tmm? -79.59 -4.88 53.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -127.46 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -47.46 117.87 1.97 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.894 0.478 . . . . 0.0 111.127 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -172.35 -106.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.036 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.09 -166.28 1.53 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.173 -0.329 . . . . 0.0 110.17 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -76.67 44.5 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.223 0.535 . . . . 0.0 111.864 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -111.72 -110.89 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 111.54 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.431 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 2.8 m120 -89.21 175.53 7.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' SER . 9.7 tp -152.24 -144.17 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.88 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 15.0 p -73.92 141.69 78.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 17.7 Cg_endo -61.92 171.77 4.54 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.708 2.939 . . . . 0.0 113.047 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.86 143.13 26.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.008 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.27 129.52 38.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.159 0.504 . . . . 0.0 111.738 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -85.07 139.81 17.96 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.763 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -158.18 143.39 16.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.1 m120 -49.03 96.82 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.273 0.629 . . . . 0.0 111.854 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.27 -141.22 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.987 -1.101 . . . . 0.0 113.063 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.725 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 7.6 t90 -171.5 125.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.499 ' NE2' ' HZ2' ' A' ' 117' ' ' TRP . 0.7 OUTLIER -155.4 157.02 36.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.246 0.546 . . . . 0.0 112.031 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.871 HG22 ' HG2' ' A' ' 161' ' ' ARG . 1.1 p -89.4 155.08 19.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.196 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -155.16 128.6 8.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.884 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . 20.4 t-20 -78.14 132.61 37.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 0.0 110.31 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.74 -34.89 62.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.804 0.335 . . . . 0.0 111.34 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.27 -46.77 1.06 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.786 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -67.33 -39.65 85.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.235 0.541 . . . . 0.0 110.35 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.25 -36.05 0.36 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 178' ' ' LYS . 1.7 mm? -66.0 159.65 25.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.887 -0.657 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 179' ' ' ALA . 92.8 mttt -136.91 139.1 41.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.166 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 34.0 t -93.96 127.09 39.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.999 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' A' ' 151' ' ' THR . 90.9 mtt180 -114.03 101.08 8.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 177.41 -158.91 24.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.475 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.725 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.4 OUTLIER -175.1 151.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.967 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.605 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 21.6 ttt -91.65 127.41 37.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 t30 -84.02 123.3 29.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.3 p -81.74 -124.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.598 0.561 . . . . 0.0 111.891 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.3 m 67.74 -148.33 0.15 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.664 0.385 . . . . 0.0 111.39 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.62 -37.6 19.62 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.497 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.714 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.1 m170 -113.2 126.77 55.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.53 136.32 33.09 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.875 HG13 ' HB3' ' A' ' 165' ' ' ASN . 8.0 pt -144.29 121.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.709 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 35' ' ' VAL . 31.0 tp -100.47 116.19 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.097 0.475 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 16' ' ' PHE . 9.5 tp10 -113.1 76.92 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.783 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 43.6 pt -118.97 127.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.322 0.582 . . . . 0.0 111.046 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.74 113.24 25.26 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 16.1 t -87.29 125.94 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.86 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 p -127.71 175.33 8.39 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.742 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.0 tttt -76.94 61.5 1.96 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.665 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.567 0.223 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.71 127.65 34.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 65.19 135.41 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.95 0.9 . . . . 0.0 112.563 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -95.86 73.9 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.801 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.76 36.7 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.56 132.67 3.31 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.681 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 138.96 33.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.259 . . . . 0.0 111.548 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -136.84 139.25 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.223 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -143.45 160.75 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.13 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.33 161.92 15.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.401 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.16 47.45 0.83 Allowed Glycine 0 C--N 1.338 0.644 0 O-C-N 123.616 0.572 . . . . 0.0 113.468 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.92 -46.66 0.94 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -83.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.023 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.46 143.08 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.0 0.429 . . . . 0.0 111.579 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -165.6 157.61 14.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.001 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 163' ' ' PHE . 6.2 m-85 -59.21 -34.71 72.5 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.409 0.443 . . . . 0.0 110.937 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.14 -42.56 90.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.055 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.3 mp -63.62 -41.14 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.97 -40.1 94.47 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -65.42 -36.54 84.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -68.95 -38.48 79.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.092 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' ILE . 52.7 t -63.51 -40.54 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.592 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -63.6 -41.8 98.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.12 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.79 -30.34 68.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.0 78.07 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.392 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.69 -55.4 27.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.337 0.113 . . . . 0.0 111.167 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.73 32.2 24.77 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 114.951 0.741 . . . . 0.0 114.951 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 60.6 t30 -100.37 -93.48 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.415 0.607 . . . . 0.0 110.104 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG22 ' H ' ' A' ' 30' ' ' LYS . 8.9 p -79.61 -176.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.778 ' H ' HG22 ' A' ' 29' ' ' VAL . 13.5 mptt -84.32 -62.89 1.45 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -85.03 141.8 30.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.36 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 23' ' ' LEU . 11.4 ptpt -170.52 165.59 8.44 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 120.94 0.4 . . . . 0.0 111.44 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.4 pt -110.38 138.66 37.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 171' ' ' ILE . . . -125.99 114.49 18.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 31.8 t -111.13 144.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.991 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 80.61 0.2 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 48.5 t -90.66 115.72 30.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 10.0 m-20 -80.94 89.77 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.315 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.523 HD22 HG12 ' A' ' 65' ' ' VAL . 60.3 t-20 -72.72 87.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -115.12 40.11 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.522 ' OG ' ' HA3' ' A' ' 155' ' ' GLY . 37.0 t -109.27 1.31 20.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.891 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 62.31 50.38 65.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.901 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG3' ' HE1' ' A' ' 45' ' ' TRP . 23.6 pttm -142.09 123.85 15.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.493 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 p -81.33 141.14 34.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m0 -116.73 135.87 53.42 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.898 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 m -125.46 142.67 51.37 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.769 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.62 122.9 15.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD22 HD23 ' A' ' 93' ' ' LEU . 40.1 tp -121.93 -50.31 2.06 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.444 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -159.82 142.75 13.86 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.84 0.352 . . . . 0.0 111.366 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 HD23 ' A' ' 61' ' ' LEU . 4.1 p -145.36 128.66 16.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.174 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.82 140.28 19.68 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.112 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -118.71 135.38 54.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.458 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -81.19 -31.08 34.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.033 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' ' 84' ' ' THR . 36.0 t -121.23 -76.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.099 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.04 -143.58 5.09 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.036 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 t -167.58 157.92 10.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.305 0.574 . . . . 0.0 111.495 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.59 -67.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.388 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.47 37.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.3 mt 65.05 -57.34 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.076 0.95 . . . . 0.0 112.778 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -112.31 150.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 111.822 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 47' ' ' ALA . 4.2 pp -75.16 169.86 18.32 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.346 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.646 ' HG2' HD11 ' A' ' 71' ' ' LEU . 80.9 Cg_exo -48.28 -77.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.363 2.708 . . . . 0.0 114.457 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.627 ' HD2' ' HG2' ' A' ' 64' ' ' LYS . 27.4 p-80 -175.07 -58.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.627 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 21.6 pttm -161.08 141.44 11.11 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.426 0.155 . . . . 0.0 110.687 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 71' ' ' LEU . 15.4 t -114.8 98.48 49.94 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.88 169.83 8.89 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.539 2.826 . . . . 0.0 113.435 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -64.62 138.79 58.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.591 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.82 38.35 56.57 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.727 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -149.87 135.71 18.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.983 0.42 . . . . 0.0 111.839 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 37' ' ' VAL . . . -89.06 132.08 34.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.94 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.646 HD11 ' HG2' ' A' ' 62' ' ' PRO . 61.6 tp -91.86 113.07 25.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.622 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -88.03 132.92 34.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 2.6 t80 -141.49 155.8 45.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.79 0.329 . . . . 0.0 110.502 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -154.78 153.19 30.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.604 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.43 142.99 9.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.382 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.489 ' OE1' HG12 ' A' ' 29' ' ' VAL . 38.1 mt-30 -134.51 163.73 29.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.25 126.77 34.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.1 137.66 32.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 111.574 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 66.6 137.55 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.802 0.841 . . . . 0.0 112.432 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 81' ' ' PRO . . . 127.07 133.88 3.88 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.75 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD3' ' HA2' ' A' ' 80' ' ' GLY . 6.3 Cg_exo -73.73 -36.56 3.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.038 2.492 . . . . 0.0 112.314 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.57 161.73 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.42 121.57 24.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.547 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 22.9 p -134.86 141.42 46.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.96 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.46 -123.16 3.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.495 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.96 108.84 5.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.301 0.572 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 105' ' ' SER . 53.3 t -137.27 133.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.36 161.93 28.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.921 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.692 HG22 ' HG ' ' A' ' 103' ' ' LEU . 51.9 t -123.0 133.34 69.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 110.667 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HE1' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -106.17 137.84 43.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.482 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -130.82 116.49 18.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.078 0.465 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 1.3 m-85 -116.91 131.78 56.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.418 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.764 HD23 HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -80.02 128.85 33.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 43' ' ' LYS . 34.9 ttm -83.25 -69.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.878 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.5 p -168.89 -48.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -89.41 32.34 0.86 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.718 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.42 42.69 72.84 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.807 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 15.1 p-10 -123.17 131.84 53.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 3.8 m -112.38 117.29 32.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.975 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 121' ' ' ILE . 3.8 tt -89.04 105.14 17.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -95.13 137.09 34.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.213 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG22 HG12 ' A' ' 119' ' ' VAL . 16.7 t -127.91 126.87 67.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.381 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.692 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.1 mp -99.04 144.64 27.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.199 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HE1' HD21 ' A' ' 90' ' ' LEU . 65.1 m-85 -138.54 141.68 39.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.218 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.629 ' HA ' HG22 ' A' ' 87' ' ' VAL . 19.4 t -150.18 129.12 12.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.293 0.371 . . . . 0.0 110.064 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 t -143.61 124.24 7.9 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 113' ' ' TYR . 3.1 Cg_exo -81.19 142.91 13.78 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.604 2.869 . . . . 0.0 113.018 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.406 ' O ' ' HD1' ' A' ' 110' ' ' TYR . 17.9 t80 -96.29 115.88 28.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.916 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p30 59.48 -38.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' A' ' 108' ' ' TYR . 55.9 m-85 -62.29 126.48 27.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.773 0.715 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -86.26 -23.27 26.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.156 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -64.08 -38.99 93.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 9.3 m-85 -79.23 152.85 30.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.39 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -127.27 162.81 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.744 0.307 . . . . 0.0 111.592 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' SER . 52.6 m-80 -72.79 160.88 31.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.06 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 142' ' ' PRO . 5.4 m-90 -155.78 138.42 15.1 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.692 0.224 . . . . 0.0 110.765 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 9.8 p-90 -146.17 139.07 25.64 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 27.7 t-20 -156.83 126.08 6.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.865 0.364 . . . . 0.0 111.591 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 102' ' ' VAL . 13.0 m -102.82 139.22 24.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.133 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -156.74 144.07 18.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.804 0.335 . . . . 0.0 111.688 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.697 HD13 ' HG ' ' A' ' 100' ' ' LEU . 26.6 mm -87.31 135.03 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -126.32 72.38 1.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.294 0.569 . . . . 0.0 110.172 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 85.4 tttt -75.11 142.82 43.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.14 44.75 1.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.647 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 48.27 -153.8 0.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.226 1.01 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 69.89 137.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.153 0.501 . . . . 0.0 110.844 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -111.75 136.01 51.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.935 0.398 . . . . 0.0 111.283 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -79.14 141.14 37.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.024 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.76 ' H ' ' HB2' ' A' ' 132' ' ' MET . 4.5 t70 -153.73 -161.94 1.35 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -59.08 -42.61 90.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 131' ' ' ARG . 39.8 mtp85 -89.97 25.75 2.03 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.76 ' HB2' ' H ' ' A' ' 129' ' ' ASP . 12.8 tmm? -90.96 -62.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.961 -0.462 . . . . 0.0 111.04 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.573 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -153.0 36.36 0.48 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.724 0.41 . . . . 0.0 110.844 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -102.55 60.56 0.81 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -77.38 -144.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.635 0.255 . . . . 0.0 111.526 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.83 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.6 pt? -83.39 -44.6 14.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -162.52 -46.5 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.776 0.322 . . . . 0.0 111.049 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -78.67 63.76 3.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 133' ' ' TYR . 4.9 p-10 -149.52 -49.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 103' ' ' LEU . 69.6 mt -150.45 141.47 22.99 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.471 0.308 . . . . 0.0 110.683 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 36.6 p -138.74 106.64 7.58 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.951 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.717 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 3.1 Cg_exo -77.28 176.08 10.53 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.783 2.988 . . . . 0.0 113.367 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -79.1 -5.81 54.98 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 89.0 mtm180 73.0 -10.6 0.97 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 48.7 103.51 0.01 OUTLIER Glycine 0 N--CA 1.47 0.939 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.54 149.85 28.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.473 -0.428 . . . . 0.0 110.959 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 1.6 m120 -54.34 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.68 -125.35 0.84 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.215 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -155.41 142.01 18.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.741 0.305 . . . . 0.0 110.288 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -147.98 138.86 23.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.522 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.522 ' OG1' ' HG3' ' A' ' 161' ' ' ARG . 1.8 m -147.47 143.86 28.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -175.69 140.32 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.797 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.838 ' HB3' ' HG2' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -71.02 138.13 49.61 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.449 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 119' ' ' VAL . 3.8 pp -154.67 -26.39 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA3' ' OG ' ' A' ' 41' ' ' SER . . . -73.91 45.77 1.4 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.471 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.2 t80 56.76 32.13 20.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.929 0.871 . . . . 0.0 109.648 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 143.31 -44.66 0.94 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.749 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.9 mm? -67.58 177.17 2.08 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.855 0.462 . . . . 0.0 110.47 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.838 ' HG2' ' HB3' ' A' ' 153' ' ' ASN . 6.5 mtmp? -136.08 149.27 48.66 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 122.006 -0.434 . . . . 0.0 111.216 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.889 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 3.6 t -107.62 123.89 49.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.522 ' HG3' ' OG1' ' A' ' 151' ' ' THR . 62.5 ttt-85 -118.8 130.95 56.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 173' ' ' GLU . . . 176.49 -139.9 4.74 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.214 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.55 ' HZ ' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 p90 179.56 177.17 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.998 0.47 . . . . 0.0 110.144 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 25.1 ttt -131.45 114.76 15.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.887 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.645 ' HB3' HG13 ' A' ' 171' ' ' ILE . 14.0 t30 -83.95 131.38 34.85 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.629 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.555 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.4 p -91.76 -124.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.496 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 44.8 m 63.52 52.04 2.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.498 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.9 -65.56 2.56 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.703 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -87.78 118.73 27.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.57 131.9 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.645 HG13 ' HB3' ' A' ' 165' ' ' ASN . 17.4 pt -132.46 115.36 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.139 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 174' ' ' ILE . 28.5 tp -95.68 117.74 31.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.558 ' O ' ' HA3' ' A' ' 162' ' ' GLY . 3.2 mt-10 -114.42 57.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.278 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.593 HG13 ' OG ' ' A' ' 160' ' ' SER . 5.1 tp -98.29 88.44 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.043 0.925 . . . . 0.0 109.057 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.9 121.28 30.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.415 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.889 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 7.2 p -91.47 130.32 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.803 0.335 . . . . 0.0 110.147 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 158' ' ' LEU . 31.0 p -141.66 -159.51 0.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 1.006 ' HA ' HD12 ' A' ' 158' ' ' LEU . 84.8 tttt -66.69 141.42 57.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.752 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.512 ' HA ' ' OD1' ' A' ' 58' ' ' ASP . 3.0 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.24 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.799 0.687 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -73.09 134.86 44.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.85 45.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.791 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 52.01 10.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.39 52.53 0.22 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.56 46.48 0.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.119 0.485 . . . . 0.0 111.104 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -141.27 132.5 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.188 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.56 161.21 16.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.376 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.26 161.05 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.439 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.25 50.94 0.78 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.038 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.58 -37.26 0.07 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.369 0.604 . . . . 0.0 110.8 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 m -84.09 50.27 1.81 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.547 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -134.64 140.81 46.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.927 0.394 . . . . 0.0 110.987 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 18' ' ' ILE . 44.2 m -154.69 158.39 39.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' ' OE1' ' A' ' 173' ' ' GLU . 20.3 p90 -54.16 -28.57 41.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.717 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -70.8 -48.82 52.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 15' ' ' SER . 11.1 tp -62.31 -32.57 55.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.52 -39.3 81.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.997 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -66.33 -35.23 79.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.6 m -68.25 -40.01 82.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.43 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' ILE . 55.9 t -61.94 -45.02 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.229 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 32' ' ' LYS . 4.0 tt -71.75 -40.95 69.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.64 -37.63 87.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.334 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.28 48.75 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.475 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.86 32.3 1.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.094 0.474 . . . . 0.0 111.317 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 44.41 2.51 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.737 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.49 -40.94 69.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.401 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.98 154.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.742 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.85 -31.51 72.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.295 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -125.7 147.1 49.47 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.304 -0.247 . . . . 0.0 110.39 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 23' ' ' LEU . 10.2 tppt? -161.81 145.39 12.33 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.572 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 15.0 pt -114.1 128.57 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.619 0.247 . . . . 0.0 111.662 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -118.0 113.36 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 109.731 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 53.2 t -106.47 140.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.766 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.95 81.38 0.19 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 38.5 t -89.18 118.29 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.19 0.519 . . . . 0.0 111.717 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.708 ' HB3' ' HA ' ' A' ' 175' ' ' HIS . 12.1 t0 -79.04 89.53 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.064 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -76.72 110.63 11.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.412 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' THR . 8.8 tp10 -136.42 92.45 2.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.564 0.697 . . . . 0.0 109.932 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t -151.94 -31.1 0.16 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 95.44 38.0 4.89 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.306 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 20.3 pttm -124.23 137.17 54.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 20.2 p -105.74 127.75 53.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 111.356 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 31.5 m0 -96.51 151.35 19.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.615 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -108.26 -104.99 0.35 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HA ' ' CD2' ' A' ' 92' ' ' TYR . . . -172.84 118.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.317 0.508 . . . . 0.0 111.618 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 93' ' ' LEU . 43.0 tp -109.08 -58.59 2.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.687 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.438 HD22 ' HG ' ' A' ' 48' ' ' LEU . 15.4 p30 -179.87 158.58 0.78 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.112 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.88 126.28 21.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.612 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -140.28 138.51 35.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.586 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.5 m-85 -108.38 138.55 44.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.954 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG3' ' OE1' ' A' ' 130' ' ' GLN . 51.8 ttp180 -77.21 -36.15 55.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.721 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.903 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.9 m -125.89 -63.04 1.14 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.05 -143.9 5.23 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.355 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -161.72 -173.45 3.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.811 0.339 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.8 t -159.03 -159.85 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 1' ' ' SER . 18.4 m-20 -83.81 44.81 1.02 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.075 0.15 . . . . 0.0 110.929 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 HG23 HG22 ' A' ' 60' ' ' VAL . 11.2 tp 55.35 -54.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 126.108 1.763 . . . . 0.0 114.785 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 HG23 ' A' ' 59' ' ' ILE . 15.5 m -143.79 143.57 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.285 0.948 . . . . 0.0 112.005 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 3.1 pp -90.59 -177.04 0.71 Allowed Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.764 ' HD2' ' HB2' ' A' ' 61' ' ' LEU . 89.5 Cg_exo -45.06 140.74 7.04 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.988 2.459 . . . . 0.0 112.613 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.468 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 71.4 m-70 -77.34 12.98 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 62.4 mttm -164.97 135.25 3.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.015 0.436 . . . . 0.0 111.292 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' THR . 63.8 t -122.48 96.89 45.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 5.0 Cg_exo -82.05 -156.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.722 2.281 . . . . 0.0 113.912 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.847 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 52.6 p-80 -97.25 137.47 36.21 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.615 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.26 54.32 17.39 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.212 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -153.44 136.09 15.22 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.194 0.521 . . . . 0.0 111.114 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -88.58 132.66 34.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.75 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD11 HD13 ' A' ' 61' ' ' LEU . 49.2 tp -92.44 111.52 23.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 3.4 mm? -89.27 138.29 31.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.087 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.595 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 3.7 t80 -149.77 142.18 24.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 70.7 m-80 -142.93 136.85 28.98 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.615 ' H ' HG13 ' A' ' 33' ' ' ILE . . . -139.42 167.89 25.1 Favored Glycine 0 C--N 1.323 -0.167 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.139 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.72 150.87 28.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.659 0.266 . . . . 0.0 110.862 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 40.1 tptt -81.5 -28.78 33.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -47.5 121.99 4.39 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.46 0.475 . . . . 0.0 111.884 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -168.45 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.37 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.62 -152.29 7.42 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.463 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.5 -37.64 16.62 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 123.122 2.548 . . . . 0.0 113.591 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -63.2 130.18 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.621 0.724 . . . . 0.0 112.112 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 108' ' ' TYR . . . -120.87 141.84 50.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.191 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -157.99 -54.44 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 0.0 111.439 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . 141.0 -140.05 10.09 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.51 95.49 3.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.858 0.837 . . . . 0.0 111.313 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 28.5 t -122.1 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.936 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -161.99 165.21 35.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.775 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 95.5 t -136.4 133.2 49.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.867 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' H ' HG12 ' A' ' 102' ' ' VAL . 1.6 pp -108.23 145.86 33.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.493 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -138.02 114.09 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.005 0.431 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.582 ' OH ' ' HG ' ' A' ' 61' ' ' LEU . 8.7 m-85 -132.93 149.31 52.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.954 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 48' ' ' LEU . 2.7 mm? -76.09 138.2 40.64 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 111.909 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 31.3 tpp -90.43 -53.2 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 t -171.9 -74.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 111.527 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.9 46.85 1.43 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.174 0.511 . . . . 0.0 112.221 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.48 34.76 49.25 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.059 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -107.91 146.38 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.515 HG21 ' HB1' ' A' ' 91' ' ' ALA . 17.6 m -130.49 120.75 24.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD12 ' HE1' ' A' ' 94' ' ' MET . 4.7 tt -89.85 113.82 25.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -93.24 142.21 27.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.22 0.533 . . . . 0.0 111.852 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.766 HG23 HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -123.53 148.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.259 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 10.0 tt -133.39 140.19 47.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 87.6 m-85 -143.13 142.97 31.64 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 87' ' ' VAL . 22.9 t -146.29 127.04 14.34 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.069 0.231 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.8 t -135.48 126.22 17.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.845 ' HB3' ' HB3' ' A' ' 113' ' ' TYR . 4.2 Cg_exo -77.8 155.11 30.67 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.946 3.098 . . . . 0.0 114.068 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.456 ' HD2' ' HB1' ' A' ' 83' ' ' ALA . 7.8 t80 -126.9 40.34 3.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.221 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.07 -141.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.205 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -79.07 -170.67 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.128 0.489 . . . . 0.0 111.743 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -82.8 54.72 2.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.483 0.658 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -113.62 -46.87 3.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.904 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.845 ' HB3' ' HB3' ' A' ' 107' ' ' PRO . 1.5 t80 -84.78 143.65 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 p -115.95 152.18 33.98 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HB3' ' HE1' ' A' ' 164' ' ' MET . 55.2 m-80 -72.01 145.88 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 5.0 m-90 -141.44 149.85 41.54 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 49.2 p-90 -146.38 141.4 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 48.7 t30 -157.39 117.92 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.766 HG12 HG23 ' A' ' 102' ' ' VAL . 6.4 m -102.85 133.62 46.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.745 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HB3' ' HE1' ' A' ' 122' ' ' TYR . 32.6 ttm180 -162.14 140.46 9.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.747 0.308 . . . . 0.0 111.093 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mp -82.79 134.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 133' ' ' TYR . 36.0 m-85 -131.37 135.71 47.44 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -72.7 136.74 45.64 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.72 -0.613 . . . . 0.0 109.681 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.4 53.34 1.14 Allowed Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -27.77 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.43 -0.453 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 4.3 mmp_? -95.25 -42.07 8.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.346 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ARG . 15.9 mtp-105 74.21 128.67 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.125 0.891 . . . . 0.0 111.045 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 132' ' ' MET . . . -89.55 139.42 30.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 132' ' ' MET . 7.5 p-10 -154.71 -146.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.447 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 53' ' ' ARG . 1.1 tp-100 -75.38 -43.33 50.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.109 0.48 . . . . 0.0 109.927 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 50.5 mmm-85 -91.11 27.21 1.92 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.677 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 13.1 ptt? -72.29 -59.36 2.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.756 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.818 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 49.2 m-85 -143.26 25.99 1.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.891 0.377 . . . . 0.0 110.355 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -99.91 54.94 0.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.093 0.473 . . . . 0.0 110.547 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -144.94 -56.55 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.6 146.84 24.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.461 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.09 -42.53 99.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -86.06 45.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.818 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 2.3 m120 -125.63 -56.75 1.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.669 HD13 ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -98.15 141.21 31.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.187 0.518 . . . . 0.0 110.318 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.2 t -152.91 68.54 6.79 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.507 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.757 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 74.2 Cg_endo -77.13 159.16 33.74 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.733 2.289 . . . . 0.0 112.185 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -98.38 132.84 43.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.415 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -73.35 125.37 27.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.111 0.481 . . . . 0.0 111.809 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.95 143.07 28.4 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.08 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -166.91 138.17 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -45.89 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.931 0.769 . . . . 0.0 112.015 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.49 -130.12 1.18 Allowed Glycine 0 C--O 1.229 -0.193 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.34 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.919 ' HA ' ' HB3' ' A' ' 163' ' ' PHE . 1.6 p90 -168.62 145.72 3.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.87 157.4 3.63 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 161' ' ' ARG . 9.5 m -115.94 149.99 37.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -146.95 126.1 12.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.803 0.335 . . . . 0.0 110.845 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 75.4 m-20 -76.2 135.97 39.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.16 -36.28 58.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 118.78 -40.73 2.19 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.998 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -83.73 42.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.439 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.74 38.97 86.25 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.692 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 178' ' ' LYS . 81.9 mt -142.96 158.36 43.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.82 ' HG2' ' HA ' ' A' ' 179' ' ' ALA . 19.5 ptpt -149.25 134.46 18.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.173 0.511 . . . . 0.0 110.35 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 18.7 m -98.87 117.99 34.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.272 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.752 ' HG3' HG23 ' A' ' 151' ' ' THR . 0.8 OUTLIER -104.14 123.5 47.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 176.76 -147.56 8.5 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.083 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.919 ' HB3' ' HA ' ' A' ' 149' ' ' TRP . 7.7 p90 -167.21 152.22 7.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.567 0.698 . . . . 0.0 112.465 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' ' HB3' ' A' ' 115' ' ' ASN . 26.1 ttt -115.52 122.59 46.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.629 ' ND2' HG13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -137.02 140.31 42.02 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.751 -179.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.776 ' HB3' ' HA ' ' A' ' 170' ' ' ALA . 57.2 p -171.82 121.72 0.49 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -96.83 -11.77 24.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.989 0.9 . . . . 0.0 109.09 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.82 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 59.6 m170 -91.12 131.12 36.88 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.776 ' HA ' ' HB3' ' A' ' 166' ' ' SER . . . -95.07 135.57 36.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.835 HG22 ' HB3' ' A' ' 34' ' ' ALA . 7.2 pt -140.89 131.67 27.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.018 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.458 HD13 ' HE2' ' A' ' 104' ' ' PHE . 3.9 mp -117.84 125.76 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.897 0.379 . . . . 0.0 111.134 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 16' ' ' PHE . 69.5 tt0 -118.55 77.41 1.17 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.957 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.687 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 21.7 pt -115.51 128.31 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.393 0.616 . . . . 0.0 111.529 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 38' ' ' ASP . 32.8 m170 -104.68 122.11 44.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.148 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 5.1 p -103.79 121.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.726 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 73.6 p -130.77 -160.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.788 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.569 ' HA ' HD23 ' A' ' 158' ' ' LEU . 83.5 tttt -74.21 143.59 45.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.55 0.214 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.82 ' HA ' ' HG2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.708 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.592 0.234 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.8 -50.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.71 135.5 35.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 p 42.25 55.41 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.146 0.978 . . . . 0.0 112.549 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.48 124.26 7.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.658 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.62 -58.2 0.07 OUTLIER Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.711 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.79 125.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 112.592 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.62 130.59 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.922 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 13' ' ' SER . 28.3 pt -101.84 165.86 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 123.546 0.529 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.37 143.75 55.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.232 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.658 ' H ' ' HA ' ' A' ' 69' ' ' LYS . . . -69.17 52.49 0.58 Allowed Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.22 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.58 -27.26 0.55 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.871 0.367 . . . . 0.0 111.498 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 9' ' ' ILE . 9.6 t -86.41 -33.78 20.35 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.93 174.72 6.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.801 0.81 . . . . 0.0 112.957 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.1 p -169.18 -174.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.213 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -62.24 -25.29 67.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.767 0.318 . . . . 0.0 110.776 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.1 -44.53 68.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.0 mp -60.11 -40.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.04 -39.41 89.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.006 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.64 -43.54 89.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -56.26 -48.89 75.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.954 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' ILE . 96.1 t -56.76 -41.55 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.509 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -64.49 -46.33 83.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.919 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -56.83 -41.56 78.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.462 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.28 -51.51 69.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 5.2 mp -83.24 46.7 1.15 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.442 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.85 56.87 1.37 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 116.368 -0.378 . . . . 0.0 113.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -84.31 -42.7 15.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.549 0.69 . . . . 0.0 109.943 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.88 150.12 26.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -83.45 40.31 0.71 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.807 0.337 . . . . 0.0 111.499 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' NH1' ' HA2' ' A' ' 168' ' ' GLY . 10.6 tpt180 -169.35 85.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.579 ' NZ ' ' HB3' ' A' ' 26' ' ' LEU . 46.4 mtpt -135.85 162.04 33.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.145 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 24.9 mt -108.94 136.36 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.783 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.825 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -128.26 119.86 26.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 46.3 t -116.73 143.12 27.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.141 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.06 77.5 0.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.93 118.77 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.821 0.343 . . . . 0.0 111.648 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 14.2 m-20 -84.62 91.05 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.216 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 176' ' ' VAL . 0.9 OUTLIER -75.39 114.22 13.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.687 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 177' ' ' THR . 31.4 mt-10 -140.21 92.89 2.57 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 121.451 0.643 . . . . 0.0 111.75 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -142.4 -80.8 0.22 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.77 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.33 48.87 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HG3' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -142.81 145.42 33.2 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -106.58 120.87 43.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 33.0 m0 -93.01 160.38 14.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.554 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -122.13 -120.18 0.29 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.56 116.87 3.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HG ' ' A' ' 93' ' ' LEU . 7.6 tt -103.34 -51.61 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.487 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -177.97 148.02 0.49 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.134 0.272 . . . . 0.0 110.368 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.818 HG21 HD13 ' A' ' 61' ' ' LEU . 11.7 p -140.62 118.35 11.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.962 0.411 . . . . 0.0 110.744 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -137.23 142.24 42.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 68.5 m-85 -99.64 158.94 15.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.29 0.567 . . . . 0.0 111.499 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HB3' HG13 ' A' ' 87' ' ' VAL . 33.7 ttm180 -92.18 -26.64 18.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.2 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . 3.1 t -145.85 -78.45 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 54' ' ' SER . . . -75.83 -144.6 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.626 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 t -166.76 156.13 10.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.544 0.688 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 40.1 t -124.09 -53.55 1.73 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.008 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -165.46 142.8 5.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.716 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 60' ' ' VAL . 1.9 pp -79.06 -21.03 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 59' ' ' ILE . 10.3 m -133.43 136.92 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.438 0.637 . . . . 0.0 111.101 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD13 HG21 ' A' ' 50' ' ' THR . 6.1 mp -120.65 156.27 56.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.04 136.06 74.41 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.965 2.443 . . . . 0.0 111.652 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.488 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 32.8 p-80 -93.6 44.08 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 52.6 mttm -161.64 113.67 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.756 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 80.6 t -130.66 87.61 49.18 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 67' ' ' HIS . 4.8 Cg_exo -78.5 -119.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.599 2.866 . . . . 0.0 113.285 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 47.0 p-80 -146.33 143.09 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.128 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.85 38.95 22.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.934 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' ' H ' ' A' ' 11' ' ' GLY . 86.1 mttt -149.22 143.85 26.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.451 0.167 . . . . 0.0 111.128 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -97.8 127.75 43.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.662 0.267 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.87 111.78 22.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.06 141.8 31.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.77 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -150.5 150.26 31.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 8.2 p-10 -155.27 123.31 5.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.302 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -111.21 156.09 15.75 Favored Glycine 0 C--O 1.239 0.416 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.322 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HB3' ' H ' ' A' ' 77' ' ' LYS . 9.7 mm100 -116.01 -138.78 0.37 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.812 -0.694 . . . . 0.0 111.008 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 76' ' ' GLN . 60.4 pttt -149.13 144.95 26.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.87 -53.17 35.03 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.475 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 72.04 131.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.202 1.001 . . . . 0.0 112.181 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.71 -138.94 4.23 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.16 -41.61 9.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.978 2.452 . . . . 0.0 112.346 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 t -104.76 142.0 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.464 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.38 123.95 28.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.812 0.339 . . . . 0.0 110.515 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -143.0 142.87 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.32 -118.28 1.68 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLN . . . -145.2 133.74 22.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.344 0.592 . . . . 0.0 112.054 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 53' ' ' ARG . 1.6 p -151.68 138.38 12.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 52' ' ' PHE . . . -166.56 159.3 32.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 103' ' ' LEU . 85.2 t -119.49 135.25 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.213 0.605 . . . . 0.0 110.863 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.0 OUTLIER -117.2 145.05 44.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' HG21 ' A' ' 99' ' ' THR . . . -139.71 125.44 19.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.238 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' HE1' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -126.77 144.16 51.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.468 -179.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -77.87 132.38 37.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.728 ' SD ' ' HG3' ' A' ' 43' ' ' LYS . 17.6 tpp -79.6 -47.7 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.154 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 t -169.53 -62.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.101 0.477 . . . . 0.0 111.616 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.95 -53.02 4.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.398 0.618 . . . . 0.0 110.505 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.25 39.61 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.841 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 1.7 p-10 -110.62 126.84 54.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.721 HG21 ' HB1' ' A' ' 91' ' ' ALA . 1.5 m -110.46 119.97 40.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 154' ' ' LEU . 5.0 tt -88.19 109.0 19.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.53 32.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.266 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 HG12 ' A' ' 119' ' ' VAL . 21.7 t -126.25 137.59 57.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' TRP . 3.2 tm? -117.03 145.84 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 111.055 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.6 ' H ' HD22 ' A' ' 103' ' ' LEU . 98.5 m-85 -142.11 143.1 32.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 8.4 t -159.84 132.11 6.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.885 0.374 . . . . 0.0 111.895 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.3 t -143.04 111.62 5.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.162 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.661 ' HG2' ' H ' ' A' ' 114' ' ' SER . 22.1 Cg_exo -68.01 168.72 18.17 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.656 2.904 . . . . 0.0 112.761 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.491 ' HD1' ' HG2' ' A' ' 31' ' ' ARG . 19.7 t80 -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 t70 70.3 -71.49 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -66.56 145.15 55.93 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -66.85 -26.44 66.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.17 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -76.72 55.95 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.385 0.612 . . . . 0.0 111.115 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -98.7 135.78 39.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.661 ' H ' ' HG2' ' A' ' 107' ' ' PRO . 67.5 m -140.61 127.97 21.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.553 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 164' ' ' MET . 6.5 m120 -75.97 143.58 41.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 6.5 m0 -133.97 139.0 45.8 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.038 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.652 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 65.7 p-90 -146.33 140.49 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.543 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.823 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 31.6 t30 -156.1 116.29 3.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 102' ' ' VAL . 3.4 m -103.4 133.49 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.717 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -165.13 148.29 8.3 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.144 0.429 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.53 HD13 ' HG ' ' A' ' 100' ' ' LEU . 24.0 mm -80.82 129.25 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 5.9 m-85 -121.01 67.47 0.87 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.203 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 13.8 tmtt? -66.06 126.16 27.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.501 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.9 43.71 93.24 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.983 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 34.5 ttpt -80.77 127.91 33.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.39 51.72 2.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 71.47 125.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.51 0.724 . . . . 0.0 111.795 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.983 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . . . -101.79 141.67 34.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.995 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.91 -154.19 0.25 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -61.62 -51.37 68.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 111.475 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -62.03 -25.83 67.89 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -48.69 67.4 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.731 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 3.5 m-85 -85.39 -49.55 8.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.092 0.472 . . . . 0.0 111.687 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -78.25 67.19 4.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.673 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -159.78 -70.93 0.08 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.454 0.645 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 139' ' ' ASN . 96.0 mt -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.09 64.86 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.18 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -164.42 -25.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.537 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.523 HD21 ' HB2' ' A' ' 136' ' ' LEU . 1.5 p30 -89.28 -41.02 12.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.731 ' HB3' ' HB3' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -87.53 130.22 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.662 0.744 . . . . 0.0 110.235 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.4 t -175.36 67.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.795 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.823 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 62.9 Cg_endo -72.64 140.12 32.14 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 121.882 1.721 . . . . 0.0 112.725 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.29 134.53 33.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.495 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.87 127.93 34.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.29 133.11 11.66 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.916 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.36 139.61 21.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 165' ' ' ASN . 15.4 m-80 -52.28 94.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.618 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.52 -140.14 2.89 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.237 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -171.65 132.52 0.74 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.716 0.258 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.76 160.8 28.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 160' ' ' SER . 1.0 OUTLIER -103.84 148.81 25.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.113 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -153.21 128.53 9.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 0.0 110.918 177.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -78.75 135.39 37.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.947 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -75.98 -37.98 57.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 0.0 111.545 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.96 -45.01 1.16 Allowed Glycine 0 N--CA 1.454 -0.114 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.103 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.0 -36.9 83.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 110.062 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 160.01 -35.33 0.45 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 154' ' ' LEU . 7.0 mp -61.64 148.91 40.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.605 -0.797 . . . . 0.0 110.412 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -138.63 132.56 31.15 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.548 ' HB3' HD11 ' A' ' 174' ' ' ILE . 15.6 m -93.56 132.03 38.24 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.837 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.2 ttp-105 -121.34 105.41 10.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.356 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.97 ' HA3' ' HA ' ' A' ' 174' ' ' ILE . . . 165.42 -158.01 30.7 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.793 ' HB2' ' HA ' ' A' ' 149' ' ' TRP . 0.5 OUTLIER -175.86 146.38 0.72 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.661 0.73 . . . . 0.0 112.424 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.593 ' H ' ' HD1' ' A' ' 163' ' ' PHE . 23.8 ttt -85.6 135.36 33.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.757 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.554 ' HB2' ' CG ' ' A' ' 147' ' ' ASN . 15.7 p30 -121.98 143.53 49.42 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.809 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.9 p -88.97 -123.85 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.483 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.4 m 71.71 48.41 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.78 0.8 . . . . 0.0 110.69 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.607 ' HA2' ' NH1' ' A' ' 31' ' ' ARG . . . 81.42 -70.88 3.02 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.569 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -89.2 128.55 35.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -100.27 135.07 42.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.825 HG22 ' HB3' ' A' ' 34' ' ' ALA . 6.0 pt -139.9 141.08 34.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.95 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 164' ' ' MET . 2.8 mp -107.92 107.41 18.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.83 61.41 1.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.97 ' HA ' ' HA3' ' A' ' 162' ' ' GLY . 15.2 tt -123.46 127.17 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.571 0.7 . . . . 0.0 111.634 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ASP . 14.1 m170 -111.1 138.01 48.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 6.9 p -102.41 131.03 51.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.939 0.4 . . . . 0.0 110.568 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 1.1 p -132.38 160.26 36.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.829 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -73.49 75.19 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.827 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.568 0.223 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.64 123.34 23.84 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.77 131.4 35.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.91 -44.21 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.02 -44.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.01 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 55.0 5.88 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.398 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 50.0 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.106 0.479 . . . . 0.0 111.582 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m -139.0 140.34 38.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.641 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -144.48 174.16 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 152.04 39.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.372 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.65 56.73 2.11 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.519 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -33.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.8 -0.7 . . . . 0.0 110.797 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -76.13 -31.96 58.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.68 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.64 159.49 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.406 0.622 . . . . 0.0 111.968 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.0 m -155.98 157.95 37.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.516 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -59.59 -26.68 65.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -64.97 -44.31 89.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -59.98 -41.08 84.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HB3' HG21 ' A' ' 171' ' ' ILE . 18.5 mt -59.8 -39.66 85.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.349 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.1 -42.91 99.68 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.6 m -60.06 -47.58 85.28 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.196 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 74.7 t -61.04 -39.93 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.913 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.75 -54.24 48.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.41 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -68.65 -43.62 75.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -26.93 67.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -68.09 -41.45 81.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.306 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.57 133.86 1.63 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.184 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -87.41 39.34 0.87 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.04 -168.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 111.413 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.9 -42.73 80.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.932 ' HA ' ' HB3' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -158.03 158.77 35.45 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HE2' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -156.05 123.46 5.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.419 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 3.6 mp -93.11 108.61 20.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 171' ' ' ILE . . . -96.93 105.31 17.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.596 0.712 . . . . 0.0 110.501 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 85.2 t -86.69 142.71 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.118 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.57 71.51 0.26 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.22 116.46 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.731 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB2' ' CD2' ' A' ' 175' ' ' HIS . 2.0 t0 -80.62 95.76 6.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.943 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 176' ' ' VAL . 71.1 m-80 -84.66 109.77 18.25 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 67' ' ' HIS . 5.5 tp10 -129.68 47.67 2.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.278 1.037 . . . . 0.0 108.894 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 52.4 m -85.41 -23.39 27.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.616 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 67' ' ' HIS . . . 81.75 38.78 13.11 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.4 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HD2' ' SD ' ' A' ' 94' ' ' MET . 4.5 pttm -160.0 137.14 9.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.599 0.36 . . . . 0.0 110.396 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.0 p -78.75 121.52 24.86 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 30.9 m0 -91.45 129.53 37.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.21 -130.86 0.08 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 61' ' ' LEU . . . -154.23 117.9 4.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.14 -59.7 1.67 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.144 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -174.13 163.73 3.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.252 0.548 . . . . 0.0 110.72 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.3 p -142.61 127.14 17.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.471 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -134.17 128.8 34.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.897 0.379 . . . . 0.0 110.405 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HA ' ' CA ' ' A' ' 88' ' ' GLY . 47.8 m-85 -106.54 142.67 35.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.25 0.547 . . . . 0.0 111.613 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.858 ' HB3' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.06 -30.77 65.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -143.84 -79.0 0.21 Allowed 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.664 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.3 -143.52 0.22 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.811 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -165.8 -176.59 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.341 -0.505 . . . . 0.0 111.254 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 33.4 t -157.33 -52.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 134.64 3.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.558 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -81.34 -28.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.33 135.15 64.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.077 -0.389 . . . . 0.0 111.057 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 98.7 mt -77.97 165.98 46.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.358 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 61' ' ' LEU . 18.6 Cg_endo -59.19 -106.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.645 2.897 . . . . 0.0 114.515 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' PRO . 38.3 p-80 -154.56 -48.36 0.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.885 -0.509 . . . . 0.0 112.287 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 66.1 mttm -151.28 129.5 11.95 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 122.28 -0.262 . . . . 0.0 111.355 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 45' ' ' TRP . 60.0 t -114.04 88.26 14.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 69' ' ' LYS . 3.7 Cg_exo -75.71 -156.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.753 2.302 . . . . 0.0 113.236 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 43.9 p-80 -94.01 140.26 29.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.62 44.62 20.27 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.763 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.858 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 57.7 mtpt -147.84 126.15 12.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 111.064 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.12 141.37 28.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.719 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.32 112.95 25.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.9 tt -109.94 125.79 53.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.864 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -150.32 148.71 29.16 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 120.843 0.354 . . . . 0.0 110.918 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 10.5 p-10 -115.3 123.62 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.255 0.55 . . . . 0.0 111.669 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -93.32 148.79 19.17 Favored Glycine 0 C--O 1.237 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.09 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -139.48 141.92 37.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 0.0 111.053 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 83' ' ' ALA . 43.0 tttm -80.4 -27.77 38.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -58.46 123.47 16.31 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -167.87 -28.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.564 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.55 -130.73 1.3 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.3 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 82' ' ' VAL . 7.0 Cg_exo -74.86 -135.79 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.439 2.759 . . . . 0.0 112.59 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' H ' ' HB2' ' A' ' 81' ' ' PRO . 27.4 m -67.68 139.36 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.816 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -145.5 156.78 43.93 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.59 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.583 ' HA ' ' CD1' ' A' ' 108' ' ' TYR . 7.8 m -80.44 -3.42 49.8 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 77' ' ' LYS . . . 115.48 -106.38 1.57 Allowed Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.382 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.41 111.58 5.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.728 0.775 . . . . 0.0 110.929 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' A' ' 53' ' ' ARG . 3.4 p -148.98 137.0 14.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 52' ' ' PHE . . . 175.91 175.58 43.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.275 -1.44 . . . . 0.0 114.106 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.996 HG22 ' HG ' ' A' ' 103' ' ' LEU . 21.4 t -129.37 134.45 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.974 -0.613 . . . . 0.0 111.799 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 102' ' ' VAL . 1.6 pt? -116.86 147.42 42.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.656 ' HB1' ' CG2' ' A' ' 99' ' ' THR . . . -144.12 127.96 17.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.496 0.665 . . . . 0.0 112.208 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.08 147.73 49.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.334 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.03 137.38 38.94 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.676 ' SD ' ' HD2' ' A' ' 43' ' ' LYS . 43.6 ttm -92.33 -60.83 1.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 t -171.07 -61.73 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 111.872 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -89.05 43.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.949 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.52 42.94 95.43 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.43 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -121.56 139.3 53.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 91' ' ' ALA . 6.3 m -119.85 125.12 47.75 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' HD13 ' A' ' 121' ' ' ILE . 2.9 tt -89.13 119.57 29.75 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' LEU . . . -103.59 135.97 44.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.828 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 119' ' ' VAL . 37.9 t -130.46 137.27 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.996 ' HG ' HG22 ' A' ' 89' ' ' VAL . 6.4 mp -115.97 149.35 38.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 11.8 m-85 -138.47 145.73 41.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' TRP . 21.8 t -156.18 125.39 6.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.175 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 167' ' ' SER . 4.7 p -147.94 128.69 6.95 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.196 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' A' ' 113' ' ' TYR . 58.1 Cg_endo -69.4 154.82 68.61 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.291 2.66 . . . . 0.0 113.212 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.583 ' CD1' ' HA ' ' A' ' 84' ' ' THR . 22.1 p90 -82.98 40.26 0.68 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.245 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 49.68 52.34 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.989 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.91 -35.52 7.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.416 ' HA ' HD22 ' A' ' 111' ' ' ASN . 0.5 OUTLIER -141.26 -129.51 0.1 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -135.19 47.49 2.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.416 ' HB2' ' HG3' ' A' ' 107' ' ' PRO . 6.6 m-85 -68.89 141.17 55.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.1 m -80.64 152.46 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 167' ' ' SER . 4.4 m120 -74.46 153.75 39.02 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.797 ' HB3' ' HB2' ' A' ' 142' ' ' PRO . 4.5 m-90 -142.35 138.14 31.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.824 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.644 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 28.7 p-90 -139.72 145.28 38.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.919 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' HB2' ' HA ' ' A' ' 142' ' ' PRO . 45.0 t30 -158.13 111.07 2.39 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.614 . . . . 0.0 112.362 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 102' ' ' VAL . 18.4 m -101.7 135.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.549 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -166.57 149.04 6.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 156' ' ' TYR . 30.9 mm -85.98 131.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.139 0.495 . . . . 0.0 112.0 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -123.19 133.86 54.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.452 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.731 ' HD2' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -70.74 136.94 49.25 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.142 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.0 50.72 1.56 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.396 -0.366 . . . . 0.0 113.758 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.03 -26.75 11.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 110.39 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -143.9 141.89 30.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.38 131.44 35.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.813 0.34 . . . . 0.0 110.298 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 132' ' ' MET . . . -76.07 143.03 41.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.177 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.56 ' H ' ' HB2' ' A' ' 132' ' ' MET . 5.0 t0 -159.96 -176.82 5.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.625 ' HA ' ' HB2' ' A' ' 134' ' ' GLU . 81.6 mt-30 -52.51 -36.22 54.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -83.67 -13.98 52.89 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.612 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 90.2 mmm -78.69 -58.03 3.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 140' ' ' LEU . 36.6 m-85 -136.16 -37.13 0.72 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . 1.9 mm-40 -54.78 159.93 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 73.48 -46.51 0.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.717 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.37 120.06 21.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -71.89 -39.87 69.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -64.99 -30.07 71.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.411 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.32 -37.56 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -136.05 129.08 31.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.207 0.527 . . . . 0.0 110.78 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.522 ' N ' HD13 ' A' ' 140' ' ' LEU . 1.5 p -139.95 104.78 6.78 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.793 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.797 ' HB2' ' HB3' ' A' ' 116' ' ' TRP . 6.2 Cg_exo -78.94 166.85 22.81 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.535 2.823 . . . . 0.0 112.473 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' TRP . 1.5 t80 -90.68 142.93 27.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 115' ' ' ASN . 99.6 mtt180 -71.29 116.45 11.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.975 0.417 . . . . 0.0 110.889 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.49 131.03 11.16 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.743 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -167.09 142.15 4.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -47.14 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.19 0.931 . . . . 0.0 113.174 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.46 128.9 1.22 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.773 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 1.2 p90 -78.71 138.24 38.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.2 0.524 . . . . 0.0 111.039 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.62 142.52 5.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.933 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.858 ' HB ' ' HG2' ' A' ' 161' ' ' ARG . 11.1 t -116.61 157.6 25.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.496 0.665 . . . . 0.0 111.788 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -171.94 152.26 2.93 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.473 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 159' ' ' LYS . 16.7 p30 -66.85 138.28 57.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.274 0.559 . . . . 0.0 111.244 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 156' ' ' TYR . 3.1 pp -75.9 -23.76 55.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.18 -47.05 0.93 Allowed Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.104 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.775 ' HB2' HG13 ' A' ' 121' ' ' ILE . 13.9 t80 -72.49 -43.93 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 179' ' ' ALA . . . 171.41 -41.21 0.18 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 178' ' ' LYS . 2.5 mm? -63.3 165.06 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 0.0 110.79 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.695 ' HE2' ' HA ' ' A' ' 179' ' ' ALA . 39.5 mtmt -128.12 149.08 50.57 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.659 ' OG ' HG12 ' A' ' 174' ' ' ILE . 8.5 t -120.98 125.06 46.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.858 ' HG2' ' HB ' ' A' ' 151' ' ' THR . 91.4 mtt-85 -94.2 106.56 18.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.905 ' HA2' ' HA ' ' A' ' 174' ' ' ILE . . . -114.42 149.38 18.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 119.75 -1.214 . . . . 0.0 115.236 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 173' ' ' GLU . 72.3 t80 -134.12 75.33 1.59 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.412 ' SD ' ' HD1' ' A' ' 117' ' ' TRP . 17.5 ttt -78.4 124.88 28.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.871 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.68 130.67 51.19 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.6 p 0.72 75.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.478 1.736 . . . . 0.0 115.037 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.686 ' HB3' ' HB ' ' A' ' 106' ' ' VAL . 11.2 t -7.84 -51.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.602 ' CA ' HG21 ' A' ' 106' ' ' VAL . . . -60.28 -106.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.828 0 CA-C-N 118.809 0.731 . . . . 0.0 113.055 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.932 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -79.17 77.4 5.68 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -163.25 -140.38 0.05 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.306 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 34' ' ' ALA . 30.2 pt -154.6 163.17 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 104' ' ' PHE . 21.1 tp -125.34 102.32 7.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 163' ' ' PHE . 64.8 tt0 -94.31 57.24 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.593 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.905 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 14.4 tt -96.35 123.92 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.526 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 38' ' ' ASP . 42.0 m170 -116.1 124.47 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.636 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 160' ' ' SER . 28.9 m -96.73 127.09 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.879 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 40' ' ' GLU . 19.3 p -147.36 -175.9 5.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.588 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HA ' HD12 ' A' ' 158' ' ' LEU . 21.5 ptmt -63.98 145.13 56.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.991 0.424 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.695 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 stop_ save_